# **II**

# **Ischemic Heart Disease**

# **Stenotic Arteriosclerotic Coronary Artery Disease 7**

| Definition      354<br>Historical Note      354<br>Morphology      355<br>DEVELOPMENT OF CORONARY ARTERY<br>STENOSIS<br>355                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | Coexisting Conditions<br>366<br>Older Age<br>366<br>Diabetes<br>366<br>Hypertension<br>366<br>Gender<br>366                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| MYOCARDIAL INFARCTION AND MORPHOLOGIC<br>SEQUELAE<br>355                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | Other Comorbidity<br>366<br>Technique of Operation      366                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| ATHEROSCLEROTIC PLAQUE RUPTURE AND<br>THROMBOSIS<br>356                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | PREOPERATIVE PREPARATION<br>367<br>OPERATING ROOM PREPARATION<br>367                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Clinical Features and Diagnostic Criteria      356                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | SURGICAL STRATEGY<br>367                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| ROUTINE METHODS<br>356<br>CORONARY ANGIOGRAPHY<br>356<br>Recording and Reporting Data<br>357<br>COMPUTED TOMOGRAPHIC ANGIOGRAPHY<br>357<br>CORONARY INTRAVASCULAR ULTRASOUND<br>357<br>CORONARY ARTERY PRESSURE AND FRACTIONAL<br>FLOW RESERVE<br>357<br>LEFT VENTRICULAR FUNCTION TESTING<br>357<br>Resting and Exercise Tests<br>357<br>Systolic and Diastolic Function<br>359<br>Global and Segmental Function<br>359<br>Load-Independent Function<br>360<br>Natural History      360<br>STENOTIC CORONARY ARTERY DISEASE<br>360<br>LEFT VENTRICULAR DYSFUNCTION<br>360<br>Stress-Induced Dysfunction<br>360<br>Dysfunction at Rest<br>361<br>UNFAVORABLE OUTCOME EVENTS<br>361<br>Stable Angina<br>361<br>Unstable Angina<br>361<br>Acute Myocardial Infarction<br>362<br>Death<br>362 | CORONARY ARTERY BYPASS GRAFTING<br>367<br>With Cardiopulmonary Bypass<br>367<br>Without Cardiopulmonary Bypass<br>371<br>VEIN GRAFT<br>373<br>ARTERIAL GRAFTS<br>376<br>Internal Thoracic Artery<br>376<br>Radial Artery<br>379<br>Right Gastroepiploic Artery<br>379<br>Inferior Epigastric Artery<br>379<br>Splenic Artery<br>379<br>DISTAL ANASTOMOSES<br>381<br>CORONARY ARTERY ENDARTERECTOMY<br>383<br>PROXIMAL ANASTOMOSES<br>384<br>EMERGENCY OPERATION FOR CARDIOGENIC<br>SHOCK<br>385<br>REOPERATION<br>386<br>Secondary Median Sternotomy<br>386<br>Left Thoracotomy<br>387<br>Special Features of Postoperative<br>Care      387<br>EARLY POSTOPERATIVE CARE<br>387<br>LATE POSTOPERATIVE CARE<br>387 |
| INCREMENTAL RISK FACTORS FOR UNFAVORABLE<br>OUTCOME EVENTS<br>362                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | FACILITATION OF COMPLETE<br>RECOVERY<br>387                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Reduced Regional Coronary Flow Reserve<br>363<br>Progression of Coronary Arteriosclerosis<br>365<br>Coronary Arteriosclerotic Plaques<br>365                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | PROMOTION OF GRAFT PATENCY<br>388<br>CONTROL OF RISK FACTORS FOR<br>ARTERIOSCLEROSIS<br>388                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Myocardial Scar<br>365                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | SURVEILLANCE FOR RECURRENT MYOCARDIAL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Secondary Conditions<br>365                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | ISCHEMIA<br>388                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Hemodynamic Instability<br>365                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | Results      388                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Ischemic Instability<br>365<br>Ventricular Electrical Instability<br>365                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | EARLY (HOSPITAL) DEATH<br>388<br>TIME-RELATED SURVIVAL<br>389                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

MORBIDITY 389 Adverse Cerebral Outcomes 389 Mediastinitis 389 Renal Dysfunction 389 MODES OF DEATH 390 INCREMENTAL RISK FACTORS FOR PREMATURE DEATH 390 RETURN OF ANGINA 395 MYOCARDIAL INFARCTION 397 SUDDEN DEATH 397 FAILURE TO WORK 399 UNSATISFACTORY QUALITY OF LIFE 399 NEUROBEHAVIORAL AND NEUROLOGIC OUTCOMES 400 USE OF MEDICATION 401 FUNCTIONAL CAPACITY 401 LEFT VENTRICULAR FUNCTION 401 Resting Perfusion 401 Exercise 401 Ventricular Arrhythmias 402 CORONARY FLOW RESERVE 402 GRAFT PATENCY 402 Internal Thoracic Arteries 402 Other Arterial Grafts 403 Saphenous Vein Grafts 403 Other Vein Grafts 404 POSTOPERATIVE PROGRESSION OF NATIVE CORONARY ARTERY DISEASE 404 SUBSEQUENT REINTERVENTION 404 **Indications for Operation 405** STABLE ANGINA 405 NUMBER OF SYSTEMS WITH IMPORTANT STENOSES 408 Left Main Stenosis 408 Three-System Disease 408 Two-System Disease 408 Single-System Disease 408 LEFT VENTRICULAR FUNCTION 408 UNSTABLE ANGINA 409 UNCOMPLICATED NON–Q-WAVE MYOCARDIAL INFARCTION OR NON–ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 409 UNCOMPLICATED Q-WAVE OR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION 409 MYOCARDIAL INFARCTION WITH HEMODYNAMIC DETERIORATION 410 ACUTE COMPLICATIONS DURING PERCUTANEOUS CORONARY INTERVENTION 410 RECURRING MYOCARDIAL ISCHEMIA 410 **Special Situations and Controversies 410** CORONARY ARTERY BYPASS SURGERY VERSUS PERCUTANEOUS CORONARY INTERVENTION 410 ENDARTERECTOMY 412 SURGICAL ANGIOPLASTY 412 SMALL DISTAL VESSELS 412 TRANSMYOCARDIAL LASER REVASCULARIZATION 412 GENE THERAPY 412 COMBINED CAROTID AND CORONARY ARTERY DISEASE 413 CORONARY ARTERY ANEURYSM AND DISSECTION 413

### DEFINITION

Stenotic atherosclerotic coronary artery disease (CAD) is narrowing of the coronary arteries caused by thickening and loss of elasticity of their walls (arteriosclerosis) that, when sufficiently severe, limits blood flow to the myocardium. Initially, the disease limits only coronary flow reserve (increase in flow that normally accompanies increased myocardial oxygen demands), but when sufficiently advanced, CAD reduces blood flow through the affected artery even at rest. In its most severe form, atherosclerotic CAD occludes the coronary artery.

### HISTORICAL NOTE

Development of coronary cineangiography by Sones and Shirey at the Cleveland Clinic during the early 1960s made possible direct identification of stenotic and occlusive atherosclerotic lesions in the coronary arteries during life and laid the foundation for coronary artery surgery.S53 Sporadic surgical attempts to improve coronary blood flow had previously been made, but these efforts were ineffective because of lack of precise anatomic diagnosis. In 1951 in Montreal, Vineberg and Miller reported direct implantation of an internal thoracic artery (ITA), also known as the internal mammary artery (IMA), into the myocardium.V11 More than a decade later, the Cleveland Clinic group demonstrated that this procedure brought new blood to the left ventricular (LV) myocardium,E10 but the new blood flow was too limited in quantity and distribution to be effective. In 1954, Murray and colleagues were considering a direct surgical approach to CAD and reported experimental studies of anastomosing the ITA to a coronary artery.M33 Shortly thereafter, Longmire and colleagues at the University of California in Los Angeles reported a series of patients in whom direct-vision coronary endarterectomy was performed without cardiopulmonary bypass (CPB).L20 Subsequently, CPB was used to facilitate the operation, and Senning reported patch grafting of a stenotic coronary artery in 1961.S23 At about this time, Effler and colleagues at the Cleveland Clinic began their pioneering efforts to achieve myocardial revascularization by a direct surgical attack on stenotic coronary lesions, as demonstrated by Sones using coronary angiography.E9,S39

Largely overlooked is the first operation for CAD by Kolesov in Leningrad in 1964, in which the ITA was anastomosed to the left anterior descending coronary artery (LAD).K22,K23 Probably without knowledge of this contribution, in May 1967, Favaloro and Effler at the Cleveland Clinic began performing reversed saphenous vein bypass grafting,F6 and by January 1971, this group had performed 741 such operations.L22 Even earlier, Garrett, at that time working with DeBakey in Houston, successfully performed a reversed saphenous vein coronary artery bypass graft to the LAD in an unplanned wayG10; at restudy 7 years later, the vein graft was patent.

Progress was rapid after this early era. In 1968 in New York, Green and colleagues re-reported anastomosing the distal end of the left ITA to the LADG26 using a dissecting microscope, and Edwards and colleagues began using this procedure at UAB in 1969.E8 In Milwaukee in 1971, Flemma, Johnson, and Lepley described the technique and advantages of *sequential grafting*, in which one vein was used for several distal anastomoses.F12 Advantages of this technique were further amplified by the reports of Bartley, Bigelow, and PageB9 in 1972 and Sewell in 1974.S32 Bilateral ITA grafting was performed at least by 1972 and probably as early as 1968.K5 Thus, within a very short time, the foundations were laid for rapid worldwide adoption of coronary artery bypass grafting (CABG).

# MORPHOLOGY

# Development of Coronary Artery Stenosis

Atherosclerosis, the most common form of arteriosclerosis, is a process that in coronary arteries, as in other blood vessels, consists of focal intimal accumulations of lipids, complex carbohydrates, blood and blood products, fibrous tissue, and calcium deposits, as well as associated changes in the media. Lipoid foci are associated with or converted into plaques of fibrous or hyaline connective tissue, although at least some atherosclerotic plaques may result from organization of thrombi.R16

Fibrolipoid plaques may become thick enough to encroach on the lumen of the artery, producing a stenotic lesion. Probably episodically and at times over a period of years, new material is deposited on the luminal side of the plaque, resulting in further narrowing and sometimes complete coronary occlusion. Small blood vessels form around and within the plaque. Gradual regression of plaque enlargement, seen clinically as regression of stenoses in a few patients,S42 and development of collateral coronary blood flow can result in at least partial spontaneous restoration of antegrade regional myocardial blood flow.

*Hemorrhage* may occur suddenly within a plaque (see "Atherosclerotic Plaque Rupture and Thrombosis" later in chapter); occasionally this may suddenly increase the degree of coronary stenosis and precipitate acute myocardial infarction (MI) or unstable angina pectoris. *Thrombosis* occasionally complicates the coronary atherosclerotic process, generally when there is luminal narrowing. Sudden complete obstruction may result, and it is generally agreed that acute thrombotic occlusion is the genesis of acute MI in most patients. Rapid recanalization frequently follows this process. *Platelet aggregation* within the lumen of an already narrowed coronary artery may induce thrombosis or suddenly narrow the lumen and provoke an acute MI or unstable angina, and it may play a role in development of the atherosclerotic plaque itself. Platelet aggregation releases thromboxane A2, an extremely potent vasoconstrictor. Thus, interrelationships among atherosclerotic narrowing, platelet aggregation, and coronary spasm are important.

The atherosclerotic process usually affects multiple coronary arteries. In 1975, Gensini reported that 40% of patients with CAD sufficient to lead to cineangiographic study had important stenoses in all three major coronary arteries, and in 30% two vessels were involved.G13 Ninety-five percent of patients with complete occlusion of one artery had important stenoses in at least one of the other two arteries.

Atherosclerotic CAD usually involves the proximal portion of the larger coronary arteries, particularly at or just beyond sites of branching. Thus, stenoses in the main trunks of the LAD, circumflex (Cx) coronary artery, and right coronary artery (RCA) often involve the first of the secondary branches (first diagonal branch of LAD, obtuse marginal branch of Cx artery, and posterior descending branch of RCA). When CAD is more extensive in the main trunks, origins and first portions of secondary branches may be involved. Diffuse distal disease severe enough to render the patient unsuitable for CABG is uncommon. In 10% to 20% of patients with atherosclerotic CAD, the left main coronary artery is importantly stenotic.

Occasionally, a major coronary artery may lie beneath a muscle bridge. This is most common in the middle third of the LAD, but sometimes one or all of the obtuse marginal branches of the Cx artery are buried in muscle throughout their course. These portions of artery are typically free of severe atherosclerotic changes.

# Myocardial Infarction and Morphologic Sequelae

When myocardial blood flow is sufficiently impaired in relation to myocardial oxygen demands, myocardial necrosis occurs. The resultant infarction may be *subendocardial* that is, not involving the entire thickness of the ventricular wall, but only the inner third. In its most extreme form, subendocardial infarction may be diffuse and result from multiple-system disease. More often, however, subendocardial infarcts are regional and result primarily from a stenotic lesion in one or two systems. These infarcts are generally less extensive than so-called transmural infarcts, but still have serious implications. A *transmural* MI involves the entire thickness of the ventricular wall. Transmural infarction usually results from a sudden increase in luminal narrowing or complete obstruction of the artery supplying that area, or a sudden generalized increase in myocardial oxygen demand in the presence of a severely stenotic coronary artery. Although categorization of acute infarctions as subendocardial or transmural is convenient, most transmural MIs are not homogeneous but contain islands of viable muscle of varying number and size.

The process of infarction is complex. Animal studies indicate that some myocardial cells die after 20 minutes of complete coronary artery occlusion, and that extensive myocardial cell death occurs after 60 minutes.S52 Although these time frames may vary, some reperfusion generally occurs within the ischemic area of myocardium within minutes of onset of acute ischemia, particularly in the zone between ischemic and nonischemic myocardium (border zone). If this spontaneous reperfusion occurs within 3 to 4 hours, the amount of necrosis is limited, at times substantially,T8 infarct size is reduced, and mortality is decreased.B13 The process is complex because, in addition to these beneficial effects, spontaneous reperfusion can result in hemorrhage, edema, and ventricular electrical instability.C36,K33

Healing of the acute MI leaves a scarred area of myocardium. In most cases, this area is a mixture of fibrous tissue and viable myocardial cells in varying proportions. Such scarring is evident from (1) intraoperative inspection of areas of previous infarction at the time of CABG and (2) change from akinesia or dyskinesia to hypokinesia or normal wall motion in some LV wall segments when patients go from a symptomatic to an asymptomatic state after percutaneous coronary intervention (PCI) or CABG. When the scar is almost all fibrous tissue, it is usually large, and the LV wall may become akinetic or aneurysmal (see Chapter 8).

These morphologic changes may be self-aggravating because of their effect on circulation to the subendocardial layer. Repeated infarctions may occur and add still more scarring. In the aggregate, myocardial scarring leads to LV systolic and diastolic dysfunction and, ultimately, if the patient survives long enough, to the syndrome of chronic heart failure with elevated right atrial and jugular venous pressure, hepatomegaly, and fluid retention. More often, however, patients with severe ischemic LV dysfunction die of another infarction or ventricular fibrillation.

### Atherosclerotic Plaque Rupture and Thrombosis

Several studies have emphasized the dynamic nature of coronary atherosclerotic plaque as a fundamental feature of CAD.D5,F2 *Fissuring*, or rupture, of atherosclerotic plaques is probably the genesis of the acute coronary syndromes termed *unstable angina* and *acute MI*. When this occurs, mural or occlusive coronary thrombi often coexist and contribute further to development of the unstable states.F25

Coronary stenoses that produce less than 50% reduction in lumen diameter are often the site of the atherosclerotic plaque rupture that precipitates unstable angina or acute MI.F3,L17,M28 More severe stenoses also undergo plaque rupture, and total vessel occlusion may occur. However, an acute ischemic episode does not always develop, possibly because severely stenotic lesions are long-standing and have stimulated development of a protective collateral circulation.

Certain atherosclerotic plaques appear to have a higher risk of rupture than others. These plaques are characterized by relative softness, a high concentration of cholesterol and cholesterol esters, and a lipid pool that tends to be situated eccentrically.M28 Rupture is through the cap of the plaque, and areas in which the cap lacks underlying collagen support seem particularly vulnerable.D5,R11

# CLINICAL FEATURES AND DIAGNOSTIC CRITERIA

#### Routine Methods

CAD is usually first suspected with development of the symptom complex of angina pectoris or an acute MI, occasionally because of electrocardiographic (ECG) evidence of a silent acute MI, a positive ECG response to a graded exercise test, or sudden death with resuscitation. Occasionally, CAD is first suspected because of cardiomegaly and symptoms of chronic heart failure without any other obvious cause.

The precise nature, location, duration, and severity of any chest pain are determined by carefully questioning the patient. Precipitating causes and maneuvers that relieve the pain are noted, as are any recent changes in pain pattern. Findings on physical examination are usually nonspecific.

Many noninvasive tests, beginning with a chest radiograph and ECG at rest and during exercise and then proceeding to more complex studies, are currently used to identify and quantify CAD and its sequelae.J3,M1,S60,S61 Such tests cannot yet define extent or distribution of anatomic coronary disease with great accuracy. From a surgical standpoint, therefore, properly performed coronary angiography remains the definitive diagnostic procedure (see "Coronary Angiography" in text that follows).F20 Contrast-enhanced computed tomographic coronary angiography (CTCA) is emerging as a promising technique for detecting coronary artery disease (see "Computed Tomographic Angiography" later in this section) and may, with increased spatial and temporal resolution, be suitable as an accurate and noninvasive method to select candidates for CABG.B15,L10,S11,S46,V3 Methods of evaluating LV function are also necessary. These may be based in part on historical data, physical findings, and chest radiography. Noninvasive and invasive special study methods may be used. Even when complex study methods are employed, results must be interpreted with knowledge of the simple but reliable clinical data. An ejection fraction (EF) of 35% has a different implication when accompanied by minimal LV enlargement seen on a chest radiograph than when enlargement is marked. An EF of 30% is much more ominous when accompanied by important elevation of jugular and right atrial pressure with hepatomegaly and fluid retention than when these pressures are normal. Exercise capacity may be variable in patients with similar EFs, and the variations are prognostically important. It should be emphasized, however, that heart size can be deceptive because it can remain normal in the presence of severe LV dysfunction.

Important associated conditions such as hyperlipidemia, arterial hypertension, and diabetes, and a history of MI, smoking, or a particularly stressful occupation or lifestyle should be noted. Because arteriosclerosis is the cause of CAD, its presence elsewhere in the circulatory system should be sought. A history suggesting transient cerebral ischemic attacks or stroke, particularly when carotid bruits are present, must be carefully pursued. A history of intermittent claudication and presence of diminished femoral, popliteal, or pedal pulses are indicative of peripheral arterial occlusive disease. The thoracic and abdominal aorta are examined for possible aneurysm or occlusive disease. Renal and pulmonary function should also be evaluated.

## Coronary Angiography

Coronary angiograms provide important information. Their quality must be sufficient to permit detailed assessment from several angles of both coronary ostia and all major and minor branches of the left and right coronary arterial systems. However, angiography remains an imperfect method. Severity of a visualized stenotic lesion may be underestimated, and diameter of vessels distal to a stenosis is often underestimated.

Assessment of coronary arteries at operation by external palpation or probing of the open vessel cannot substitute for coronary angiography. When the arteries cannot be adequately filled by contrast media, however, or the available study is incomplete and cannot be repeated (this should be uncommon), intraoperative observations can be used to supplement angiographic findings. The surgeon should assess all coronary arterial branches carefully at the time of operation, rather than assume the coronary angiogram is a totally accurate diagnostic tool.

![](_page_4_Figure_2.jpeg)

**Figure 7-1** Diagrammatic representation of relationship between two methods of estimating severity of coronary artery stenosis. (From Brandt and colleagues.<sup>BSO</sup>)

#### Recording and Reporting Data

Whatever the techniques used for coronary angiography, methods of recording and analyzing the data are crucial. A 75% cross-sectional area loss (50% diameter) is considered an important but moderate stenosis, and a 90% cross-sectional area loss (67% diameter) is considered severe (Fig. 7-1). Some groups consider only those lesions with 70% or more diameter loss (90% or more cross-sectional area loss) as important, H6,K7,W13 but an appropriately documented basis for this has not been established.

Extent of important coronary artery stenoses has conventionally been summarized as "single-vessel," "double-vessel," or "triple-vessel" disease, usually with left main coronary artery disease as a separate category. This chapter uses the terms *single-system*, *two-system*, and *three-system* disease, because each coronary system (LAD, Cx, and RCA) consists of several vessels. Use of the term *system* is therefore more accurate than *vessel*.

These classifications have been criticized G15,821 because they give no indication of the amount of LV myocardium rendered ischemic by the lesions. For example, a stenosis in the LAD system has a different significance when it lies at the origin of a large first diagonal artery than when it involves the middle third of the LAD beyond its major septal and diagonal branches, or only the first portion of a large first diagonal branch. A single stenosis in the proximal portion of the Cx artery varies in significance depending on whether this artery is dominant. Single-system disease involving the proximal RCA has a different implication from that involving only the posterior descending branch of the RCA. Many other examples can be given of the inadequacies of these classifications.

A few classification systems have been described to circumvent these limitations. These include Gensini's old and rather complex scheme that takes into account severity of the stenoses, the various segments of the coronary artery tree involved, and the area of myocardium usually perfused by them<sup>G12,G14,G15</sup>; a simple scheme from Massachusetts General Hospital<sup>17</sup>; and the method of the Coronary Artery Surgery Study (CASS) of the U.S. National Heart, Lung, and Blood Institute (NHLBI), dividing the coronary arteries into a total of 27 specified segments. Some *myocardial jeopardy scores* have attempted to provide similar information but are limited by the assumption that akinetic areas cannot be revascularized. R21

Whatever the recording and reporting methods, they are not a substitute for the surgeon critically reviewing

cineangiograms before deciding for or against operation, and again immediately before operation.

#### Computed Tomographic Angiography

Although conventional coronary angiography remains the gold standard to determine extent and severity of CAD and indications for CABG, CTCA using 64-slice multidetector CT scanners (MDCT) has been evaluated as an alternative method to select patients for CABG<sup>B15,L10,S46</sup> (Fig. 7-2).

Initial studies suggest that this technique is a suitable alternative to conventional coronary angiography in selected patients. However, concerns regarding exposure to excessive radiation and the small but defined increased risk of cancer in later life associated with exposure to radiation may limit its widespread application. <sup>B64</sup>

#### Coronary Intravascular Ultrasound

Intravascular ultrasound (IVUS) uses a high-frequency miniaturized ultrasound transducer positioned on the tip of a coronary artery catheter to provide detailed cross-sectional images of the coronary vessel wall (Fig. 7-3, A). Unlike coronary angiography, which details only luminal encroachment, IVUS provides images of the atherosclerotic plaque, characterizes its composition, and assesses severity of stenosis (Fig. 7-3, B). K12 When compared with formalin-fixed and fresh histologic specimens of coronary arteries, it correlates significantly (P < .0001) with coronary artery cross-sectional area (r = 0.94), residual lumen cross-sectional area (r = 0.85), and percent cross-sectional area (r = 0.84). P18 It is useful in determining the need for CABG in situations when the severity of coronary artery stenosis cannot be precisely determined by angiography, particularly for left main and LAD disease (Fig. 7-3, C).<sup>N</sup>

#### Coronary Artery Pressure and Fractional Flow Reserve

Fractional flow reserve (FFR) is a simple, reliable, and reproducible physiologic index of lesion severity in patients with intermediate stenosis, and is another method to determine the need for CABG and PCI in equivocal situations, particularly stenosis of the left main coronary artery. The concept of FFR is illustrated in Fig. 7-4. Pressure measured distal to the stenotic coronary lesion during maximum hyperemia (Pd) divided by mean aortic pressure (Pa) correlates with maximum myocardial blood flow in the presence of a stenosis  $\dot{\mathbf{Q}}^{S}$  divided by the normal maximum myocardial blood flow  $\dot{\mathbf{Q}}^{N}$ . FFR 0.75 to 0.80 or less is generally an indication for intervention.

### Left Ventricular Function Testing

#### Resting and Exercise Tests

Because resting LV function is presumed to depend on the amount of myocardium that is free of scar, severity of LV dysfunction may be a surrogate for amount of myocardial scar. This may not be entirely accurate in patients with ischemic heart disease, because ischemia may result in myocardial stunning or hibernation and reversible depression of at least systolic LV function (see "Myocardial Cell Stunning" in Chapter 3). CABG and PCI do not favorably affect myocardial scarring.

![](_page_5_Figure_2.jpeg)

**Figure 7-2 A-C,** Multidetector computed tomographic volume rendering images show significant stenoses of major coronary arteries *(arrows)*, suggestive of three-system disease. These coronary lesions *(arrows)* were confirmed on conventional coronary arteriography **(D-E),** and patient underwent coronary artery bypass grafting. Key: *LAD,* Left anterior descending coronary artery; *LCx,* left circumflex coronary artery; *RCA,* right coronary artery. (From Lee and colleagues.L10)

![](_page_6_Figure_2.jpeg)

**Figure 7-3** Coronary intravascular ultrasound (IVUS). **A,** Schematic of IVUS catheter within blood vessel, cross-sectional imaging plane, and resultant image. Transducer types are shown. **B,** Vessel wall thickness assessed by IVUS imaging. Mild *(left, arrows)* and moderate *(right, arrows)* amounts of intimal thickening are shown. **C,** Angiographic underestimation of disease. Although angiogram *(top)* shows only mild luminal irregularities, two sites in left anterior descending coronary artery *(arrows)* show major arteriosclerosis by IVUS *(below)*. (From Kimura and colleaguesK12 and Nissen and Yock.N8)

*Exercise LV function* in patients with ischemic heart disease is characteristically depressed; this reflects loss of coronary flow reserve imposed by the distribution and severity of CAD. Amount of decrease in EF or other measures of the heart's response to stress is a surrogate for the distribution and severity of coronary arterial stenoses.

# *Systolic and Diastolic Function*

LV function can be expressed as systolic or diastolic function. *Systolic function* is determined by *contractility* of the ventricle (see "Cardiac Output and Its Determinants" in Section I of Chapter 5). *Diastolic function* describes compliance, or extensibility, of the ventricle, which is related to preload.

### *Global and Segmental Function*

*Global LV function* is usually described by an index of overall ventricular systolic function, most often EF. EF is not independent of preload or afterload and therefore is not an ideal index, but it is the one most frequently used and is reasonably satisfactory. EF is obtained commonly and least accurately by visual estimation from a cineangiographically recorded left ventriculogram, more accurately (and originally) by quantitative angiography, and also by noninvasive methods such as radioisotopic imaging and echocardiography.

The CASS score was developed by CASS investigators as a measure of global LV function and actually is a summation of five segmental wall scores based on wall motion observed in the right anterior oblique (RAO) projection of the

![](_page_7_Picture_2.jpeg)

**Figure 7-4** Concept of fractional flow reserve (FFR). Key:  $P_{\alpha}$ , Mean aortic pressure;  $P_{\alpha}$ , hyperemic distal coronary pressure;  $\dot{Q}^{N}$ , normal maximal myocardial blood flow;  $\dot{Q}^{S}$ , maximal myocardial blood flow in the presence of a stenosis. (From Iwasaki and Kusachi.<sup>14</sup>)

**Table 7-1** General Interrelations Among Modifiers Describing Left Ventricular Dysfunction, Ejection Fraction, and Coronary Artery Surgery Study Score

|                | EF      |     | CASS Score<br>(Normal = 5) |    |  |  |
|----------------|---------|-----|----------------------------|----|--|--|
| LV Dysfunction | < Ratio | ≤   | < Score                    | ≤  |  |  |
| None           | .60     |     |                            | 5  |  |  |
| Mild           | .50     | .60 | 5                          | 9  |  |  |
| Moderate       | .35     | .50 | 9                          | 15 |  |  |
| Severe         |         | .35 | 15                         |    |  |  |

Key: CASS, Coronary Artery Surgery Study; EF, ejection fraction; LV, left ventricular.

cineangiogram. C15 Table 7-1 shows the relationship between EF and CASS scores. Other scoring systems have also been developed.

Segmental wall function refers to function, usually systolic, of segments of the LV wall. Methods usually depend on observation of wall motion or wall thickening throughout the cardiac cycle. Analysis of segmental wall motion is particularly informative in patients who have previously sustained MIs.

#### Load-Independent Function

High LV afterload tends to depress LV systolic function and therefore cardiac output, and high LV preload generally increases cardiac output (see "Cardiac Output and Its Determinants" in Section I of Chapter 5). Methods previously discussed generally do not reflect load-independent LV function and are therefore suboptimal.

#### **NATURAL HISTORY**

Gaps exist in knowledge of the natural history of atherosclerotic CAD. Many of these gaps will be permanent because withholding treatment is no longer justifiable. The closest approach to natural history comes from data gathered in patients seen and treated medically before about 1970. Unfortunately, many studies from that era have the disadvantage that patients were not categorized according to anatomic extent of their disease and LV function.

A further complexity is that in nearly all studies since 1970, patients initially undergoing no treatment or medical treatment have properly been allowed thereafter to cross over to interventional treatment (PCI or CABG). This has made it even more difficult to generate accurate information about the natural history of CAD.

# Stenotic Coronary Artery Disease

The natural history of patients with a given severity and distribution of CAD depends in part on the rate of progression of both. As an added complexity, regression of some lesions also occurs. B58,W3 In general, however, both severity and distribution of CAD tend to increase with time, B16,M8 although the rate of increase is highly variable and difficult to predict. A1 In general, over a 2-year period in patients with already important stenoses, 20% of the stenoses increase in severity, and about half of patients develop important new lesions. B61,S42 The mechanism of increase in severity is variable, but atherosclerotic plaque rupture and thrombosis play important roles in some cases (see "Atherosclerotic Plaque Rupture and Thrombosis" earlier in this chapter).

Of the usually accepted risk factors for *presence* of stenotic CAD, not all have been helpful in predicting its rate of *progression*. B61,K34,S42 Aggressiveness of the atherosclerotic process seems to be a risk factor for progression; surrogates for it include young age at presentation with symptomatic CAD, peripheral arterial disease, diabetes, and hyperlipidemia. B16,K34,M8 Nature of the atherosclerotic plaque is a risk factor because plaque rupture is frequently the inciting incident leading to progression in severity of coronary artery stenosis. Eccentric positioning of the lipid pool within the plaque appears to predispose to rupture F25 and thus progression in severity of stenosis. Rheologic factors play a role; the more severe the stenosis, the more rapid the progression toward total occlusion. B61,K35,W5

#### Left Ventricular Dysfunction

#### Stress-Induced Dysfunction

First indications of LV dysfunction in patients with ischemic heart disease are localized abnormalities of regional wall motion (LV systolic function) during exercise or other forms of stress. S18 These abnormalities are the result of transient myocardial ischemia, which can be demonstrated as myocardial perfusion defects during exercise. S35,S36

Global LV systolic function improves during exercise in normal persons, except in old age. By contrast, when initially localized areas of myocardial ischemia become sufficiently extensive, global LV systolic function declines during exercise. B41,H15,J5,R9,S35 Exercise-induced ECG changes also reflect these reversible myocardial perfusion abnormalities, which may be so severe as to cause hypotension during exercise testing. B59 Related to this exercise-induced decrease in function in some patients, LV end-diastolic volume responds abnormally to exercise by increasing, often to more than 50% above resting value. B21,H15,J5,R9 These reversible abnormalities of regional myocardial perfusion and wall motion occasionally occur at rest, most often in patients with unstable angina. K25

Abnormalities of LV diastolic function during stress can be demonstrated in most patients with extensive CAD.M7,R5 These abnormalities take the form of reduced peak LV filling rate and increased time to peak filling rate.B36,R5 These phenomena are the clinical reflection of the laboratory demonstration that ischemia impairs rate of diastolic relaxation of papillary muscle, related to the fact that myocardial relaxation during early diastole is an active, energy-dependent process. Abnormalities of diastolic function in patients with coronary artery stenoses may also reflect lack of an increase in early diastolic coronary blood flow.

In the aggregate, these purely ischemic abnormalities of LV systolic and diastolic function may be severe enough during stress to result in a considerable increase in LV enddiastolic pressure. This may produce dyspnea and even transient paroxysmal nocturnal dyspnea and pulmonary edema, as well as angina, during severe ischemic episodes. Further evidence that these abnormalities of LV systolic and diastolic function can result from myocardial ischemia alone is provided by their reversal after successful PCI or CABG.B37,B38

### *Dysfunction at Rest*

LV dysfunction with the patient at rest and under no stress has been considered the result of myocardial scar. Therefore, it can be expected that it will not improve after neutralization of the coronary arterial stenoses by CABG or PCI. However, there is evidence that myocardial stunning or hibernation, or both, may be responsible at times for considerable LV dysfunction, and that this element of resting LV dysfunction can be relieved by revascularization.

Myocardial scars from previous MIs also result in abnormalities of LV diastolic function.S67 Both clinical and experimental studies indicate that increase in LV end-diastolic volume, which results from both diastolic and systolic abnormalities of function, is directly related to the amount of scar in the ventricle.

Patients whose LV function is depressed from myocardial scarring exhibit morphologic, physiologic, and functional variability. Some have moderately increased LV end-diastolic pressure at rest and a considerably reduced exercise capacity but only a mildly increased cardiac size on chest radiography. These patients have moderate scarring and marked ischemic dysfunction in scarred or non-scarred parts of the ventricles that can often be improved by revascularization. Some have chronic symptoms of pulmonary venous hypertension and may still be helped by revascularization. A few have moderate or severe cardiomegaly, reduced cardiac output, importantly elevated right atrial and jugular venous pressure, hepatomegaly, and fluid retention. Patients in the latter group have advanced LV dysfunction from extensive myocardial scarring, and it generally cannot be improved by operation unless the scar is discrete, is full thickness (aneurysmal or akinetic), and can be resected (see Chapter 8).

#### Unfavorable Outcome Events

# *Stable Angina*

Development of chest discomfort or pain on exertion is common in patients with coronary artery stenosis,C33 but chest discomfort is not an inevitable accompaniment of even important CAD. Severity of angina is typically categorized by the Canadian class system, which differs from the New York Heart Association (NYHA) classification for heart failure.C4

- *Class I: angina* occurring only with strenuous or prolonged exertion at work or recreation and *not* with ordinary physical activity (thus, Class 0 means no angina under any circumstance).
- *Class II:* angina occurring with walking rapidly on level ground or a grade and with rapidly walking up stairs. Ordinary walking for fewer than two blocks on level ground or climbing one flight of stairs does *not* cause angina except during the first few hours after awakening, after meals, under emotional stress, in the wind, or in cold weather. This implies slight limitation of ordinary activity.
- *Class III:* angina occurring when walking fewer than two blocks on level ground at a normal pace, under normal conditions, or when climbing one flight of stairs. This implies marked limitation of ordinary physical activity.
- *Class IV:* angina occurring with even mild activity. It may occur at rest but must be brief (<15 minutes) in duration. (If the angina is of longer duration, it is called *unstable angina*.) This implies inability to carry out even mild physical activity.

Angina generally results from reduction in coronary flow reserve in a portion of the myocardium; the more severe the reduction, the greater the severity of angina. However, severity of angina also depends on amount of stress or exercise, which increases myocardial oxygen demand in proportion to the intensity of the activity. Standardization of demand gives graded exercise testing its advantage in quantifying to some extent the amount of "reversible ischemia" (more properly, the amount of reduction of coronary flow reserve). Absence of angina does not eliminate the possibility that the patient has "reversible ischemia." Although angina tends to become more severe as time passes, a number of patients do not experience this trend.

#### *Unstable Angina*

Unstable angina undoubtedly signifies a prognostically important change in the coronary circulation, but the syndrome takes so many different forms that its precise definition has been difficult. Not surprisingly, different practitioners and even different randomized trials have used different definitions.B23,R26 In 1989, Braunwald devised a classification system to ensure uniformity of categorization and provide diagnostic and prognostic information.B51

Although "unstable angina" implies several syndromes, no differences in outcome have been identified among its subgroups. The term applies to patients with severe and persisting angina on presentation to the physician or hospital, with ECG evidence of ischemia and only minor enzymatic evidence (available only later) of MI. The syndrome is considered more ominous if it occurs in the absence of stimuli that increase total body oxygen consumption or catecholamine release (e.g., unusual emotional stress, fever, infection, hypotension or uncontrolled hypertension, tachyarrhythmia, hypoxemia). Unstable angina also applies to patients who have onset of severe angina (Canadian class IV) within 2 months of presentation or who have recurring or prolonged (>15 minutes) severe angina within 10 days of presentation, whether or not it is of new onset. The term is also appropriate for patients who develop (or continue to have) severe angina in the first 2 weeks after an acute MI. All subsets usually demonstrate ECG evidence of myocardial ischemia during severe pain, and no enzymatic evidence of more than minimal myocardial necrosis.

The cause of unstable angina is now considered to be an acute change in coronary circulation with or without changes in related neurohumoral responses. Unstable arteriosclerotic plaque, which may fissure and rupture, is the genesis of unstable angina in many patients (see "Arteriosclerotic Plaque Rupture and Thrombosis" earlier in this chapter).F25 However, superimposed thrombosis and platelet aggregation complicate local situations,G25,V10 and the clinical state largely depends on activity of the patient's thrombolytic state and mechanisms for reversing platelet aggregation. The process is reversible but tends to recur either as another episode of unstable angina or as an acute MI.

# *Acute Myocardial Infarction*

Prevalence of acute MIs in patients with coronary artery stenoses is not known precisely, but it is surely affected by prevalence of risk factors. For example, patients with severe proximal LAD lesions have a particular tendency to develop acute and often fatal MI.S15 Among patients who are sufficiently symptomatic and undergo coronary angiography, at least 10% have an acute MI within 1 year, 30% within 5 years, 40% within 10 years, and 50% within 15 years, as determined from patients assigned to initial medical treatment in the Veterans Administration (VA) randomized trial of stable angina.B29

Acute MI is usually caused by acute subtotal or total occlusion of the vessel supplying the infarcted region, and the vessel usually does not have well-formed collateral arteries. This fact has been suspected for many years and gave rise to the early phrase "coronary thrombosis." However, thrombosis was first convincingly demonstrated by DeWood and colleagues in Spokane, Washington, in a series of patients undergoing emergency CABG for acute infarction.D14 Often the acutely occluded vessel has not previously had a severe stenosis, which is consistent with the concept that the myocardium supplied by the diseased vessel is usually devoid of important collateral vessels. Current information suggests that rupture of an unstable arteriosclerotic plaque is the genesis of the acute reduction in luminal diameter, often accompanied by thrombosis and platelet aggregation (see "Arteriosclerotic Plaque Rupture and Thrombosis" earlier in this chapter).F3,T13

The greater the number of MIs, the greater the likelihood the patient will have another one, which may indicate that some people generate more unstable plaques than others. Also, the more coronary artery systems (LAD, Cx, RCA) that contain important stenoses, the greater the probability of an acute MI.B29 This may simply be due to the increased number of coronary arteriosclerotic plaques available to rupture.

Early (3-month) mortality after acute MI is difficult to define for the current era. Hospital mortality is usually described, but the early phase of the hazard function continues for about 3 months. In the past, hospital mortality in a heterogeneous group of patients admitted with acute MI was 10% to 50%, depending on prevalence of risk factors. Death was usually in acute or subacute cardiac failure, or suddenly with ventricular fibrillation.B42 Size of the infarct was an important risk factor; hospital mortality was 5% for patients with small infarcts vs. 50% for those with large infarcts (involving 40% or more of LV mass).B26,P1 Reserve in the adjacent "nonischemic" myocardium appeared also to relate to probability of surviving an acute MI, indicating the importance of metabolically supporting this area and revascularizing it even if the stenoses are not severe.B24 Overall probability of death was higher after the second infarction and still higher after the third, related to scarring imposed by previous infarctions. Development of pulmonary edema soon after acute MI increased risk of death, but 1-year mortality was as low as 10% when other risk factors were favorable.D21

Currently, therapy is directed toward use of inhibitors of platelet aggregation, thrombolytic agents, heparin, and PCI as soon as possible after onset of infarction. Although the optimal protocol may be arguable, effectiveness of this therapy is not. Hospital mortality has been reduced to about 7% to 10% by these measures. When cardiogenic shock develops, emergency PCI or CABG with maximal measures for myocardial management can salvage many patients (see "Cold Cardioplegia, Controlled Aortic Root Reperfusion, and [When Needed] Warm Cardioplegic Induction" in Chapter 3).A14,A15,G17,H19,H20,L5

# *Death*

Approximately 70% to 80% of a heterogeneous group of patients with CAD of sufficient severity to cause them to seek medical advice ultimately die a *cardiac death.* The remaining 20% to 30% die of unrelated causes. Overall survival for a heterogeneous group of patients with clinically evident CAD is 75% at 5 years after initiation of medical treatment, 60% at 10 years, and 45% at 15 years.B29 However, time-related probability of death in a group of CAD patients is so related to prevalence of risk factors that overall estimates are of little value.

Most often, death occurs with acute or subacute cardiac failure, often within a few months of an acute MI and sometimes precipitated by a ventricular arrhythmia.B29 Infrequently, death is attributable to chronic heart failure, either late after one or more infarctions or without any identifiable earlier episode of infarction. This mode of death is generally characterized by a slow downhill course, eventually leading to hepatomegaly, ascites, and ultimately death. Death in this mode is usually the direct result of myocardial scarring.

About 20% of patients with important CAD who have had no interventional therapy die suddenly.B29 Acute MI is not the only cause of sudden death. Presumably, sudden cardiac death in patients with ischemic heart disease can result from acute, severe myocardial ischemia, resulting in ventricular fibrillation, asystole, or acute severe depression of ventricular function.B14

#### Incremental Risk Factors for Unfavorable Outcome Events

Understanding the benefit of interventional therapy, whether CABG or PCI, demands a knowledge of the incremental risk factors for unfavorable outcome events in patients treated medically for CAD.

Multivariable analysis is used to generate incremental risk factors for various unfavorable events after CABG, PCI, or medical treatment. However, those identified are often surrogates for more basic risk factors, and at times several surrogates for the same basic risk factors appear. Box 7-1 presents the basic risk factors as currently perceived. In the future, these factors themselves may become more clearly identifiable.

**Box 7-1** Incremental Risk Factors for Death and Other Unfavorable Outcome Events in Patients with Stenotic Atherosclerotic Coronary Artery Disease*a*

# **Severity of Reduction in Regional Coronary Flow Reserve***b*

- Angina severity (Canadian class I to IV)
- Degree of positive response to stress testing
- Severity and number of stenoses

#### **Number of Myocardial Regions with Reduced Coronary Flow Reserve***b*

- Left main stenosis and severity
- Distribution and severity of coronary stenoses
- Myocardial score

# **Nature of Coronary Arteriosclerotic Plaque**

- Number of previous myocardial infarctions
- Acute myocardial infarction
- Distribution of coronary stenoses

# **Internal Milieu (Thrombotic or Fibrinolytic)**

- Number of previous myocardial infarctions
- Acute myocardial infarction
- Distribution of coronary stenoses

# **Aggressiveness of Atherosclerotic Process**

- Diffusely narrowed coronary arteries
- Peripheral arterial disease
- Cerebrovascular disease
- Hyperlipidemia
- Diabetes
- Hypertension
- Younger age at intervention

# **Rate of Progression of Coronary Arterial Stenoses**

# **Amount and Distribution of Myocardial Scar**

- Number of previous acute myocardial infarctions
- Left ventricular ejection fraction
- Left ventricular Coronary Artery Surgery Study (CASS) score
- Left ventricular end-diastolic pressure
- Defects identified by exercise or resting thallium-201 scintigraphy (delayed or after reinjection)

# **Secondary Conditions**

- Hemodynamic instability
- Cardiogenic shock
- Ischemic instability (unstable angina)
- Ventricular electrical instability

#### **Coexisting Conditions (Comorbidity)**

- Older and younger age
- Larger and smaller body size
- Ethnicity
- Diabetes
- Hyperlipidemia
- Hypertension
- Chronic pulmonary disease
- Chronic renal disease
- Smoking
- Previous stroke

### *Reduced Regional Coronary Flow Reserve*

Reduced regional flow reserve results from severity of the coronary arterial stenoses and number of coronary arterial systems with important stenoses. The left main coronary artery is an additional "system."

Time-related survival for a heterogeneous group of patients with *single-system stenosis* is high, approximately 90% to 95% at 5 years (Fig. 7-5, *A*). At 15 years, survival is about 50%. Additional risk factors relating to reduction in regional coronary flow reserve include (1) specific vessel(s) diseased, (2) location of stenosis within the vessel, and (3) severity of stenosis. Because time-related mortality from single-system disease is relatively low, the differences attributable to further refinements in this category will be small and therefore difficult to identify. Also, inferences from the analyses are only as good as reliability of the cineangiogram.

In any event, single-system disease with stenosis in the RCA appears to confer better survival than can be expected with LAD disease, at least for 5 years (RCA 96%, LAD 92%).C2 When single-system stenosis is in the LAD, a very proximal location (proximal to the large septal branch) imposes less favorable survival than more distal lesions (proximal 90% at 5 years, distal 98%).C2 Although not conclusively demonstrated, more severe stenoses (>90%), especially those proximal in the artery, probably impose higher time-related mortality than less severe stenoses.

Patients with *two-system disease* as a heterogeneous group have lower survival than those with single-system stenoses, with 5-year survival of about 88% (Fig. 7-5, *B*). At 15 years, survival is about 56%. When the LAD is one of the two systems, the same effects of location and severity as mentioned for single-system disease pertain.V6 Differences in outcome between single- and two-system disease are not as great as those between two- and three-system disease.

As a heterogeneous group, patients with *three-system disease* have a 5-year survival without interventional treatment of about 70% (Fig. 7-5, *C*) and a 10- and 15-year survival of about 60% and 40%, respectively.B67 Factors affecting survival in patients with important single-system disease involving the LAD also affect survival in patients with threesystem disease. Also, the greater the number of systems with important proximal stenoses, the lower the time-related survival: at 5 years, survival with no, one, two, and three systems with proximal stenoses is 71%, 64%, 51%, and 45%, respectively.M35

Important *left main coronary artery disease* imposes an even lower survival: 40% to 60% at 5 years (Fig. 7-5, *D*). Survival falls to about 10% to 26% by 15 years (Fig. 7-6).

*Severity of angina* is a surrogate for the basic risk factor of severity of reduction in coronary blood flow reserve (Fig. 7-7). Also, *graded exercise testing* (GXT) is a surrogate for the basic risk factor of severity of reduced coronary blood flow reserve and is related to outcome events in CAD patients. For example, in the heterogeneous group of patients randomly assigned to initial medical treatment in the European Coronary Surgery Study Group randomized trial, 1-, 5-, and

These categories constitute reversible ischemia. Factors/events listed are not the result of a formal multivariable analysis, but rather a composite of many such analyses.

![](_page_11_Figure_2.jpeg)

Figure 7-5 Survival of medically treated men with coronary artery disease, stable angina of at least 6 months' duration, and less than severe left ventricular dysfunction enrolled in the U.S. Veterans Administration (VA) Cooperative Study (solid squares).<sup>83</sup> For comparison, survival is shown of a population matched for age and gender from the 1976 U.S. life tables (solid line). Data for other groups of medically treated patients published earlier by Burggraf,<sup>867</sup> Oberman,<sup>O2</sup> and Webster<sup>W4</sup> and their colleagues are also shown. Lower survival in the last three groups may have been the result of less restrictive selection of patients than for the VA group and better medical treatment in the more recent VA group. Data from the Coronary Artery Surgery Study (CASS), in which important stenosis meant a 70% diameter reduction, are also presented.<sup>M27</sup> These data include patients treated medically in the current era with all types of ventricular function. Left main coronary artery data from CASS refer to left main coronary artery plus triple-system disease. **A**, Single-system disease. **B**, Two-system disease. **C**, Three-system disease. **D**, Left main coronary artery disease. (From Kirklin and colleagues.<sup>K15</sup>)

![](_page_11_Figure_4.jpeg)

Figure 7-6 Nomograms of specific solutions of multivariable risk factor equations illustrating effect of number of coronary artery systems with important stenoses on time-related freedom from cardiac death in patients randomly assigned to initial medical treatment in Veterans Administration randomized trial of chronic stable angina. For this depiction, patients were censored if they crossed over to coronary artery bypass grafting. Values for each risk factor in the specific solutions of the multivariable equation represented by these nomograms are provided in the American College of Cardiology/American Heart Association Joint Task Force Subcommittee on Coronary Artery Bypass Graft Surgery. A Patients with normal left ventricular (LV) function. B, Patients with importantly impaired LV function. Key: ACC, American College of Cardiology; AHA, American Heart Association; CABG, coronary artery bypass grafting; LM, left main coronary artery disease; SD, systems diseased.

![](_page_12_Figure_2.jpeg)

Figure 7-7 Nomograms illustrating effect of severity of angina (expressed as Canadian class) on survival in patients randomly assigned to initial medical treatment in the Veterans Administration randomized trial of chronic stable angina (same equation as in Fig. 7-6). **A,** Survival, leaving patients in follow-up evaluation after crossover to coronary artery bypass grafting (CABG) ("intent to treat" analysis). **B,** Freedom from cardiac death, censoring patients at time of crossover to CABG.

10-year survival was 94%, 83%, and 71% in patients with a mildly positive GXT but 92%, 77%, and 62% in those with a strongly positive GXT. V6 Similarly, in a study from the CASS Registry, survival at 12 years after medical treatment was substantially lower among patients with a strongly positive GXT (55% for men, 62% for women) than among those with a mildly positive test (75% for men, 82% for women). W7

### Progression of Coronary Arteriosclerosis

Rate of progression of coronary arteriosclerosis, which could also be termed *aggressiveness of the arteriosclerotic process*, cannot as yet be examined directly in multivariable risk factor analyses. Its surrogates have appeared in a number of such analyses. The surrogates may be a substitute not solely for one basic risk factor but at times for several factors. Among them are young age at presentation, diabetes, hypertension, and hyperlipidemia.

An important advance has been the demonstration that progression of arteriosclerotic CAD can be slowed, and that regression of some lesions in some circumstances can be initiated by intensive lipid-lowering therapy. B58,W3

#### Coronary Arteriosclerotic Plaques

Number of previous episodes of acute MI may be a surrogate for coronary arteriosclerotic plaques as well as for total area (or number) of arteriosclerotic plaques within the coronary arterial tree. Presence of unstable angina and number of recent episodes may likewise be surrogates. In this regard, however, status of the patient's fibrinolytic and disaggregating systems also plays a role. During very active periods, these systems may neutralize the effects of plaque rupture and minimize severity and frequency of unstable angina and acute MI.

#### Myocardial Scar

To the extent that resting LV dysfunction in patients with CAD is related directly to amount of scar in the myocardium, surrogates for presence and extent of this basic risk factor include number of prior episodes of acute MI, resting LV systolic and diastolic dysfunction (presence and severity) determined by any of several methods, and a history of chronic heart failure.

Reversible ischemia is capable of producing resting LV dysfunction. Myocardial stunning may persist after reversible ischemia has disappeared and result in LV dysfunction. Unfortunately, methods for distinguishing between scar and reversible ischemia, although useful, are neither entirely accurate nor precise. The frequent finding of only a 0.05 to 0.10 increase in preoperatively depressed EF in many patients after CABG suggests that the proportion of LV dysfunction not attributable to myocardial scarring is small.

In CAD patients treated noninterventionally, mild resting LV dysfunction (EF 35%-50%) minimally affects survival, but severe dysfunction (EF < 35%) substantially reduces it. Thus, other factors being equal, 1- and 5-year survival in patients with mild LV dysfunction is about 95% and 80%, respectively, whereas with severe dysfunction it is about 70% and 40%. Cl,M35 Good LV function is found more frequently in patients with single-system disease than those with three-system disease (Table 7-2).

#### Secondary Conditions

Certain conditions develop secondary to ischemic heart disease and are additional incremental risk factors for death and other unfavorable events.

Hemodynamic Instability Grade 1 hemodynamic instability is mild and responds to catecholamine infusion. Grade 2 is more severe and responds only when intraaortic balloon pumping is added. Grade 3 is unresponsive even to addition of intraaortic balloon pumping and requires cardiopulmonary support (cardiopulmonary bypass, extracorporeal membrane oxygenation) or a ventricular assist device (see Section I in Chapter 5). Because hemodynamic instability in patients with ischemic heart disease typically reflects acute myocardial ischemia or necrosis and produces secondary deleterious effects throughout the body, it adversely affects outcome.

**Ischemic Instability** Ischemic instability is a state of unstable angina and implies acute myocardial ischemia. It carries the risk that severe myocardial stunning and necrosis or ischemic ventricular electrical instability can develop acutely.

Ventricular Electrical Instability Either ischemic or secondary to phenomena associated with myocardial scarring,

| Ejec        | tion Fract | ion  | Si    | ngle-Sys | stem D | isease | Two-System Disease |     |    | Three-System Disease |       |     |    |        |               |
|-------------|------------|------|-------|----------|--------|--------|--------------------|-----|----|----------------------|-------|-----|----|--------|---------------|
| ≤           | Ratio      | <    | n     | No.      | %      | CL (%) | n                  | No. | %  | CL (%)               | n     | No. | %  | CL (%) | $P[\chi^2]^b$ |
| 0.50        |            |      | 761   | 723      | 95     | 94-96  | 415                | 386 | 93 | 91-94                | 227   | 186 | 82 | 79-85  | <.0001        |
| 0.35        |            | 0.50 | 184   | 167      | 91     | 88-93  | 144                | 120 | 83 | 79-87                | 88    | 62  | 70 | 65-76  | .0001         |
|             |            | 0.35 | 57    | 42       | 74     | 66-80  | 57                 | 32  | 56 | 48-64                | 69    | 35  | 51 | 44-58  | .03           |
| $P[\chi^2]$ |            |      | <.000 | 1        |        |        | <.000              | 1   |    |                      | <.000 | 1   |    |        |               |

Recalculated from CASS Registry by Mock and colleagues. M27

"In current era, as estimated by global ejection fraction. Severe disease is 70% or greater reduction in diameter. These data must be interpreted in light of the fact that during the study period, approximately 20%, 30%, and 45% of patients with single-, two-, and three-system disease, respectively, crossed over to surgical treatment.

<sup>b</sup>P values for difference in predicted survival.

Key: CL, 70% confidence limits; n, total patients; No., patients with disease.

![](_page_13_Figure_8.jpeg)

**Figure 7-8** Nomogram illustrating effect of diabetes on survival after percutaneous coronary intervention (*PCI*) in elderly patients (same equation as in Fig. 7-6). (Equation from Garrahy and colleagues. <sup>G9</sup>)

ventricular electrical instability is a risk factor incremental to that of the basic milieu that gives rise to it.

# Coexisting Conditions

**Older Age** Older age at presentation is a risk factor for death in patients with ischemic heart disease, and probably acts as a coexisting condition rather than directly affecting CAD.

**Diabetes** Diabetes is a strong risk factor for death in CAD patients because of its effect as a coexisting condition and its accelerating effect on the arteriosclerotic process. Fig. 7-8 illustrates the powerful effect of diabetes in elderly patients who have undergone PCI.

**Hypertension** The strong effect of hypertension as a risk factor for death in CAD patients is related to kidney damage, intracranial complications, LV hypertrophy, and acceleration of the arteriosclerotic process (Fig. 7-9).

**Gender** Although overall mortality is lower in women with angina than men, for patients older than 65, relative risks are similar (2.7 vs. 2.4, respectively). L1,M32

**Other Comorbidity** Any serious coexisting disease adversely affects survival in patients with CAD. Of particular importance, because of their prevalence in this group of

![](_page_13_Figure_17.jpeg)

**Figure 7-9** Nomogram illustrating effect of hypertension on time-related probability of freedom from cardiac death in patients randomly assigned to initial medical treatment in the Veterans Administration randomized trial of chronic stable angina (same equation as in Fig. 7-6). Key: *CABG*, Coronary artery bypass grafting.

patients, are *chronic obstructive pulmonary disease* and *chronic renal disease*. *Smoking* can be considered an important coexisting condition.

# **TECHNIQUE OF OPERATION**

Most patients undergoing CABG have extensive three-system disease, often with important stenoses in four, five, or six arteries. Many have substantial impairment of LV function. This discussion focuses on operation under these circumstances and tactics for accomplishing optimal revascularization and optimal intraoperative management of the myocardium.

Surgical management of arteriosclerotic CAD has evolved from treatment primarily of patients with stable coronary syndromes undergoing elective operation, to treatment of more heterogeneous groups of patients with various clinical syndromes who are older and have more comorbid conditions, including patients who require urgent or emergency operation. A3,F8 Economic and other external pressures often result in CABG being performed within hours after diagnostic coronary angiography or PCI.

At present, CABG with use of total CPB through a full sternotomy remains the most widely used surgical technique. Because of extensive experience, this approach is the technique to which all others must be compared. Other techniques currently in use include CABG through a full sternotomy but without use of CPB, and operations through smaller sternal, parasternal, or thoracotomy incisions with or without use of CPB (see Fig. 2-23).

Here, the conventional operation with CPB, as well as the off-pump procedure, are presented. Other procedures are discussed under Special Situations and Controversies later in this chapter.

# Preoperative Preparation

Many patients come to CABG taking β-adrenergic receptor or calcium channel blocking agents, angiotensin-converting enzyme (ACE) inhibitors, digitalis preparations, antiarrhythmic agents, and platelet antiaggregating drugs. Some are receiving intravenous heparin and nitroglycerin. It is advisable in most circumstances to continue β-adrenergic receptor and calcium channel blockers, as well as ACE inhibitors, up to the time of operation (see "Management of Preoperative Medications" in Section I of Chapter 4). Several studies have shown a tendency toward development of acute MI in patients in whom β-adrenergic receptor agents are discontinued. Boudoulas and colleagues demonstrated an important increase in adrenergic tone in most patients the day before operation that could be reduced by propranolol.B44 Propranolol has also been shown to lessen prevalence of intraoperative ventricular arrhythmiasS48 without compromising LV function in low or moderate dosages.R4 Patients receiving preoperative β-adrenergic receptor agents, amiodarone, or sotalol are less likely to develop atrial fibrillation postoperatively.D4,G22,K3

Digitalis preparations can be discontinued preoperatively unless atrial fibrillation is present (see Chapter 4). They can be administered intraoperatively and postoperatively for control of heart rate if atrial fibrillation or other atrial arrhythmias are present.

Platelet antiaggregating drugs such as abciximab, eptifibatide, tirofiban, clopidogrel, prasugrel, and ticagrelor bind to the glycoprotein IIb/IIIa platelet receptors. When feasible, these drugs as well as aspirin should be discontinued at the appropriate time interval before operation (each has a different half-life) if the patient has a stable coronary syndrome, because their use is associated with increased postoperative bleeding and need for transfusion of blood products.G2,G21,J1,S66

Patients who have received plasminogen-activating (fibrinolytic) agents such as streptokinase, alteplase, and reteplase preoperatively require careful attention intraoperatively and postoperatively to manage excessive bleeding.

# Operating Room Preparation

Anesthetic methods for CABG are described in Chapter 4. After inserting an endotracheal tube and appropriate monitoring devices (see Chapter 2), the skin is prepared over the chest, abdomen, groin, one or both arms if indicated, and the complete circumference of both legs, including the feet. Draping includes isolating the feet, genitalia, and pubis and placing sterile waterproof drapes beneath the legs.

# Surgical Strategy

The prime objective of CABG is to obtain *complete revascularization* by bypassing all severe stenoses (at least 50% diameter reduction) in all coronary arterial trunks and branches having a diameter of about 1 mm or more.B63,J9 Because five or more individual conduits cannot be conveniently used in most patients, at least some of the grafts may require sequential (side-to-side) anastomoses. To increase the likelihood that the entire graft will remain patent, the distal end-to-side anastomosis of a sequential graft should be made, whenever possible, to a relatively large artery with a substantial proximal stenosis and good runoff. Although it is not clearly established whether grafts with more than one distal anastomosis have the same, higher, or lower patency rates than those with only a single distal anastomosis, several studies suggest that sequential grafts are associated with higher mean flows and graft patency.K11,O6,V14 As a general principle, conservation of conduit by employing sequential grafting is prudent because of the likelihood of subsequent CABG or peripheral arterial procedures that may require use of saphenous vein grafts.

A widely used strategy involves routine use of the left ITA to the LAD and segments of saphenous vein to the remaining coronary arteries requiring revascularization. The right ITA, one or both radial arteries, and the right gastroepiploic artery can also be used in combination with the left ITA. Sequential anastomoses with the ITA and radial artery can be performed with satisfactory results.B55,C24,D20,S5,T7 Figs. 7-10 and 7-11 show the most widely used combinations and configurations of bypass grafts. Details of graft placement are often individualized according to location and severity of arteriosclerotic disease, surgeon preference, availability of suitable conduit, and knowledge of the long-term function of various conduits.

The cineangiogram provides key information for planning CABG, but based on either the cineangiogram or observations made at operation, the surgeon may elect to open vessels suspected of having important stenosis. A few errors will inevitably be made regarding which vessels should be grafted. The surgeon must decide which error is more acceptable: opening and grafting an artery that does not need it or failing to open and graft a vessel with an important stenosis. The latter is generally considered a more serious error.

# Coronary Artery Bypass Grafting

#### *With Cardiopulmonary Bypass*

A median sternotomy is made, and at the same time a segment of greater saphenous vein (or radial artery or other conduit) is removed. Before the pericardium is opened, the left ITA (and the right if indicated) is completely mobilized. Heparin is administered as dissection of the ITA is being completed. The ITA is then divided. A bulldog clamp or clip is placed on the artery near the open end, and the distal segment of the artery on the chest wall is ligated or clipped. The pericardium is opened, and pericardial stay sutures are placed. Pursestring sutures are placed at the sites for cannulation and also in the ascending aorta and right atrial wall for controlled aortic root perfusion and delivery of cardioplegia into the coronary sinus (see Fig. 2-22). Because arteriosclerosis is frequently present in the ascending aorta and proximal aortic arch in patients with CAD, particularly elderly patients, epiaortic ultrasonographic scanning of the aorta is advisable

E

![](_page_15_Picture_2.jpeg)

coronary artery branch is placed at end of sequence.

Circumflex coronary artery

RCA

![](_page_16_Picture_2.jpeg)

**Figure 7-11** Combinations and configurations of internal thoracic artery *(ITA)* bypass grafts. **A,** Left *ITA* is most often used to bypass the left anterior descending coronary artery *(LAD).* **B,** Sequential grafting using left ITA may include a diagonal branch of LAD. **C,** Right ITA can be used to bypass right coronary artery *(RCA)* alone or in combination with an ITA graft to LAD system. **D,** Alternatively, right ITA can be passed through transverse sinus and anastomosed to one or more marginal branches of left circumflex coronary artery.

*Continued*

before aortic cannulation to obtain information that can lead to safe positioning of cannulae and aortic clamps (see "Epiaortic Ultrasonography" in Chapter 26).B10,C42,F23,G7,W2

CPB is established using a single venous cannula. Catheters for administering cardioplegic solution are placed into the ascending aorta and coronary sinus through the previously placed purse-string sutures and secured with tourniquets. The aorta is clamped and cardioplegic solution infused (see "Cold Cardioplegia, Controlled Aortic Root Reperfusion, and [When Needed] Warm Cardioplegic Induction" in Chapter 3). The heart can be covered with cold saline during administration of cold cardioplegia to facilitate cooling.

With the heart retracted out of the pericardial cavity and toward the head of the patient by an assistant standing to the surgeon's left or by traction sutures placed on the acute margin of the heart, the first anastomosis of the conduit that has been selected is made to the distal RCA or to the posterior descending artery (PDA) (see Fig. 7-10, *D*). (See "Distal Anastomosis" later in this chapter.) Sequential anastomoses of the conduit can be performed to more distal branches of the RCA or to the marginal branches of the Cx coronary artery (see Fig. 7-10, *E*). The graft is then distended gently with cardioplegic solution, positioned along the right atrium up to the right side of the ascending aorta, and transected at the point that will permit a smooth course of the conduit without kinking or tension. The free end of the graft is spatulated.

The heart is then retracted to the right by the assistant. A separate conduit is anastomosed to one or more of the marginal branches of the Cx artery (see Fig. 7-10, *B*). The graft is properly oriented to avoid twisting, and the heart is repositioned in the pericardial cavity. The graft is distended gently

![](_page_17_Picture_2.jpeg)

**E,** Right ITA can be brought across midline and used to bypass LAD, and if indicated, left ITA can be anastomosed to one or more marginal branches of left circumflex coronary artery. **F,** When extensive revascularization of posterior wall of left ventricle (LV) is required, a posteriorly positioned sequential vein graft (or radial artery) in combination with a left ITA graft to the LAD is typically used. **G,** Radial artery graft may be used as a sequential graft to bypass arteries on lateral and posterior surfaces of LV. Radial artery can be anastomosed proximally to left ITA, which is used to bypass the LAD. Alternatively, radial artery can be anastomosed directly to ascending aorta. **H,** Right gastroepiploic artery or splenic artery may be used to bypass branches of right and circumflex coronary arteries in combination with ITA or other grafts to LAD circulation. **Figure 7-11, cont'd**

with cardioplegic solution, cut to the appropriate length, and spatulated. This graft can be positioned anterior to the pulmonary artery or passed through the transverse sinus for anastomosis to the right side of the aorta.G35 A third segment of conduit can be anastomosed to one or more diagonal branches of the LAD. This segment can be brought anterior to the pulmonary artery or through the transverse sinus.

The ITA is cut to the appropriate length, and a bulldog clamp is placed on the proximal portion. If the operation has been performed using hypothermia, rewarming is begun at this time. The pericardium is incised widely to permit proper alignment of the ITA with the LAD and its diagonal branches, taking care to avoid injury to the left phrenic nerve. A pad is placed beneath the LV, and the LAD is isolated and incised. The distal end of the ITA is spatulated and sutured to the LAD and sequentially to a diagonal branch of the LAD if indicated (see Fig. 7-11, *A* and *B*).

The aortic clamp is removed, a partially occluding clamp is placed on the ascending aorta, and two or three openings are made with a punch in the isolated aortic segment. The grafts are sutured to the aorta so that they are free of kinking or tension. If grafts have been passed through the transverse sinus, they are anastomosed to openings made on the right lateral surface of the ascending aorta. Because of increasing evidence implicating the arteriosclerotic ascending aorta as an important source of emboli to the brain and other organs, it may be preferable to avoid placing the partially occluding clamp on it and to perform the proximal anastomoses during a single period of aortic clamping with the heart arrested.A25

The partially occluding clamp (or the aortic clamp if a partially occluding clamp has not been used) is then removed. Air is evacuated from the ascending aorta, and controlled aortic reperfusion, if indicated, is begun. Once rewarming has been completed and the heart is beating well, CPB is discontinued and cannulae are removed. Temporary atrial and ventricular pacing wires and chest drainage tubes are placed. Remainder of operation is completed in the standard manner (see "Completing Cardiopulmonary Bypass" in Section III of Chapter 2).

### *Without Cardiopulmonary Bypass*

Perfection of techniques and equipment for stabilizing the beating heart has resulted in an increased number of CABG procedures performed without use of CPB (OPCAB). Procedures involving placement of grafts to more than one of the three major coronary arteries are generally performed through a median sternotomy. With development of stabilization devices that permit adequate and safe exposure of all surfaces of the LV, OPCAB can be safely performed in patients with three-system disease and with left main coronary artery disease.C43,K36,P20,Y1

In contrast to CABG performed with CPB, methodology for OPCAB continues to evolve, and many issues relating to preoperative selection and preparation of patients, their anesthetic management, and conduct of the operation remain incompletely defined and unresolved. The following discussion presents a generalized representation of OPCAB, with schematic illustrations of the techniques and equipment for exposing and stabilizing surfaces of the LV.

Anesthetic management of patients undergoing CABG without CPB is discussed in Section I of Chapter 4. Close communication between the surgeon and anesthesiologist is essential during OPCAB. The surgeon must inform the anesthesiologist when and how the heart is being displaced, when a coronary artery is occluded, and when a shunt or other perfusion device is used. The anesthesiologist must keep the surgeon informed of ischemic changes detected by the ECG, occurrence of arrhythmias, and the patient's overall hemodynamic status. When the heart is displaced, amplitude of the ECG signal may be greatly decreased, and thus severity of ST-segment changes indicative of ischemia may be underestimated. Transesophageal echocardiography is used to monitor regional wall motion and right and left ventricular volumes.

A median sternotomy is made, and at the same time a segment of the greater saphenous vein (or a radial artery or other conduit) is removed (see "Vein Graft" in text that follows). Before the pericardium is opened, the left ITA and right ITA (if indicated) are completely mobilized (see "Internal Thoracic Artery" later in this chapter). Heparin is administered as dissection of the ITA is being completed. The ITA is then divided. A bulldog clamp is placed on the artery near the open end, and the distal segment of the artery on the chest wall is ligated or clipped. The pericardium is opened and pericardial stay sutures placed. Epiaortic ultrasonographic scanning of the ascending aorta to detect severe arteriosclerosis that may affect the conduct of the operation is advisable in older patients (see Chapter 26).B10,C42,F23,G7,W2

Heparin dose, optimal activated clotting time (ACT), and protocol for administering protamine vary from institution to institution. Heparin dose varies from a minimum of 5000 units to full heparinization (3 mg · kg<sup>−</sup><sup>1</sup> ). Protocols to reverse heparin activity with protamine range from no administration to partial or full doses.

Hypothermia should be avoided. Normothermia can be maintained by use of warm intravenous and irrigating fluids or a heated mattress or blanket, by humidification of the airway, and by maintaining a warm temperature in the operating room.

Hemodynamic stability during manipulation of the heart can be preserved by several maneuvers. These include placing the patient in the head-down (Trendelenburg) position, which increases preload by redistributing blood volume; rotating the operating table; and opening the right pleural space by incising the pericardium vertically. The latter two maneuvers minimize the manipulation required to create optimal exposure of the lateral wall of the LV. Placing and using temporary ventricular pacing wires will prevent prolonged periods of bradycardia. Preoperative insertion of an intraaortic balloon pump in high-risk patients may increase tolerance of the heart to manipulation.

Exposure of the LV surfaces containing the arteries to be bypassed is achieved by different combinations of elevation (apex of heart toward ceiling) and lateral displacement (apex of heart to right or left). To facilitate these maneuvers, a heavy suture (size 0 silk or polyester) is placed in the posterior pericardium opposite the oblique sinus and midway between the right and left inferior pulmonary veins (Fig. 7-12, *A*), the most dependent portion of the pericardial cavity.R10 This should be done quickly to avoid prolonged hypotension. The suture should not be placed too deeply because this may result in injury to the descending aorta or esophagus. The suture is passed through a wide strip of cloth tape (Fig. 7-12, *B*), and a snare is placed over both ends of the suture and tightened (Fig. 7-12, *C*). By adjusting orientation of the snare and tape sling and the traction placed on them, adequate exposure of the coronary arteries requiring bypass grafting can be accomplished in nearly all patients.R10 Circumferential pressure on the heart should be avoided.

Next, the artery to be grafted is stabilized with a device that depresses the myocardium to expose the segment to be grafted (Fig. 7-13, *A*). Alternatively, a device that elevates the myocardium on both sides of the segment of artery to be grafted (typically a suction device) can be used (Fig. 7-13, *B*).

Exposure of the posterior descending branch of the RCA is achieved by marked elevation of the apex of the heart with minimal lateral displacement. This is facilitated by applying traction on the ends of the cloth tape upward toward the head and to the left (avoiding compression of the heart) and using downward traction on the snare (Fig. 7-14, *A*). A stabilizing device is then applied.

Exposure of the distal RCA is obtained by leftward traction on the ends of the cloth tape, downward traction on the snare, rotation of the table to the left, and use of Trendelenburg position.

The LAD is exposed by traction on the ends of the cloth tape to the left and upward toward the head and gentle downward traction on the snare. A stabilizing device is then applied (Fig. 7-14, *B*). These maneuvers are applied more

![](_page_19_Picture_2.jpeg)

**Figure 7-12** Maneuvers to facilitate exposure of surfaces of left ventricle. **A,** Heavy suture (size 0 silk or polyester) is placed in posterior pericardium opposite oblique sinus and midway between right and left inferior pulmonary veins. **B,** Suture is placed through a wide strip of cloth tape. **C,** Snare is placed over both ends of suture and tightened.

![](_page_19_Picture_4.jpeg)

**Figure 7-13** Stabilization devices to facilitate exposure of segment of artery to be grafted. **A,** Generic device that depresses myocardium on both sides of artery. **B,** Generic device that elevates myocardium on both sides of artery, using suction.

![](_page_20_Figure_2.jpeg)

**Figure 7-14** Exposure of posterior and anterior descending coronary arteries. **A,** Posterior descending coronary artery. Heart is elevated with minimal lateral displacement by upward traction toward the head on ends of tape and downward traction on the snare. Stabilizing device is then applied. **B,** Anterior descending coronary artery. Ends of tape are pulled upward and slightly to patient's left, and downward traction in opposite direction is exerted on snare. Stabilization device is then applied.

forcefully to obtain exposure of diagonal branches of the LAD.

Exposure of the marginal branches of the Cx artery requires a combination of elevation of the apex of the heart and substantial lateral displacement to the right. This can be accomplished by pulling the ends of the cloth tape upward and to the left and applying rightward traction on the snare. Lateral displacement of the heart to the right can be facilitated by incising the right side of the pericardium and right pleura vertically to allow positioning the apex of the heart in the right pleural cavity, rotating the operating table rightward, and using Trendelenburg position.R10

After exposing the appropriate wall of the LV, the artery to be grafted is encircled proximal to the site of the arteriotomy with a fine suture, an elastic vessel loop, or a tourniquet. Encircling the artery distal to the arteriotomy site is not always necessary and should be avoided when possible. After the stabilization device is applied, the artery is incised, and anastomosis to the appropriate conduit is performed using techniques described later in this chapter (see "Distal Anastomoses"). Performing the anastomosis can be facilitated by use of a blowing device that disperses humidified carbon dioxide over the anastomotic site to remove blood. This device should be directed at the anastomotic site only during actual placement of sutures to minimize injury to the endothelium of the coronary artery. An intracoronary shunt may also facilitate performing the anastomosis, although it also may result in injury to the endothelium (Fig. 7-15). When the anastomosis is performed on a distal RCA that is not critically narrowed or occluded proximally, a shunt may be particularly valuable because bradycardia and hypotension may occur when the artery is temporarily occluded. A shunt may also provide sufficient distal flow to an arterial segment that may be an important source of collateral blood flow to other segments of the LV that have not been bypassed, thus preventing hypotension and cardiac decompensation.P21

Proximal anastomoses of vein grafts, radial arteries, or free ITA grafts to the ascending aorta are performed after placing a partially occluding clamp on the aorta (see "Proximal Anastomoses" later in this chapter). These can be performed before or after the distal anastomoses. Temporary atrial and ventricular pacing wires (if not already in place) and chest drainage tubes are placed. Remainder of the operation is completed in the standard manner (see Chapter 2).

When OPCAB is used in patients with multisystem disease, sequence of performing the distal anastomoses becomes important. As a general rule, it is advisable to first graft the artery or arteries that have evidence for collateral blood supply to the distal arterial bed. If an ITA graft is used, the clamp on the ITA pedicle is released as soon as the distal anastomosis to the coronary artery is completed. If a vein graft or another conduit is used, the proximal anastomosis of this conduit to the aorta is performed before the distal anastomosis. Flow is thus established to the distal arterial bed as soon as the distal anastomosis is completed. Vessels without demonstrable collateral blood supply are then grafted. With this approach, important collateral flow is not interrupted before flow through the grafts is established.

The common practice of performing the left ITA to LAD anastomosis first is based on the principle of restoring flow to the anterior wall and septum of the LV before substantial manipulation of the heart is performed to expose the Cx arterial branches. This approach may be valid in many patients, but it is not advised if the LAD provides substantial collateral flow to the remainder of the LV.P21

#### Vein Graft

After preoperative examination of both legs with the patient erect, and with ultrasonic imaging when indicated, the right or left greater saphenous vein is chosen for removal. Presence of superficial varicosities does not indicate an unusable saphenous vein. However, wound healing may be poor in such extremities. If possible, a leg without varicosities is chosen; multiple large varicosities in the saphenous vein render it

![](_page_21_Picture_2.jpeg)

**Figure 7-15** Intracoronary shunt can be used to facilitate performing distal anastomosis.

unsuitable. If vein from one leg is too short or too abnormal for use, an additional segment of appropriate length is removed from the other leg. Occasionally, particularly during reoperations, suitable segments of greater saphenous vein cannot be found, and the lesser saphenous vein can be used if it is of adequate diameter. If suitable segments of vein cannot be found in the legs by any method, use of alternative conduits becomes necessary. These include the right ITA, one or both radial arteries, right gastroepiploic artery, inferior epigastric artery, and, in rare circumstances, the splenic or ulnar artery. The cephalic vein can be taken from wrist to shoulder, but its walls are usually thinner than those of leg veins, and its late patency is less.W15 In critical situations in which sufficient autologous conduit is not available, suitable prepared allograft veins may be used, recognizing their reduced long-term patency.

For removal of the greater saphenous vein, the leg is abducted and the knee flexed about 45 degrees and supported (Fig. 7-16, *A*). If the vein from the lower leg is to be used, the initial skin incision is made just anterior to the medial malleolus. If the upper portion of the vein will be used, the initial skin incision is made in the groin. The desired plane is accessed by blunt dissection with scissors down to the level of the vein. Skin and subcutaneous fat are undermined with the scissors, staying just superficial to the saphenous vein and spreading the tips of the scissors over the vein. A continuous incision or multiple small incisions over the length of the vein may be used (Fig. 7-16, *B* and *C*). Creation of flaps is avoided. Care is taken to preserve the saphenous nerve. The vein may divide just above the knee, becoming confluent again just below the knee. Either of the two branches may be the larger vessel, which is preserved. The saphenous vein usually becomes too large and unsuitable for bypass purposes just before it penetrates the fascia lata and joins the femoral vein. Therefore, dissection is usually not performed in this area.

Whenever possible, a single long segment (usually 50-65 cm) of the greater saphenous vein is removed. About 12 to 15 cm may be needed for diagonal branches of the LAD, about 20 to 24 cm for marginal Cx branches, and about 18 to 22 cm for the RCA and its branches. So long as the external diameter of the vein is greater than about 3.0 to 3.5 mm, vein width is probably not an important consideration. Large veins generally reduce in size with time after insertion, and thus adaptation to function can occur.S47 Veins of overall poor quality should be avoided whenever possible; experience in peripheral vascular surgery indicates they are prone to failure.

When the usable vein has been exposed and its length measured, the proximal (femoral) end is isolated and divided between ligatures. A vascular clamp is placed on the vein to mark what will become the *distal* end of the graft. The vein is then removed, retracting it upward so that just enough tension exists to expose but not tear the branches. Branches may be ligated with fine sutures and divided, or divided between hemostatic clips (Fig. 7-17, *A*). The saphenous vein must not be narrowed by ligating or clipping the branches too close to it (Fig. 7-17, *A [upper inset]*). Branches should be ligated or clipped flush with the saphenous vein to avoid creating diverticula, which can be the nidus for thrombus formation (Fig. 7-17, *A [lower inset]*). After division of all branches and removal from its bed, the vein is divided between ligatures at its peripheral end (*proximal end* of the graft) and removed.

Alternatively, the greater saphenous vein can be removed endoscopically. Using small transverse or vertical incisions, a lighted dissector is introduced into the wounds (Fig. 7-18, *A*). A plane of dissection anterior to the vein is established with a balloon-tipped dilator or other device (Fig. 7-18, *B*) and the dissector used to isolate the vein and its branches (Fig. 7-18, *C*). The branches are clipped and divided with a cautery, and after ligating its proximal and distal ends, the vein is removed. Time required to remove veins with this technique is somewhat longer than with the conventional method, but a lower prevalence of leg wound complications and leg discomfort have been observed.A16,A21,C25,C41

If the *lesser saphenous vein* is to be used, it can be removed with the patient in the prone or supine position with the leg

![](_page_22_Picture_2.jpeg)

**Figure 7-16** Removing greater saphenous vein. **A,** Location of greater saphenous vein and line of incision. **B,** Continuous incision over entire length of saphenous vein. **C,** Multiple small incisions over saphenous vein.

![](_page_22_Picture_4.jpeg)

**Figure 7-17** Division of side branches of saphenous vein using fine ligatures or hemostatic clips. **A,** Venous branches should be secured just flush with saphenous vein to avoid narrowing *(upper inset)* or creating diverticula *(lower inset)*, which can be a nidus for thrombus formation. **B,** Avulsed branches are secured with a double-loop 7-0 polypropylene suture.

![](_page_23_Picture_2.jpeg)

**Figure 7-18** Endoscopic removal of greater saphenous vein. **A,** Insertion of lighted dissector into incision over saphenous vein. **B,** Plane of dissection immediately above saphenous vein is established with a balloon-tipped dilator. **C,** Isolation of saphenous vein and branches with lighted dissector. *Inset,* Endoscopic view.

either straightened (prone position) and elevated or flexed at the knee and rotated medially (supine position). If the prone position is used, the patient is subsequently repositioned and redraped in the supine position. Initial skin incision is made posterior to the lateral malleolus and extended superiorly toward the popliteal fossa. The vein is divided at the level where it penetrates the deep fascia to join the greater saphenous vein. The sural nerve lies parallel to the vein and is preserved. Branches of the vein are secured and divided as described for the greater saphenous vein.

Leg incisions are closed with continuous absorbable suture in the subcutaneous layers. A small drainage catheter is placed beneath these layers in the thigh, and the skin is closed with a continuous subcuticular suture or with metal clips. This can be done immediately after the vein is removed or deferred until after CPB has been discontinued and protamine administered.

The vein is removed to a preparation table, and a small adaptor is inserted into the open peripheral end and secured with a ligature. The previously placed clamp on the central end of the graft is removed. The vein is flushed with a roomtemperature, heparinized, balanced salt solution (500 mL) to which a small amount of heparinized blood (30 mL) has been added. Vasodilating drugs (nitroprusside, papaverine) can be added to reduce vasospasm. The vein is gently distended (<150 mmHg) with the solution. Any remaining unsecured branches are ligated or clipped and any constricting adventitial bands removed. Branches that have been avulsed are secured with 7-0 polypropylene sutures (see Fig. 7-17, *B*). The vein is then gently distended and clamped at the end, and a thin straight line is drawn along its length with an indelible surgical pencil. The vein is placed in the heparinized solution at room temperature until used.

It is generally agreed that details of removing and storing saphenous veins until their insertion are important in minimizing damage, which may include intimal disruption, deposition of platelets and leukocytes on the intimal surface, damage to smooth muscle, and disruption of the extracellular matrix.C16,G40,G44,L8,L18,L19,S56 Despite this general agreement, opinions differ as to which maneuvers or interventions result in the least injury. Overdistention of the veinH13 and venous spasmL18 are surely disadvantageous. No consensus exists as to the optimal temperature to maintain the graft or the optimal solution to flush and distend the graft before its insertion.

#### Arterial Grafts

# *Internal Thoracic Artery*

The ITA is usually mobilized immediately after dividing the sternum, and before incising the pericardium and administering heparin. A standard sternal retractor can be used to widely separate the divided sternal edges, tilting the retractor to elevate the left half of the sternum and expose the ITA. Alternatively, an externally positioned retractor, such as that developed by Favaloro, can be used. With either type of retractor, the operating table is elevated and rotated to optimally expose the undersurface of the left sternal segment and left ITA. The ITA can be *skeletonized* or removed as a *pedicle* with the internal thoracic veins, fat, muscle, and pleura. Skeletonization better preserves blood supply of the sternum and may be preferable in situations in which risk of sternal infection may be increased (e.g., obese patients, diabetic patients, use of both ITAs).

Fig. 7-19 shows the technique for removing the ITA with a pedicle. An incision using the electrocautery at low power is made in the parietal pleura and muscle on the medial side of the ITA, several millimeters from the accompanying internal thoracic vein (Fig. 7-19, *A*). The incision is extended along most of the length of the vessel down to the sixth intercostal space. A parallel incision lateral to the ITA and the accompanying lateral internal thoracic vein (if present) is made. Dissection is begun in the sixth intercostal space, where there are usually no branches. Using the tip of the electrocautery blade without current, the pedicle is freed from the sixth costal cartilage. With the pedicle gently retracted downward and with gentle blunt dissection, the intercostal arteries are identified and either occluded with small metal clips and divided, or simply divided with the electrocautery (Fig. 7-19, *B*). The ITA should not be grasped with instruments.

The pedicle is dissected up to the level of the second or first rib (Fig. 7-19, *C*), and the left phrenic nerve is identified and protected. If there is sufficient length, the internal thoracic vein is preserved at its junction with the brachiocephalic vein; if not, the vein is ligated or clipped and divided. It is not necessary to routinely divide the proximal branches of the ITA, although it is recognized that such branches, if not

![](_page_24_Figure_2.jpeg)

**Figure 7-19** Preparation of internal thoracic artery *(ITA)* pedicle. **A,** Using electrocautery, pleura and muscle are incised on either side of ITA and its accompanying veins. **B,** Branches of ITA and accompanying veins are divided between clips or with electrocautery. **C,** Dissection is continued to level of second or first rib. **D,** ITA pedicle is divided at level of sixth or seventh intercostal space. **E,** End of ITA is freed from adherent fascia, muscle, and veins. *Continued*

divided, can result in "steal" of blood from the LAD in some situations.S10

After proximal dissection is completed, heparin is administered and the ITA divided in the sixth or seventh intercostal space (Fig. 7-19, *D*). The proximal end is controlled with a small bulldog clamp or clip and the distal end ligated or clipped. The ITA is wrapped in a sponge saturated either with a balanced salt solution containing papaverine (20 mg) dissolved in 20 mL of saline solution, or with 500 mL of lactated Ringer solution to which 50 mg of sodium nitroprusside and 30 mL of heparinized blood have been added. If the ITA bleeds freely, even though not briskly, the graft is generally considered satisfactory for use. The ITA is not probed or injected with fluid unless there is no flow; probing or

![](_page_25_Picture_2.jpeg)

**F,** ITA is incised to appropriate length. **G,** For a side-to-side anastomosis using the ITA, pleura is incised over artery at site of anastomosis. **H,** Anastomosis is completed using a continuous 7-0 or 8-0 polypropylene suture. **Figure 7-19, cont'd**

injecting may produce endothelial damage and dysfunction.J6 If the right ITA is to be used, it is prepared in the same manner. The internal thoracic vein leaves the chest wall to enter the brachiocephalic vein at a lower level on the right than on the left, and it is usually divided. Care is taken to avoid injuring the phrenic nerve.

The left ITA pedicle is brought into the surgical field after the LAD has been opened, usually through a wide incision in the pericardium. The ITA is cut obliquely at the site for anastomosis and freed from adjacent tissue for a short distance (Fig. 7-19, *E*). It is then incised at the bottom of the bevel for the appropriate distance to correspond to the size of the opening in the artery (Fig. 7-19, *F*). It is anastomosed to the artery with a continuous 7-0 or 8-0 polypropylene suture. The ITA is not dilated or otherwise manipulated, and only the adventitia is grasped with forceps. After anastomosis is completed, the pedicle is tacked to the epicardium with a fine suture on both sides of the artery.

If the ITA is to be anastomosed to a diagonal branch of the LAD as well as to the LAD itself, anastomosis to the diagonal artery is performed first. The pleura is incised over the ITA at the site of the anastomosis (Fig. 7-19, *G*). The anastomosis is completed with a 7-0 or 8-0 polypropylene suture (Fig. 7-19, *H*). Anastomosis to the LAD is then performed.

When the left ITA does not reach the LAD but is patent, it can be used as a free graft. The proximal end of the ITA can be anastomosed directly to the aorta, to the right ITA, or to a segment of vein that has been used to bypass other coronary arteries. Patency of free ITA grafts is almost as good as that of in situ ITA grafts.L23 If the ITA has been used as a pedicle graft and is under tension after CPB is discontinued, it can be lengthened by completely dividing the tissues of the pedicle at several sites.

#### *Radial Artery*

Before operation, an Allen test is performed on the nondominant hand. The radial and ulnar arteries are compressed at the wrist while the patient opens and closes the fist vigorously (5-10 times) to produce blanching of the skin on the palm of the hand. Pressure on the ulnar artery is then released while the radial artery remains compressed. Skin of the palm of the hand should immediately become flushed as flow is restored to the palmar arch from the ulnar artery. If the test is equivocal, ultrasonic imaging may be necessary to establish the safety of removing the radial artery.

The arm is positioned on an arm board at the side of the patient. An incision is made in the forearm beginning over the radial pulse at the wrist (Fig. 7-20, *A*). It is then extended proximally over the belly of the brachioradialis muscle. The lateral antebrachial cutaneous nerve is located lateral to the incision and retracted. The deep fascia is opened at the wrist, exposing the radial vascular pedicle. Incision in the fascia is extended proximally, exposing the muscles of the forearm (Fig. 7-20, *B*). The superficial radial nerve is also lateral to the incision and should be preserved.

The vascular pedicle containing the radial artery and accompanying veins is mobilized in the middle of the forearm, then encircled in this area with an elastic vessel loop for retraction (Fig. 7-20, *C*). Dissection proceeds proximally up to the origin of the recurrent radial artery and distally to the tendons at the wrist. Branches of the artery and accompanying veins are controlled with small hemostatic clips or with cautery and are divided lateral to the accompanying veins. Proximal and distal ends of the artery are ligated, and the artery is removed. Alternatively, the artery can be removed using an endoscopic technique.

After removal, a small olive-tipped catheter is inserted into the distal end of the artery. The artery is gently irrigated and dilated with heparinized whole blood or a solution of lactated Ringer solution (500 mL) to which 50 mg of sodium nitroprusside and 30 mL of heparinized blood have been added. The graft is then immersed in this solution until it is used. The incision in the arm is closed with two continuous absorbable sutures in the subcutaneous and subcuticular layers. A compression dressing is applied, and the arm is repositioned parallel to the patient's trunk before proceeding with the remainder of the operation.

When the graft is anastomosed to the coronary arteries, it is positioned so that the smooth (posterior) surface of the radial artery lies on the surface of the heart and the anterior surface, which contains most of the branches, is visible. This surface can also be marked with an indelible surgical pencil for proper orientation.

# *Right Gastroepiploic Artery*

To expose the right gastroepiploic artery, the midline incision over the sternum is extended over the upper abdomen, and the linea alba is divided halfway from the tip of the xiphoid to the umbilicus (Fig. 7-21, *A [inset]*). With the sternum divided, excellent exposure of the upper abdomen can be obtained. The triangular ligament of the liver is divided, and the liver is retracted superiorly and to the right. Branches of the right gastroepiploic artery to the stomach and omentum are ligated or clipped and divided, creating a pedicle (Fig. 7-21, *A*). Dissection extends from the pylorus along the greater curvature of the stomach until sufficient length is achieved. After the distal end is divided, the arterial pedicle is wrapped in a sponge saturated with a solution containing 50 mg of sodium nitroprusside and 30 mL of heparinized blood dissolved in 500 mL of lactated Ringer solution.

The prepared pedicle can be positioned either anterior or posterior to the duodenum and stomach, depending on anatomic conditions (Fig. 7-21, *B*). The pedicle should be positioned where there is the least amount of tension and distortion. A circular opening is made in the diaphragm medial to the inferior vena cava, and the pedicle is passed through this opening into the pericardial cavity.

The right gastroepiploic artery can be used to bypass most coronary arteries, but it is usually anastomosed to the distal RCA or PDA (see Fig. 7-11, *H*) because these arteries are closer to the proximal portion of the gastroepiploic artery than other vessels. This approach allows creation of an anastomosis with a relatively large diameter. Anastomoses can be performed to the LAD or its diagonal branches by bringing the pedicle anteriorly over the acute margin of the heart. The pedicle can also be positioned adjacent to the atrioventricular groove posteriorly and anastomosed to a marginal branch of the Cx coronary artery (see Fig. 7-11, *H*).

#### *Inferior Epigastric Artery*

The inferior epigastric artery (IEA) originates from the medial side of the external iliac artery posterior to the inguinal ligament. The IEA pursues a course along the medial edge of the deep inguinal ring, encircling the vas deferens in men and the round ligament in women. It then ascends obliquely toward the umbilicus. In an angiographic study of 100 right IEAs by Schroeder and colleagues, 96 were considered suitable as conduits for CABG.S13 The mean length in situ from the origin to the distal bifurcation was 13 ± 1.3 cm, and the mean diameter measured 5 cm from its origin was 2.4 ± 0.40 mm.

The IEA is removed through a paramedian incision beginning at the umbilicus. Incision follows the external edge of the rectus muscle and ends 2 to 3 cm above the inguinal ligament. The anterior sheath of the rectus muscle is divided and the muscle retracted medially. The artery is mobilized with accompanying veins, and branches of the IEA and accompanying veins are clipped and divided. The pedicle containing the artery is divided at or near its origin and at the level of the first major bifurcation. The IEA is removed and wrapped in a gauze sponge soaked with a solution containing papaverine or sodium nitroprusside and immersed in this solution until it is used (see "Radial Artery" earlier in this chapter). The abdominal wound is packed with a gauze sponge and closed in two layers with absorbable suture after discontinuing CPB.

#### *Splenic Artery*

When no other conduit is available, the splenic artery can be used. It is exposed through a midline extension of the median sternotomy. The lesser peritoneal sac is opened to gain access to the splenic artery, which courses along the superior margin of the pancreas. Branches of the artery to the pancreas are ligated or clipped and divided, and the artery is then mobilized in the hilum of the spleen, where it is ligated and divided. It is not necessary to remove the spleen because it is also supplied with blood from short gastric branches of the

![](_page_27_Figure_0.jpeg)

**Figure 7-20** Removing radial artery. **A,** Location of radial artery and line of incision. **B,** Deep fascia is divided over vascular pedicle, which contains radial artery and accompanying veins. **C,** Elastic vessel loop is passed around pedicle and branches of radial artery and accompanying veins are doubly clipped and divided.

![](_page_28_Picture_2.jpeg)

![](_page_28_Figure_3.jpeg)

**Figure 7-21** Preparing right gastroepiploic artery. *Inset,* Midline sternotomy is extended onto abdomen, and linea alba is divided halfway from tip of xiphoid to umbilicus. **A,** Triangular ligament of liver is divided, and liver is retracted superiorly and to the right. Branches of right gastroepiploic artery to stomach and omentum are ligated or clipped and divided. **B,** Prepared pedicle can be positioned anterior or posterior to duodenum. It is then passed through opening in diaphragm medial to inferior vena cava.

left gastric artery. The splenic artery is passed into the pericardial cavity through a circular opening in the diaphragm medial to the inferior vena cava. The splenic artery can be anastomosed to branches of the RCA and Cx coronary artery.

# Distal Anastomoses

The technique for anastomosing the ITA to the LAD and its diagonal branches is described earlier (see Fig. 7-19, *E* to *H*). Here, techniques for anastomosis of a segment of vein are described. Although the description is explicitly for vein grafts, the techniques are applicable to anastomosis of ITA, radial artery, and other conduits to a coronary artery.

The epicardium is incised over the area of the coronary artery that has been selected for anastomosis using a scalpel blade with a rounded end or small scissors. The anterior surface of the artery can be cleared by gentle brushing with the scalpel blade. Even when crystalloid cardioplegic solution has been infused, careful inspection of the artery usually reveals a thin central line that is red or translucent, indicating location of the lumen. The anterior wall of the artery is opened longitudinally in this area with a pointed scalpel blade to avoid injury to the posterior wall (Fig. 7-22, *A*). The blade must enter the artery obliquely to avoid this injury. The incision is enlarged with fine angled scissors to a length of 4 to 6 mm (Fig. 7-22, *B* and *C*). The incision in the epicardium must extend beyond each end of the arteriotomy to facilitate the anastomosis. The artery is sized by passing calibrated probes into it, and patency of the proximal and distal segments is assessed.

When the end of the vein (or other conduit) is being prepared for the most distal anastomosis, it is beveled so that the circumference of the opening is slightly larger than the opening of the artery. The incision is made about 10% to 20% longer than that in the artery, and sutures in the vein are placed slightly farther apart than those in the artery to create the desired "cobra head" configuration. If the vein is small, a larger vertical incision provides a larger hood over the distal anastomosis.

The technique of anastomosis uses one double-armed 6-0 or 7-0 polypropylene suture placed as a continuous stitch (Fig. 7-23, *A*). Stitches in the coronary artery generally are placed from intima to adventitia (inside to outside). The stitch pierces the intima near the vessel edge, but often emerges through periarterial tissue several millimeters away from the edge. Stitches in the vein are passed from outside to inside. The stitches are generally placed separately through the artery and the vein unless it is convenient to place them with one pass of the needle holder. Even then, the vein and artery should be held apart so that the needle can be visualized after it has pierced the vein and before it pierces the artery (Fig. 7-23, *A*). This maneuver ensures that the stitch is placed accurately and no extraneous tissue has been incorporated.

The sequence of stitching varies from one location on the heart to another and may vary in the same location because of special conditions of exposure or arterial pathology. For anastomoses to the *left coronary system*, the suture is passed first through the vein (outside to inside) near the midpoint of the arterial wall opposite the surgeon for the LAD system (see Fig. 7-23, *A*) and to the surgeon's right for branches of the Cx system. The suture is then passed through the artery (inside to outside) and continued to the heel of the anastomosis. The vein is approximated to the artery by tension on both ends of the suture (Fig. 7-23, *B*). The suture line is then continued around the toe of the anastomosis, and the two ends of the suture are tied (Fig. 7-23, *C*).

For anastomoses to the *right coronary system*, the suture is passed first through the vein (outside to inside) near the midpoint of the wall of the artery opposite the surgeon (Fig. 7-24, *A*). It is then passed through the artery (inside to outside) and continued to the toe of the anastomosis. The vein is approximated to the artery, and the suture line is completed around the heel of the anastomosis and remaining far wall of the artery (Fig. 7-24, *B*). The two ends of the suture are then tied (Fig. 7-24, *C*).

![](_page_29_Figure_2.jpeg)

**Figure 7-22** Distal anastomosis in coronary artery bypass grafting. **A,** Anterior wall of coronary artery is opened with a scalpel. **B** and **C,** Incision is enlarged to the appropriate length with angled scissors.

C

**Figure 7-23** Technique of anastomosis for left coronary system grafts. **A,** Suture is passed through artery and continued to heel of anastomosis. *Inset,* Direction of suture placement. **B,** Vein is approximated to artery. **C,** Suture line is continued around toe of anastomosis and ends of suture tied.

![](_page_30_Picture_2.jpeg)

**Figure 7-24** Technique of anastomosis for right coronary system grafts. **A,** Suture line begins near midpoint of arterial wall and is continued to toe of anastomosis. *Inset,* Direction of suture placement. **B,** Vein is approximated to artery, and suture line is continued around heel of anastomosis. **C,** Suture ends are tied.

For sequential anastomoses in which the vein or other conduit will lie perpendicular to the arterial branches, the conduit can be opened perpendicular to its long axis for the *side-to-side anastomosis* if it is of sufficient diameter (Fig. 7-25, *A*). The incision should not exceed one third of the circumference of the conduit. The anastomosis is begun at the midpoint of the arteriotomy on the right side. The suture is passed inside to outside on the artery and then through the vein at the midpoint of the incision on its right side (Fig. 7-25, *B*). The suture is continued across the heel of the anastomosis, along the left side, across the toe of the anastomosis, and completed at the midpoint on the right side. If the vein is small or if the radial artery or ITA is used, the conduit is incised parallel to its long axis (Fig. 7-25, *C*), the *diamond anastomosis.*G37 The anastomosis is begun close to the midpoint of the arteriotomy on the right side, and the suture is passed through the graft close to the right end of the longitudinal incision (Fig. 7-25, *D*). The suture line is continued leftward across the heel of the anastomosis and completed as already described.

For terminal *end-to-side anastomosis*, the conduit is beveled and the suture line begun at the midpoint of the arteriotomy on the left side (Fig. 7-25, *E*). The suture line is continued to the right across the proximal end of the arteriotomy and along the right side of the artery to its midportion. Using the other end of the suture, the anastomosis is completed by continuing the suture line across the distal end of the arteriotomy and completing it at the midpoint on the right side.

If the conduit and artery are parallel rather than perpendicular, a side-to-side anastomosis is performed as shown in Fig. 7-25, *F* and *G*. The technique is identical to that for side-to-side anastomosis of the ITA to the LAD (see Fig. 7-19, *G*-*H*). After each sequential anastomosis is completed, the conduit is gently distended by injection of cardioplegic solution or a balanced salt solution to avoid excessive length or tension between sequential anastomoses.

#### Coronary Artery Endarterectomy

Endarterectomy is most often performed on the distal RCA and its major branches and only infrequently on branches of the Cx artery and LAD. If the distal RCA and its branches are diffusely diseased or occluded, endarterectomy is an alternative to bypass of the branches.

A common procedure involves incising the distal RCA just proximal to the origin of the PDA (Fig. 7-26, *A*). An endarterectomy plane in the outer third of the medial layer of the artery is developed with a dissector (Fig. 7-26, *B*). A small curved clamp is placed beneath the isolated atheromatous core, which is divided (Fig. 7-26, *C*). Using the dissector, the core is freed distally from the arterial wall (Fig. 7-26, *D*)*.* The core is then teased from the PDA and distal RCA using a clamp and exerting pressure on the core in the opposite direction from the clamp (Fig. 7-26, *E*). The core usually separates cleanly from the distal vessels and is then removed from the proximal RCA using the same technique (Fig. 7-26,

![](_page_31_Picture_2.jpeg)

**Figure 7-25** Technique of sequential grafting. **A,** Vein graft is opened perpendicular to its long axis. **B,** Anastomosis is begun at midpoint of arteriotomy on its right side. **C,** Alternatively, vein is incised parallel to its long axis. **D,** In alternative approach (diamond anastomosis with longitudinal incision in graft), suture is passed through graft close to right end of incision and continued across heel of anastomosis. **E,** End-to-side anastomosis. *Inset,* Direction of suture placement for side-to-side and end-to-side anastomoses. **F** and **G,** Side-to-side anastomosis. Technique is identical to that in Fig. 7-16, *G* and *H*. Key: *A,* Coronary artery; *G,* graft.

*F*). A saphenous vein or other conduit is then sewn to the edges of the artery with 6-0 or 7-0 polypropylene suture (Fig. 7-26, *G*).

#### Proximal Anastomoses

After completing the last distal anastomosis, and when the procedure is being performed with CPB, the proximal anastomoses are performed. The aortic clamp can be removed, and a partially occluding, side-biting clamp placed on the ascending aorta. This permits reperfusion of the heart and resumption of cardiac contractions as rewarming is completed. However, the side-biting clamp is not necessary, and is not used when there is important arteriosclerosis of the ascending aorta (see "Surgical Strategy" earlier in this chapter) or if it is of insufficient length. In these situations, the aortic clamp is left in place and the heart remains arrested.

Using a punch, openings are made in the ascending aorta. Vein grafts or other conduits are positioned so that they will be free of kinking or tension when the heart is filled with blood. They are aligned properly using the mark previously placed on the conduit to avoid twisting. The vein is cut obliquely and incised to create a circumference that is 10% to 20% larger than that of the circular opening in the aorta, resulting in a "cobra head." A double-armed 5-0 or 6-0 polypropylene suture line is begun in the middle of the right

![](_page_32_Picture_2.jpeg)

**Figure 7-26** Endarterectomy of right coronary artery *(RCA).* **A,** RCA is incised just proximal to origin of posterior descending coronary artery *(PDA)*. **B,** Endarterectomy plane is developed with a dissector. **C,** Atheromatous core is divided over a clamp. **D,** Core is freed distally from arterial wall. **E,** Core is teased from posterior descending coronary artery and distal RCA. **F,** Core is removed from proximal RCA. **G,** Vein graft is sewn to edges of artery (see Fig. 7-24).

edge of the vein graft, passing the suture from outside to inside on the vein and then inside to outside on the aorta (Fig. 7-27, *A*). This suture line is continued leftward across the heel of the anastomosis. The vein is approximated to the aorta by exerting tension on both ends of the suture. The suture line is continued across the toe of the anastomosis (Fig. 7-27, *B*), and the ends of the suture are tied on the right side of the anastomosis (Fig. 7-27, *C*).

When CPB is not used, these proximal anastomoses are generally performed before the distal anastomoses using a partially occlusive, side-biting clamp (see "Without Cardiopulmonary Bypass" under Coronary Artery Bypass Grafting earlier in this chapter). When CPB is used, proximal anastomoses can be performed before or after CPB is established, but before the aorta is occluded and cardioplegic solution is administered. Use of CPB facilitates performing proximal anastomoses because of lower pressure in the ascending aorta.

Several devices are available to attach vein grafts to the aorta without use of sutures. Other devices permit suture of grafts to the aorta without need for aortic clamping.

#### Emergency Operation for Cardiogenic Shock

If the patient is hemodynamically unstable at the time of operation, an intraaortic balloon pump is inserted if one is not already in place. Appropriate monitoring devices are inserted, the sternum quickly opened, and CPB expeditiously established. The left ITA can be mobilized after CPB is established, with the heart decompressed but still beating. Saphenous vein is removed from one or both legs as needed.

![](_page_33_Picture_2.jpeg)

**Figure 7-27** Proximal anastomosis in coronary artery bypass grafting. **A,** After incising conduit on its undersurface and creating an opening in aorta, suture line is passed from outside to inside on conduit and then inside to outside on aorta. **B,** Conduit is approximated to aorta. **C,** Suture line is continued across toe of anastomosis and completed.

Optimal myocardial management is essential under these circumstances, and use of warm cardioplegic induction and controlled aortic reperfusion may be advantageous (see "Methods of Myocardial Management during Cardiac Surgery" in Chapter 3). Operation is completed as described under "Surgical Strategy" earlier in this chapter. If intraaortic balloon pumping is insufficient to permit safe discontinuation of CPB, use of extracorporeal membrane oxygenation (ECMO) or a temporary ventricular assist device may be necessary (see "Temporary Ventricular Assistance" in Section I of Chapter 5).

#### Reoperation

#### *Secondary Median Sternotomy*

The technique of most (but not all) CABG reoperations is similar to that of the original operation, with a few important differences. Sternotomy is most often made with an oscillating saw (see Section III of Chapter 2 for technique). Vein grafts are obtained from the leg, and one or both ITAs can be mobilized if they were not used at the initial operation. The radial artery can also be used. If difficulties are anticipated with mobilizing the heart, ascending aorta, or previously inserted vein grafts (i.e., they are adherent to the undersurface of the sternum), provisions are made for peripheral cannulation, such as through the femoral or axillary artery and femoral vein (see "Cardiopulmonary Bypass Established by Peripheral Cannulation" in Section III of Chapter 2). CPB can be established before dividing the sternum, then temporarily discontinued until the heart has been mobilized, or it can be established and maintained until the operation is completed.

After the sternum is divided, and if peripheral cannulation is not used, the right atrium and ascending aorta are mobilized to permit placing cannulae and clamps. Mobilization of the ventricles (the left in particular) is begun only after CPB is initiated.L27 The heart is completely mobilized. If the left or right ITA was used at the initial operation and is patent, the pedicle is sufficiently mobilized to permit placing a small clamp across it. Manipulation of previously placed vein grafts is minimized to avoid dislodging atheromatous debris into the distal coronary circulation.

The aorta is occluded after CPB is established and cardioplegic solution is administered into the aortic root. Subsequent infusions are given into the aortic root or retrogradely into the coronary sinus (see "Technique of Retrograde Infusion" in Chapter 3). Severely narrowed or diffusely atherosclerotic vein grafts are divided and ligated immediately after the first dose of antegrade cardioplegia. If there is concern about possible dislodgement of atheromatous debris into the distal coronary circulation as a result of manipulating a diseased graft, it is divided and ligated proximally, and retrograde cardioplegia is then administered. This may permit washout of debris from the opened graft. The distal end of the divided graft is then ligated.

Managing vein grafts that have no or minimal evidence of atherosclerosis (as determined by angiography) and that are soft and relatively normal in appearance is controversial. Some centers favor complete removal of grafts that have been in place for more than 5 or 6 years; other centers leave such grafts in place. If a diseased graft is to be removed and there is no important obstruction in the coronary artery distal to the site of attachment, it is possible in some circumstances to leave a small cuff of this graft adjacent to the artery, which can then be anastomosed to the new graft. If there is important occlusive disease in the coronary artery distal to the site of the previous anastomosis, a new vein graft should be anastomosed directly to the artery beyond the obstruction. If an ITA is to be attached to the LAD previously bypassed by a vein graft that is not occluded or critically stenotic, the vein graft should not be ligated, because the ITA may not initially provide sufficient flow to prevent serious myocardial ischemia.J10

A diligent search should be made for all graftable vessels. After completing the distal anastomoses, proximal anastomoses to the ascending aorta are completed. In general, it is preferable to perform these anastomoses with the aortic clamp in place, thus avoiding need for placing a partially occluding clamp on the aorta. After completing the proximal anastomoses, the aortic clamp is removed and the operation completed as previously described.

Reoperations can be performed without use of CPB, employing the OPCAB technique described previously in this chapter.S16,S55

# *Left Thoracotomy*

An alternative approach through a left thoracotomy is a convenient and safe method for reoperationB69,B71,C30,G3,U1 and is frequently chosen when branches of the Cx artery and diagonal branches of the LAD are to be revascularized. Occasionally, branches of the posterolateral segment of the RCA are accessible through this approach. It is particularly useful in the presence of a patent and functioning ITA graft to the LAD. It may also have value when the ascending aorta is heavily calcified and therefore hazardous to manipulate.

It is sometimes necessary to remove the needed segment of saphenous vein with the patient supine. After rotating the patient to a near right lateral decubitus position, a left thoracotomy is made through the bed of the resected or nonresected fifth rib. The left femoral artery and vein are simultaneously exposed through a vertical or oblique groin incision after rotating the patient's hips back toward the surgeon. The femoral artery and vein are cannulated, making certain the 28F, 30F, or 32F long venous cannula passes over the promontory of the sacrum and into the inferior vena cava (see "Cardiopulmonary Bypass Established by Peripheral Cannulation" in Section III of Chapter 2). CPB is established in the usual manner, and the patient's body temperature is reduced to about 22°C with perfusate. If an additional route of venous return is necessary, the pulmonary artery is cannulated with an angled cannula (28F, 30F, or 32F) positioned across the pulmonary valve into the right ventricle. Usually the heart spontaneously fibrillates, but if not, it is electrically fibrillated. Once the patient's nasopharyngeal temperature is below about 25°C, CPB flow can be reduced to about 1.0 to 1.5 L · min<sup>−</sup><sup>1</sup> · m<sup>−</sup><sup>2</sup> . A left-sided heart vent may be needed and can be inserted into the left atrial appendage or through the left inferior pulmonary vein. Distal anastomoses are made as usual, using fine sutures or elastic tourniquets around the coronary artery.

When these maneuvers have been completed, rewarming is begun, and the heart usually spontaneously defibrillates. Proximal anastomoses, performed with a side-biting clamp, are made to the proximal descending thoracic aorta, curving the bypass graft superiorly over the hilum of the lung or inferiorly around the hilum, attaching the vein to the lower descending thoracic aorta. The left subclavian artery can also be used as a site for attaching grafts. Remainder of operation is completed in the usual manner.

Reoperations using the left thoracotomy approach can also be performed without CPB.B71,S54

# SPECIAL FEATURES OF POSTOPERATIVE CARE

#### Early Postoperative Care

Most patients are extubated either in the operating room or a few hours postoperatively and discharged from the intensive care unit the following day. Discharge from the hospital to outpatient supervision may occur on the third or fourth postoperative day. Thus, postoperative care is simple in most patients (see Chapter 5).

Occasionally, 8 to 12 hours after operation, arterial blood pressure falls to levels 10% to 20% below normal, whereas pedal pulses remain full and cardiac index is greater than 2.0. No treatment or a low-dose (2.5 µg · kg<sup>−</sup><sup>1</sup> · min<sup>−</sup><sup>1</sup> ) infusion of dopamine is indicated.

Oral β-adrenergic receptor blocking agents may be given beginning 4 to 6 hours postoperatively. This regimen is continued until discharge as prophylaxis against supraventricular tachyarrhythmias.F22,W16 Alternatively, no prophylactic medication is given, although a case can be made for prophylaxis in elderly patients, who are more susceptible to postoperative atrial fibrillation.F22,H12 Digitalis is not routinely used prophylactically because it may produce atrial and ventricular arrhythmias and is less effective than other drugs.K32 Other drugs or combinations of drugs are recommended by some authors.G22,K3,K32,P4,R22 Biatrial pacing may reduce the prevalence of postoperative atrial fibrillation.D3,F4,G27,L14

Warfarin is not routinely administered. A modification of the aspirin-dipyridamole protocol evolved by Chesebro and colleagues is used to enhance graft patency because of its antiplatelet effect.C27,C28 In this modified protocol, aspirin (325 mg) is administered through a nasogastric tube 1 hour after operation. Another 325 mg is given by nasogastric tube 7 hours postoperatively and is continued by mouth once daily thereafter.G19,G20 Although perioperative bleeding may be increased with this protocol, major complications are not encountered. The patient is advised to continue this protocol for at least 1 year.P14 Aspirin in a dose of 80 mg daily may be sufficient for maintenance, except in large patients. In patients with a history of aspirin intolerance, clopidogrel, ticlopidine, or prasugrel may be substituted. Heparin (5000-7500 units every 8 to 12 hours) can be administered subcutaneously as prophylaxis against deep venous thrombosis and pulmonary embolism in the first 48 to 72 hours postoperatively.

Occasionally, intraaortic balloon pumping is required for a few hours to a few days after operation (see Chapter 5). The indication is usually low cardiac output with high left atrial pressure or occasionally occurrence of intractable ventricular arrhythmias intraoperatively or early postoperatively. If this is not effective, placing temporary left and right ventricular assist devices may be necessary (see "Temporary Ventricular Assistance" in Section I of Chapter 5).

#### Late Postoperative Care

In contrast to many surgical procedures, CABG is simply one facet of treatment of patients with arteriosclerotic CAD. Late postoperative care relative to the basic disease arteriosclerosis—is as important as late postoperative care relative to the bypassing conduits. This has been discussed in considerable detail in reports by the American College of Cardiology/American Heart Association (ACC/AHA) Joint Task Force Subcommittee on Coronary Artery Bypass Graft Surgery.A5,E2

#### Facilitation of Complete Recovery

During the first 6 to 8 weeks of convalescence from CABG, patients often have a poor appetite, insomnia, emotional depression, loss of sexual ability, lack of desire to return to

|           | Coronary Artery   |     |     | Dipyridamole and Aspirin |    |        |     |                    |    |        |           |  |
|-----------|-------------------|-----|-----|--------------------------|----|--------|-----|--------------------|----|--------|-----------|--|
|           | Internal Diameter |     |     | Anastomosis Patent       |    |        |     | Anastomosis Patent |    |        |           |  |
| ≤         | mm                | <   | n   | No.                      | %  | CL (%) | n   | No.                | %  | CL (%) | P[χ2<br>] |  |
|           |                   | 1   | 9   | 6                        | 67 | 44-85  | 15  | 6                  | 40 | 25-57  | .21       |  |
| 1         |                   | 1.5 | 128 | 120                      | 94 | 91-96  | 113 | 80                 | 71 | 66-75  | <.0001    |  |
| 1.5       |                   | 2.0 | 98  | 90                       | 92 | 88-95  | 38  | 20                 | 53 | 43-62  | <.0001    |  |
| 2.0       |                   |     | 15  | 14                       | 93 | 79-99  | 19  | 18                 | 95 | 83-99  | .9        |  |
| P[χ2<br>] |                   |     | .04 |                          |    |        |     | .001               |    |        |           |  |

**Table 7-3** Association of Late (1-Year) Graft Patency after Coronary Artery Bypass Grafting with Regimen of Pre/Postoperative Dipyridamole/Aspirin and with Coronary Artery Size

Modified from Chesebro and colleagues.C28 Key: *CL,* 70% confidence limits.

work, and visual, memory, or intellectual deficits and other potentially disabling manifestations of the postoperative state. Studies have documented the transient nature of most of these phenomena. The responsible physician and staff should reassure the patient in this regard and help him or her return to usual activities as rapidly as possible. During this period, excessive medications may predispose the patient to symptoms, and their minimization is frequently beneficial.

A program of daily exercise should be started as soon as the patient leaves the hospital, with emphasis on regular walking for progressively longer periods. This program should be individualized, based primarily on knowledge of completeness of the operation and LV function, and on preoperative physical status of the patient. Formal programs of rehabilitation can be helpful in guiding some patients through the resumption of physical activity. Ultimately, and unless specifically contraindicated, patients should be encouraged to obtain some form of regular physical activity daily and to increase this over the months after operation. Patients who were active and gainfully employed before surgery are urged to return to full activity and employment as soon as possible and, except in unusual circumstances, no later than 2 to 3 months postoperatively.

# Promotion of Graft Patency

Aspirin (325 mg · day<sup>−</sup><sup>1</sup> ) should be administered immediately after operation and continued for at least 1 year postoperatively. Efficacy of this regimen has been well established,F24,G11,G19,G20,P14 particularly when anastomoses have been made to smaller coronary arteries (Table 7-3). However, more recent studies indicate that a lower dose of 80 to 100 mg daily appears to be as effective as 325 mg. Ticlopidine, clopidogrel, or prasugrel can be used in patients who are allergic to or intolerant of aspirin.

Control of risk factors for arteriosclerosis probably retards, and may even reverse to some extent, development of atherosclerosis in vein grafts.B30,C5,C7,K20,P3,P17,S51,S57,S58 This is an added reason for recommendations in the text that follows.

# Control of Risk Factors for Arteriosclerosis

A well-developed body of knowledge exists concerning risk factors for arteriosclerosis. The general consensus is that this knowledge should be focused on patients who have established CAD and who undergo CABG. Smoking must be stopped, and cessation must be emphasized to the patient even before operation. An appropriate body weight should be maintained, even if special dieting is required. Hypertension and saturated fats in the diet must be controlled, and serum lipids should be kept within proper levels through dietary measures and administration of specific medication if required.A5,B58,C12,G24,K1,W3

# Surveillance for Recurrent Myocardial Ischemia

Stress testing should be performed 6 weeks to 3 months after operation to obtain a baseline and to prescribe an appropriate cardiac rehabilitation program. When a postoperative patient with an initially negative post-CABG stress test later develops a positive one, this is usually a reliable indicator of either graft closure or progression of disease in the native circulation.A26,M17 In addition, myocardial perfusion imaging with either exercise stress or dipyridamole infusion can enhance detection of recurrent myocardial ischemia in patients with resting ST–T wave abnormalities.M17

# RESULTS

Because CABG is probably the most completely studied operation in history, an enormous amount of information is available about outcomes. There is minimal value in presenting outcome simply as "survival" or "freedom from some unfavorable event" of a heterogeneous group of patients. Only risk-adjusted depictions are truly informative, as emphasized early by DeRouen, Detre, Green, Kouchoukos, and their colleagues.D7,D10,G28,K30

This section makes no comparisons of outcomes after medical treatment or PCI. Instead, this information is presented later in this chapter under Indications for Operation, because such comparisons are the basis for these indications. Where appropriate, comparisons between CABG performed with and without CPB are presented.

# Early (Hospital) Death

Risk of early (hospital) death has been extensively studied. Risk stratification models have been created to provide accurate prediction of operative risk for groups of patients

![](_page_36_Figure_2.jpeg)

Figure 7-28 Operative mortality for coronary artery bypass grafting in various age cohorts in New York State Cardiac Surgery Reporting System for 1991-1992 (n = 30,972). (From Eagle and colleagues.<sup>E2</sup>)

undergoing CABG (see "Risk Stratification" in Section VI of Chapter 6). S34 Large databases have been established in single institutions and in multicenter studies, and analyses of these data have established the predictive power of certain preoperative variables. In an analysis of seven large datasets representing more than 172,000 patients, Jones and colleagues identified seven variables most predictive of early mortality. The same control of the seven variables most predictive of early mortality.

- Older age (Fig. 7-28)<sup>E2,H8</sup>
- Female gender<sup>E6</sup>
- Previous CABG
- Urgency of operation
- Increasing LV dysfunction
- Left main disease
- Increasing extent of coronary artery disease

The relative mortality risks of these variables are shown in Table 7-4 for six of the data sets.

Older age has consistently predicted operative risk after CABG<sup>E2,H8</sup> (see Fig. 7-28). Female gender is also independently associated with increased operative risk. E6 Previous CABG and emergency operation are associated with substantial increases in relative risk (2.0 or greater). Other variables associated with increased early mortality are recent (<30 days) Q-wave myocardial infarction and comorbidities (e.g., diabetes, metabolic syndrome, end-stage renal disease, valvar heart disease, chronic obstructive pulmonary disease, severe peripheral arterial disease, anemia, atrial fibrillation), A7,E2,E4,K37,V4 and perhaps lack of use of the ITA.

In randomized clinical trials comparing on-pump and off-pump procedures, no difference in early mortality was observed,  $^{B66,O5,P22,V2}$  although Tarakji and colleagues have raised the possibility of decreased intermediate-term survival in their meta-analysis of randomized trials.  $^{C26,F7,M29,S41,T2}$ 

#### Time-Related Survival

In general, after isolated CABG, approximately 98% of heterogeneous groups of patients survive at least 1 month, and 97%, 92%, 81%, and 66% survive 1, 5, 10, and 15 years or more, respectively (Fig. 7-29, *A*). S24

The hazard function for death has an early and rapidly declining phase that merges with a constant hazard phrase at about 6 months, and this gives way to a gradually rising phase of hazard at about 1 year (Fig. 7-29, *B*). This rising phase probably results from closure of grafts, progression of native arterial disease, but mostly from comorbidities. This phase of hazard is particularly favorably affected by use of ITA grafts. A6,C3,K16,L26

#### Morbidity

Common postoperative complications that result in substantial morbidity and their management are discussed in Chapter 5. Several of these morbidities deserve special emphasis.

#### **Adverse Cerebral Outcomes**

Postoperative neurologic deficits are an important cause of postoperative morbidity and mortality after CABG. Important neurologic injury occurs in up to 5% to 6% of patients who undergo CABG with CPB. In several randomized trials, a lower prevalence of neurologic injury was not observed among patients undergoing OPCAB procedures. P22,S41,V2

A multicenter study by Roach and colleagues of 2108 patients undergoing CABG with CPB documented adverse cerebral outcomes in 129 patients (6.1%). Type 1 deficits (major focal deficits, stupor, and coma) occurred in 3.1%, and type 2 deficits (deterioration in intellectual function or memory) in 3.0% of the patients. In addition to increased early mortality in these groups (21% for type 1 and 10% for type 2 deficits), hospital length of stay and likelihood of discharge to a nursing home were substantially increased compared with the remaining patients. Predictors of type 1 deficits included presence of proximal aortic arteriosclerosis, history of prior neurologic disease, use of intraaortic balloon pump, diabetes, hypertension, unstable angina, and older age.

Tarakji and colleagues differentiated intraoperative strokes from those occurring after awakening, finding that either operative or off-pump techniques that avoided manipulation of the arteriosclerotic aorta were associated with fewer intraoperative strokes.<sup>T2</sup>

#### Mediastinitis

Deep sternal wound infection occurs in 1% to 4% of patients after CABG with CPB and is associated with increased mortality. E2,L24,S41 Obesity is a risk factor for mediastinitis. M21,N1 Other factors associated with an increased prevalence of deep wound infection include diabetes, previous CABG, use of both ITAs, and duration of operation. K31,M21,N1 Randomized trials have shown that off-pump CABG is not associated with a lower prevalence of sternal wound infection. B66,S41,V2

#### Renal Dysfunction

In a multicenter study of renal dysfunction after CABG with CPB in 2222 patients, "dysfunction" was defined as a post-operative serum creatinine level of 2.0 mg · dL<sup>-1</sup> or greater, or an increase of 0.7 mg · dL<sup>-1</sup> or more from preoperative level.<sup>M5</sup> Renal dysfunction occurred in 171 (7.7%) patients,

**Table 7-4** Relative Risks for Early Mortality after Coronary Artery Bypass Grafting in Six Large Data Sets

|                            | NNEO1      | VAG36     | STSE7             | NYSH9       | CCH17     | AGHM3       |
|----------------------------|------------|-----------|-------------------|-------------|-----------|-------------|
| Number of patients         | 3055       | 12,712    | 774,881           | 57,187      | 5051      | 1567        |
| Year of publication        | 1992       | 1993      | 2008              | 1994        | 1992      | 1996        |
| Years included             | 1987-1989  | 1987-1990 | 2002-2007         | 1989-1992   | 1986-1988 | 1991-1992   |
| Type                       | Vol reg    | Man nat   | Vol nat           | Man state   | SI        | SI          |
| Database Variables         |            |           |                   |             |           |             |
| Age (years)a               | 1.04       | 1.04      | b                 | 1.04        | 1.05      | NA          |
| Female gender              | 1.2        | NA        | c                 | 1.52        | 1.63      | 1.48        |
| Prior heart operation      | 3.6        | 3.2       | 3.1               | 3.73        | 1.72      | 1.39        |
|                            |            |           | 4.2 (multi reops) |             |           |             |
| Left main disease (≥70%)   | NS         | NA        | NA                | 1.43 (>90%) | NA        | NA          |
| Number of Diseased Systems |            |           |                   |             |           |             |
| One                        | 1.0        | NA        | 1.0               | NA          | NA        | NA          |
| Two                        | 1.3        | NA        | 1.17              | NA          | NA        | NA          |
| Three                      | 1.6        | NA        | 1.17d             | NA          | NA        | NA          |
| Urgency of Operatione      |            |           |                   |             |           |             |
| Elective                   | 1.0        | 1.0       | 1.0               | 1.0         | 1.0       | 1.0         |
| Urgent                     | 2.1        | 2.4       | 1.16              | 1.42        | NA        | 3.5         |
| Emergency                  | 4.4        | 3.8       | 2.8               | 3.98        | 5.07      | 7.14        |
| Salvage                    | NA         | NA        | 8.0               | NA          | NA        | 29.9        |
| Ejection Fraction          |            |           |                   |             |           |             |
| Per 0.1-unit decrease      | NA         | NA        | 1.19              | NA          | NA        | NA          |
| ≥0.60                      | 1.0        | NA        | NA                | 1.0 (>40%)  | NA        | NA          |
| 0.50-0.59                  | 1.4        | NA        | NA                | NA          | NA        | NA          |
| 0.40-0.49                  | 1.6        | NA        | NA                | NA          | NA        | NA          |
| 0.30-0.39                  | 1.9 (<40%) | NA        | NA                | 1.63        | NA        | 2.89 (<30%) |
| 0.20-0.29                  | NA         | NA        | NA                | 2.21        | NA        | NA          |
| <0.20                      | NA         | NA        | NA                | 4.06        | NA        | NA          |

Data from Eagle and colleagues.E2

and 30 (1.4%) required dialysis. Early mortality was 0.9% among patients who did not develop renal dysfunction, 19% in those with renal dysfunction who did not require dialysis, and 63% among those who required dialysis. Preoperative risk factors for renal dysfunction included advanced age, moderate to severe cardiac failure, previous CABG, diabetes, and preexisting renal disease.M5 In two randomized trials, prevalence of postoperative renal failure was similar in on-pump and off-pump groups.B66,V2

# Modes of Death

Most deaths early and late after CABG are from cardiac failure, which could be termed *cardiac death* (Table 7-5). A smaller proportion of deaths (about 15%) are sudden, considerably less than in the natural history of patients with CAD. Although it is difficult to be certain, about 25% of all deaths early and late after CABG are unrelated to the ischemic heart disease or the operation.

#### Incremental Risk Factors for Premature Death

Many patient-specific risk factors for death in patients with arteriosclerotic heart disease pertain to patients who have undergone CABG (see Box 7-1). In addition, procedural and institutional incremental risk factors affect outcome (Table 7-6).

Relative risk coefficient for age indicates additional mortality risk per year of age > 50 years.

Age 60 vs. 50 years, 1.36; age 70 vs. 50 years, 2.53; age 80 vs. 50 years, 4.70.

Among females: BSA 1.6 vs. 2.0, 1.26; BSA 1.8 vs. 2.0, 1.02; BSA 2.2 vs. 2.0, 1.20. Among males: BSA 1.6 vs. 2.0, 1.75; BSA 1.8 vs. 2.0, 1.20; BSA 2.2 vs. 2.0, 1.01. Female vs. male at BSA 1.8, 1.31.

Three- vs. two-system disease.

*e Urgent* indicates that patients are required to stay in hospital but may be scheduled and operated on within a normal scheduling routine; *emergency,* ongoing refractory cardiac compromise unresponsive to other forms of therapy except for cardiac surgery; *salvage,* ongoing cardiopulmonary resuscitation en route to operating room.

Key: *AGH,* Allegheny General Hospital; *CC,* Cleveland Clinic; *Man,* mandatory; *multi reops,* multiple reoperations; *NA,* not available; *nat,* national; *NNE,* Northern New England Cardiovascular Disease Study Group; *NS,* not significant; *NYS,* New York State's Cardiac Surgery Reporting System; *reg,* regional; *SI,* single institution; *state,* single state; *STS,* Society of Thoracic Surgeons National Cardiac Surgery Database; *VA,* Veterans Affairs Cardiac Surgery Database; *Vol,* voluntary.

![](_page_38_Figure_2.jpeg)

**Figure 7-29** Survival after coronary artery bypass grafting (CABG). **A,** Time-related survival in a heterogeneous group of patients. *Circles,* Individual deaths, positioned along horizontal axis at time of death and along vertical axis according to Kaplan-Meier estimator; *vertical bars,* 70% confidence limits; *(parentheses),* number of patients still being traced; *solid line* (not visible in some areas because of density of circles), nomogram of separately determined parametric survival; *dashed lines* enclose 70% confidence limits; *dot-dash-dot line,* survival of age-gender-ethnicity–matched general population. **B,** Hazard function for death in same group of patients. Note (1) early, rapidly declining phase; (2) constant phase, which elevates entire hazard function above baseline; and (3) slowly rising third phase. (Modified from Sergeant and colleagues.S24)

**Table 7-5** Modes of Death after Coronary Artery Bypass Grafting*<sup>a</sup>*

|                                     |     | All Deaths after CABG |
|-------------------------------------|-----|-----------------------|
| Mode                                | No. | Percent of 545        |
| Cardiac                             | 298 | 55                    |
| Failurea                            | 216 | 40                    |
| Acute                               | 145 | 27                    |
| Subacute                            | 35  | 6                     |
| Chronic                             | 36  | 7                     |
| Sudden                              | 78  | 14                    |
| Arrhythmia                          | 4   | 0.7                   |
| Cancer                              | 90  | 17                    |
| Neurologic                          | 53  | 10                    |
| Trauma                              | 27  | 5                     |
| Pulmonary failure                   | 19  | 3                     |
| Pulmonary<br>thromboembolism        | 10  | 2                     |
| Hemorrhage                          | 10  | 2                     |
| Acute intraabdominal<br>catastrophe | 6   | 1                     |
| Hepatic failure                     | 6   | 1                     |
| Infection                           | 5   | 0.9                   |
| Renal failure                       | 3   | 0.6                   |
| Miscellaneous                       | 8   | 1                     |
| Uncertain                           | 10  | 2                     |
| TOTAL                               | 545 | 100.7                 |
|                                     |     |                       |

Data from Sergeant and colleagues.S28

Cardiac failure, which could be termed *cardiac death*, is considered *acute* when it occurs within 3 days of an operation or a new myocardial infarction; *subacute* when it occurs between 3 days and 6 weeks of such events; and *chronic* when it occurs more than 6 weeks after an event that appears responsible for it, or when death is in the syndrome of chronic heart failure but is not preceded by an identified proximal previous event.

**Table 7-6** Procedural Risk Factors for Death after Coronary Artery Bypass Grafting*<sup>a</sup>*

|           | Incomplete revascularization                                                        |
|-----------|-------------------------------------------------------------------------------------|
|           | Nonuse of internal thoracic artery to left anterior<br>descending artery            |
| (Longer)  | Global myocardial ischemic time interacting<br>with method of myocardial management |
| (Longer)  | Cardiopulmonary bypass time                                                         |
|           | Surgeon                                                                             |
| (Earlier) | Date of operation                                                                   |

Institution where procedure is performed may also be a risk factor.

The Califf-Harrell nomogram and its conceptual bases are fundamental to understanding risk factors and outcome after interventional therapyC1 (Fig. 7-30). Only patient risk factors summarized as "reversible ischemia" (see Box 7-1) can be neutralized by CABG (or PCI), and when neutralized, outcome is determined in large part by other risk factors. "Vessel stenoses neutralized" (see Fig. 7-30) depicts *potential* for improvement ("comparative benefit") by interventional therapy because this possibility is determined by number of systems (vessels) stenosed. *Actual* improvement, or "comparative benefit," is determined by the *actual* number of systems with important stenoses that are in fact neutralized by interventional therapy.

The depiction emphasizes that the greater the number and severity of patient-specific risk factors, the greater the comparative benefit (in terms of survival) of interventional therapy. At the same time, 5- or 10-year survival is less when patient risk factors are numerous. It also illustrates that the favorable effect of interventional therapy is difficult to demonstrate, even though present on conceptual grounds, in most patients with good LV function and few unfavorable risk factors.

A classic parsimoniously derived multivariable risk factor equation for death after CABG has been derived by

![](_page_39_Figure_2.jpeg)

**Figure 7-30** Nomogram of an equation describing comparative benefit of coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) over medical treatment. *Comparative benefit* is difference in percent freedom from cardiovascular deaths after two treatments at some time*.* Patient's position on horizontal axis conceptually is determined by sum of all patient risk factors, such that the higher the percent freedom from cardiovascular death, the fewer the risk factors in the particular patient. Comparative benefit, along vertical axis, is determined by interrelationship between patient's position along horizontal axis and number of coronary arteries with stenoses completely neutralized by interventional therapy *(isobars)*. Values of isobars are in fact hazard ratios that represent effect on comparative benefit of number of arteries with important stenosis in patients undergoing CABG, assuming all stenoses are neutralized by interventional therapy. Nomogram pertains when time *(t)* is 2 to 7 years (time of approximately proportional hazards) after CABG (or PCI) and when early risks of intervention (CABG or PCI) are negligible. Abstract equation is as follows:

Comparative benefit = 
$$S_{CABG}(t) - S_{M}(t)$$
  
 $S_{M}(t)^{h} = SCABG(t)$ 

Key: *CABG,* Coronary artery bypass grafting; *h,* hazard ratio; *LM,* left main coronary artery; *SCABG,* survival after CABG; 5*D,* vessels diseased (stenosis > 50%); *SM,* survival with medical treatment; *t;* time. (Modified from Califf and colleagues,C1 and from Califf RM, Harrell FE Jr: personal communication; 1990.)

Blackstone, working with Sergeant and colleaguesK16,S24,S28 (Table 7-7). Actual risk factors are similar to those derived from other experiences.

*Strength* and *shape* (time of maximal effect) of risk factors are best determined by nomograms that also have the advantage of presenting risk-adjusted depictions (see Chapter 6). *Number* of systems with important stenoses is a weak risk factor for death after CABG in the first 5 years (Fig. 7-31, *A*) when revascularization is complete and the ITA is used for the LAD graft. Also, number of diseased vessels and even left main coronary artery stenosis, as well as number of distal anastomoses, are not risk factors for hospital death when an adequate operation has been performed.

Pre-CABG LV function, expressed as *ejection fraction*, has a powerful effect on time-related outcome (Fig. 7-31, *B*-*C*), particularly when it is low.A8,C34 Surprisingly, some patients with low EF have none of the symptoms of *chronic heart failure*. Presence of this syndrome, often associated with secondary mitral regurgitation (see Chapter 10), increases the risk above that for low EF alone.P11,W6

*Unstable angina* has a minimally unfavorable effect on survival (Fig. 7-31, *D*).

Some patients undergo CABG soon after an acute MI. Use of CABG for primary reperfusion during Q-wave MI has been largely superseded by thrombolysis and PCI. Early risks of CABG are increased only when operation is performed for acute hemodynamic deterioration after an acute (usually Q-wave) MI or for any reason within about 8 days of a Q-wave infarction.K6,K16 Early mortality in patients operated on for cardiogenic shock after an acute MI also depends on other risk factors and largely on methods of treatment. When intense resuscitative measures such as intraaortic balloon pumping stabilize the hemodynamic state before operation, early mortality may be as low as 5%.G44 When cardiogenic shock is present until operation or until establishment of CPB, mortality is higher.A24 However, using best available methods of myocardial management intraoperatively (see "Cold Cardioplegia, Controlled Aortic Root Reperfusion, and [When Needed] Warm Cardioplegic Induction" in Chapter 3) and with intensive postoperative care, including ventricular assist devices when needed (see "Treatment of Low Cardiac Output" in Section I of Chapter 5), at least 50% of patients survive the early postoperative period.A14,L5,N5 Late survival depends on prevalence of other risk factors.

Nonuse of the ITA as a bypass graft to the LAD is a strong procedural risk factor and the basis for its near-routine use (Fig. 7-32) (see "Internal Thoracic Arteries" under Graft Patency later in this chapter). Older age at operation does

**Table 7-7** Incremental Risk Factors for Death after Primary Isolated Coronary Artery Bypass Grafting

|                                 |                                        |       | Hazard Phase |      |
|---------------------------------|----------------------------------------|-------|--------------|------|
| Risk Factors                    |                                        | Early | Constant     | Late |
| Patient Risk Factors            |                                        |       |              |      |
| DEMOGRAPHIC                     |                                        |       |              |      |
| (Older)                         | Age                                    | •     | •            | •    |
| (Younger)                       | Age                                    |       | •            | •    |
| (Lighter)                       | Weight                                 | •     |              |      |
| (Higher)                        | Weight/height ratio                    |       | •            |      |
| SYMPTOMS OF REVERSIBLE ISCHEMIA |                                        |       |              |      |
| (Higher)                        | Canadian angina class                  | •     |              |      |
|                                 | No angina                              |       | •            |      |
| (Higher)                        | Unstable angina grade                  | •     |              |      |
| CARDIAC COMORBIDITY             |                                        |       |              |      |
|                                 | Mitral regurgitation (mild)            | •     |              |      |
|                                 | Aortic regurgitation                   |       |              | •    |
|                                 | Chronic atrial fibrillation            |       | •            | •    |
|                                 | Ventricular tachycardia/fibrillation   |       | •            |      |
|                                 | Cardiac pacemaker                      |       |              | •    |
| NONCARDIAC COMORBIDITY          |                                        |       |              |      |
|                                 | Overweight                             |       |              | •    |
|                                 | History of vascular disease            | •     |              |      |
|                                 | History of cerebrovascular disease     |       | •            |      |
|                                 | Previous vascular surgery (noncarotid) |       | •            |      |
|                                 | History of smoking                     |       |              | •    |
| (Lower)                         | 1-second expiratory rate (% of normal) | •     | •            | •    |
|                                 | History of renal failure               |       |              | •    |
|                                 | On renal dialysis                      | •     |              |      |
|                                 | Serum creatinine > 2.5 mg · dL−1       |       |              | •    |
|                                 | Hypertensive                           |       |              | •    |
| (Higher, younger)               | Grade of diabetes and age              |       | •            | •    |
|                                 | History of malignancy                  |       | •            |      |
|                                 | History of hepatic disease             |       | •            |      |
| (Higher)                        | Triglyceride level                     |       |              | •    |
| LEFT VENTRICULAR FUNCTION       |                                        |       |              |      |
|                                 | Cardiogenic shock                      | •     |              |      |
| (Better)                        | Clinical status                        |       | •            |      |
| (Lower)                         | Ejection fraction (lower) and          | •     | •            | •    |
|                                 | Date of operation (earlier)            |       |              | •    |
| (Greater)                       | Limitation by heart failure            |       | •            |      |
| CORONARY DISEASE                |                                        |       |              |      |
| (Earlier)                       | 90% left main stenosis and             | •     |              |      |
|                                 | Date of operation                      | •     |              |      |
| (Greater)                       | Number of diseased systems             |       |              | •    |
|                                 | Three-system disease                   | •     |              |      |
|                                 |                                        |       |              |      |

*Continued*

Table 7-7 Incremental Risk Factors for Death after Primary Isolated Coronary Artery Bypass Grafting—cont'd

|                          |                                                      | Hazard Phase |          |      |
|--------------------------|------------------------------------------------------|--------------|----------|------|
| Risk Factors             |                                                      | Early        | Constant | Late |
| Procedural Risk Factors  |                                                      |              |          |      |
| CORONARY OPERATION       |                                                      |              |          |      |
|                          | Grafting to LAD                                      |              |          | •    |
|                          | Use of arterial grafts                               |              |          | •    |
|                          | Use of only arterial grafts in single-system disease |              | •        | •    |
|                          | Use of patch grafts                                  |              |          | •    |
| (Higher)                 | Ratio of distals to conduits                         | •            |          |      |
| (More)                   | Coronary endarterectomies                            | •            |          |      |
| (Higher)                 | Proportion of distals to small vessels               | •            |          |      |
|                          | Incomplete revascularization                         | •            |          |      |
| CONCOMITANT PROCEDURE    | ES                                                   |              |          |      |
|                          | Left ventricular incision or plication               | •            |          |      |
| INSTITUTIONAL EXPERIENCE |                                                      |              |          |      |
|                          | One surgeon                                          | •            |          |      |
| (Lower)                  | Preceding year per surgeon volume                    | •            |          |      |

Data from Sergeant and colleagues<sup>524</sup>; KU Leuven, 1971-1992; n = 9600. Key: *LAD*, Left anterior descending coronary artery.

![](_page_41_Figure_5.jpeg)

Figure 7-31 Nomograms of specific solutions of KU Leuven multivariable risk factor equation for death after coronary artery bypass grafting (CABG), illustrating strength and shape of certain risk factors for death (see Table 7-7).<sup>524</sup> In all figures, dashed lines represent 70% confidence limits. **A**, Risk-adjusted effect on survival after CABG of number of stenosed systems. **B**, Risk-adjusted effect of moderate and severe left ventricular dysfunction. **C**, Risk-adjusted effect of left ventricular ejection fraction (*EF*), continuously represented along horizontal axis, on survival to 5, 10, and 20 years after operation. **D**, Risk-adjusted effect of pre-CABG unstable angina, both after "cooling" and when refractory to treatment, compared with moderately severe but stable angina.

![](_page_42_Figure_2.jpeg)

**Figure 7-32** Nomograms illustrating advantage in terms of **(A)** survival and **(B)** hazard function, using internal thoracic artery *(ITA)* in coronary artery bypass grafting for an elderly patient in current era. Note that advantage of an ITA is not apparent before about 4 years after operation. (From Sergeant and colleagues.S26)

**Figure 7-33** Freedom from return of angina after coronary artery bypass grafting (CABG); representations as in Fig. 7-26. **A,** Timerelated probability of freedom from angina after CABG in a heterogeneous group of patients. **B,** Hazard function for return of angina in same group of patients. (From Sergeant and colleagues.S26)

not contraindicate use of the ITA, because its use decreases early risks, even in elderly patients.G6,K16,N11,S26 Whether bilateral ITA grafting has a beneficial effect on survival remains controversial,J8,K16,S28 but some studies suggest that it does.E17,L31,L34 Risk of sternal wound complication is increased by the double-ITA procedure in obese or diabetic patients.K31

*Older age* as a risk factor for death is receiving increasing attention as the population ages. Although hospital stay is longer and early complications more frequent in elderly patients, highly favorable results can be obtained with CABG, even in those over age 75.A27,H24,I3,S4,U3 This situation has been well summarized in the reports by the ACC/AHA Joint Task Force Subcommittee on Coronary Artery Bypass Graft Surgery.A5,E1,E2,P9

# Return of Angina

Evidence from evaluation of symptoms and from graded exercise testing shows that CABG usually relieves angina.K18,M13 However, return of angina is the most common post-CABG ischemic event. In a heterogeneous group of patients, only about 60% were free of angina 10 years after CABGC9,K16,S26,S28 (Fig. 7-33, *A*).

The hazard function for return of angina, although also having a constant phase, is dominated by an early phase that peaks at about 3 months after operation and by a late, steadily rising phase that becomes evident about 3 years postoperatively (Fig. 7-33, *B*). The early-peaking phase is probably most often due to incomplete revascularization, as well as early graft closure. Therefore, return of angina early after CABG is an indication for restudy of the coronary circulation. The late-rising phase of hazard for return of angina is due to progression of native-vessel disease and narrowing or closure of one or more grafts.

The most interesting aspect of risk factors for return of angina is that nonuse of the ITA has only a mild effect, at least in the KU Leuven (Katholieke Universiteit, Leuven, Belgium) experienceS26,S29 (Table 7-8). This appears to be limited to the early hazard phase, however (Fig. 7-34). This finding suggests that survival depends greatly on a continuing blood supply to the LAD with its septal branches. Also, angina may return from recurrent or new ischemia in the myocardial regions supplied by the Cx artery or RCA, as well as from recurrent or new ischemia in the distribution of the LAD. In fact, as best as can be determined, patients who experience return of angina have nearly the same survival thereafter as other patients (Fig. 7-35).

**Table 7-8** Incremental Risk Factors, Based on Patient, Procedure, and Institutional Variables, for Return of Angina, without Infarct or Death the Same Day, after Primary Isolated Coronary Artery Bypass Grafting

| Hazard Phase                                       |       |      |                                                                                  |       | Hazard Phase |  |
|----------------------------------------------------|-------|------|----------------------------------------------------------------------------------|-------|--------------|--|
| Risk Factors                                       | Early | Late | Risk Factors                                                                     | Early | Late         |  |
| Patient Risk Factors                               |       |      | Absence of overweight now or previously                                          |       | •            |  |
| DEMOGRAPHIC                                        |       |      | and age (interaction)                                                            |       |              |  |
| Younger age                                        | •     | •    | Higher preoperative triglyceride level                                           |       | •            |  |
| Female                                             | •     | •    | History of renal failure                                                         |       | •            |  |
| ANGINAL STATUS                                     |       |      | Procedural Risk Factors                                                          |       |              |  |
| Longer duration of angina history                  | •     | •    | DETAILS OF CONDUIT USED                                                          |       |              |  |
| Higher angina class                                |       | •    | Nonuse of vein grafts only                                                       | •     |              |  |
| Unstable ST segment at operation                   | •     |      | Use of vein grafts to the LAD system                                             |       | •            |  |
| Clinically positive cycloergometric test and       | •     |      | Use of patch grafts                                                              | •     |              |  |
| Electrocardiogram negative exercise test           | •     |      | DETAILS OF DISTAL ANASTOMOSES                                                    |       |              |  |
| (interaction)                                      |       |      | Proportion of total distal anastomoses to<br>anastomosed vessels ≤1 mm           | •     |              |  |
| LEFT VENTRICULAR FUNCTION                          |       |      | Nongrafting to the LAD                                                           | •     |              |  |
| Absence of preoperative anterior or septal infarct |       | •    |                                                                                  |       |              |  |
| CORONARY DISEASE DISTRIBUTION                      |       |      | Ratio of number of arterial anastomoses to total<br>number of distal anastomoses | •     |              |  |
| Lesser stenosis of left main coronary artery       | •     | •    | COMPLETENESS OF REVASCULARIZATION                                                |       |              |  |
| Multisystem coronary artery disease                |       | •    | Incomplete revascularization and                                                 | •     |              |  |
| COMORBIDITY (CARDIAC)                              |       |      | Use of internal thoracic artery grafts only                                      | •     |              |  |
| Left ventricular hypertrophy                       |       | •    | (interaction)                                                                    |       |              |  |
| Aortic valve stenosis (mild)                       |       | •    | OTHER SURGICAL DETAILS                                                           |       |              |  |
| COMORBIDITY (VASCULAR)                             |       |      | Number of coronary endarterectomies                                              | •     |              |  |
| History of peripheral arterial disease             | •     |      | Institutional Risk Factors                                                       |       |              |  |
| History of noncarotid vascular operation           |       | •    | SURGEONS                                                                         |       |              |  |
| Calcified ascending aorta                          |       | •    | High risk for angina return surgeon                                              | •     |              |  |
| COMORBIDITY (NONCARDIAC, NONVASCULAR)              |       |      | Low risk for angina return surgeon                                               | •     |              |  |
| Hypertensive                                       |       | •    | EXPERIENCE                                                                       |       |              |  |
| Higher diabetic grade                              |       | •    | Later date of operation                                                          |       | •            |  |

Data from Sergeant and colleaguesS26; KU Leuven, 1971-1992; *n* = 9600. Key: *LAD,* Left anterior descending coronary artery.

![](_page_43_Figure_5.jpeg)

**Figure 7-34** Effect of use of internal thoracic artery *(ITA)* on return of angina after coronary artery bypass grafting, illustrated in nomograms of specific solutions of multivariable risk factor equations represented by Table 7-8. **A,** Time-related, risk-adjusted freedom from return of angina. **B,** Hazard function for return of angina. (From Sergeant and colleagues.S26)

![](_page_44_Figure_2.jpeg)

**Figure 7-35** Survival after return of angina after coronary artery bypass grafting, represented by depiction labeled *Actual (circle)*, compared with that predicted for an equal number of patients *(smooth line enclosed within 70% confidence limits)*, each individually identical to a patient in the Actual group but without return of angina. Probability of death within 1 year after angina return is twice that predicted for those without return, but survival still is 95%. (Predictions based on method of Ferrazzi and colleagues,F10 using risk factor equation from KU Leuven experience.S24,S26)

Patient incremental risk factors for return of angina are not powerful compared with those for death. This implies that return of angina is inherent in stenotic arteriosclerotic CAD.

Procedural risk factors for return of angina are likewise not very powerful, as seen in the case of the ITA. The inference again may be that the process leading to return of angina is inherent in arteriosclerotic CAD.

### Myocardial Infarction

Perioperative MI, usually defined by appearance of new Q waves in the ECG or elevation of serum levels of myocardial biomarkers, is most often related to inappropriate myocardial management, but can also result from technical problems or incomplete revascularization. Prevalence of MI is highly variable and depends on the criteria used, but it is approximately 2.5% to 5%.C19,C21,K17,O3,S9 Perioperative infarction, when quantitatively more than trivial, is a risk factor for later death.B54,N3,S9

Including perioperative cases, MI is relatively uncommon after CABG, with 94% of patients in the KU Leuven experience free of infarction for at least 5 years, and 73% for at least 15 years (Fig. 7-36). However, the hazard function for MI begins to increase at about 4 years postoperatively. Risk factors for the first post-CABG infarction (excluding those that occur perioperatively) are relatively few (Table 7-9).

Survival appears to be considerably adversely affected by occurrence of post-CABG MIC14,P13,S25 (Fig. 7-37). Furthermore, time-related freedom from subsequent post-CABG MI declines with each MI episode (Fig. 7-38).

# Sudden Death

Time-related prevalence of sudden death is low after CABG; this may be an important factor in the survival benefit derived from CABG.E18 In the KU Leuven experience, 97% of patients

![](_page_44_Figure_12.jpeg)

![](_page_44_Figure_13.jpeg)

**Figure 7-36** Freedom from first myocardial infarction after coronary artery bypass grafting, including those occurring perioperatively. Format is as in Fig. 7-26. **A,** Time-related probability of freedom from first myocardial infarction. **B,** Hazard function for first myocardial infarction. (From Sergeant and colleagues.S25)

![](_page_44_Figure_15.jpeg)

**Figure 7-37** Survival after first postbypass myocardial infarction. Format is as in Fig. 7-26. (From Sergeant and colleagues.S25)

were free of sudden death 10 years after CABG (Fig. 7-39, *A*). The late phase of the hazard function rises more slowly than in other post-CABG ischemic eventsS29 (Fig. 7-39, *B*). Not unexpectedly, poor LV function before CABG is statistically the most significant risk factor for sudden death

**Table 7-9** Incremental Risk Factors, Based on Patient, Procedure, and Institutional Variables, for Freedom from First Infarct after Primary Isolated Coronary Artery Bypass Grafting

|                            |                                                             | Hazard Phase |          |      |  |
|----------------------------|-------------------------------------------------------------|--------------|----------|------|--|
| Risk Factors               |                                                             | Early        | Constant | Late |  |
| Patient Risk Factors       |                                                             |              |          |      |  |
| DEMOGRAPHIC                |                                                             |              |          |      |  |
| (Younger)                  | Age                                                         |              | •        |      |  |
|                            | Blood group A                                               |              |          | •    |  |
| (Taller)                   | Height of patient                                           |              |          | •    |  |
| (Shorter)                  | Height of patient                                           | •            | •        |      |  |
| ANGINAL STATUS             |                                                             |              |          |      |  |
| (Higher)                   | Previous infarct within 30 days of operation                |              |          | •    |  |
| (Lower)                    | Previous infarct within 30 days of operation                | •            |          |      |  |
| (Lower)                    | Stable angina before operation                              |              | •        |      |  |
| (Lower)                    | Clinic or ECG + result of preoperative cycloergometric test |              | •        |      |  |
|                            | Unstable ST segment, but not acute infarct                  | •            |          |      |  |
|                            | LEFT VENTRICULAR FUNCTION                                   |              |          |      |  |
| (Lower)                    | Previous inferior infarct                                   | •            |          |      |  |
|                            | CORONARY DISEASE DISTRIBUTION                               |              |          |      |  |
|                            | Two- or three-system disease                                |              |          | •    |  |
| (Lower)                    | Higher percent stenosis of left main                        |              | •        |      |  |
| COMORBIDITY (CARDIAC)      |                                                             |              |          |      |  |
|                            | Aortic valve regurgitation                                  |              | •        |      |  |
|                            | Concomitant planned pacemaker insertion                     | •            |          |      |  |
| COMORBIDITY (VASCULAR)     |                                                             |              |          |      |  |
|                            | History of peripheral arterial disease                      | •            |          | •    |  |
|                            | History of abdominal aortic disease                         |              | •        |      |  |
|                            | Cerebral, noncarotid, vessel disease                        |              |          | •    |  |
|                            | COMORBIDITY (NONCARDIAC, NONVASCULAR)                       |              |          |      |  |
|                            | BUN > 50 mg/dL                                              |              | •        |      |  |
| (Lower)                    | Pulmonary vital capacity as percent of normal               | •            |          | •    |  |
| (Higher)                   | Grade of diabetes                                           |              |          | •    |  |
| (Higher)                   | Preoperative cholesterol level                              |              |          | •    |  |
| Procedural Risk Factors    |                                                             |              |          |      |  |
|                            | GENERAL TECHNICAL ASPECTS                                   |              |          |      |  |
|                            | Patch graft                                                 |              | •        |      |  |
|                            | Coronary endarterectomy                                     | •            |          |      |  |
|                            | Incomplete revascularization                                | •            | •        |      |  |
| ARTERIAL GRAFTING          |                                                             |              |          |      |  |
|                            | Absence of at least one arterial graft                      | •            | •        |      |  |
|                            | Absence of only arterial grafts and single-system disease   |              | •        |      |  |
|                            | Nonarterial graft to the LAD                                |              |          | •    |  |
|                            |                                                             |              |          |      |  |
| Institutional Risk Factors |                                                             |              |          |      |  |
| SURGEONS                   |                                                             |              |          |      |  |
|                            | Lower-risk surgeons for first infarct                       | •            |          |      |  |

Data from Sergeant and colleaguesS25; KU Leuven, 1971 to 1992; *n* = 9600. Key: *BUN,* Blood urea nitrogen; *ECG,* electrocardiogram; *LAD,* left anterior descending coronary artery.

**Figure 7-38** Freedom from myocardial infarction after coronary artery bypass grafting *(CABG)* exclusive of perioperative infarction, according to number of previous post-CABG episodes of infarction. Time zero is time of CABG in depiction of freedom from *first* post-CABG infarction; it is time of first post-CABG infarction in depiction of time-related probability of a second post-CABG infarction; and so on. Format is as in Fig. 7-29. (Depictions from analyses of KU Leuven experience, 1971 to July 1987; *n* = 5880.A5,K16,S28)

![](_page_46_Figure_3.jpeg)

![](_page_46_Figure_4.jpeg)

**Figure 7-39** Sudden death after coronary artery bypass grafting. Format is as in Fig. 7-26. **A,** Freedom from sudden death. **B,** Hazard function. (From Sergeant and colleagues.S29)

(Table 7-10). A patient with a preoperative EF of 65% has only a small probability of dying suddenly within 15 years, whereas a patient with EF of 25% before CABG has a 15% probability of sudden death within that periodS29 (Fig. 7-40).

# Failure to Work

Time-related freedom from failure to work has been less well documented than for other outcome events. Its time course is probably similar to that of freedom from angina. Patients who are free of angina after CABG are more likely to be working than those with angina.S49

A common belief is that CABG does not improve prevalence of gainful employment among patients with ischemic heart disease,B7,C13,R13,S70 but this has not been a universal finding.A23,B45 Failure to take into account the differing prevalences of risk factors for failure to work after CABG explains many of the discrepancies in results.B45 Patients working before CABG have the highest probability of continued employment after operation.B7,S49 Under "favorable circumstances" (as defined by risk factors listed in Table 7-11), more than 80% of patients not working at the time of CABG are working 1 year later; 20% or fewer are working after CABG when the risk factors are "unfavorable."H30,R20

# Unsatisfactory Quality of Life

Even though unsatisfactory quality of life after CABG is one of the most important unfavorable outcome events, quantifying it is difficult because it is a composite of at least three factors: (1) freedom from limiting angina or heart failure; (2) reasonable freedom from need for medication, rehospitalization, and reintervention; and (3) preservation of a reasonable exercise capacity. Most surviving patients have a satisfactory quality of life early after CABG, but the probability of retaining this gradually begins to decline after about 5 years.B40 Rate of decline is probably similar to that of freedom from angina.

# Neurobehavioral and Neurologic Outcomes

Unrelated to cardiac aspects of CABG, the damaging effects of CPB usually required for operation are postulated to result in neurobehavioral disturbances and decline in cognitive function in some patients (see "Neuropsychological Subsystem" in Section I of Chapter 5). These disturbances are sufficiently mild that they might not be apparent unless patients are tested specifically for them. Their prevalence has been reduced by incorporating appropriate filters into the arterial tubing from the pump-oxygenator to the patient. As many as 75% of patients may exhibit these subtle defects when tested 8 days after CABG, but by 3 to 6 months

**Table 7-10** Incremental Risk Factors for Sudden Death after Primary Isolated Coronary Artery Bypass Grafting (Events = 78)

| Triniary isolated coronary rittery bypass draiting (Events 70) |          |       |  |  |  |  |
|----------------------------------------------------------------|----------|-------|--|--|--|--|
|                                                                | Hazard F | Phase |  |  |  |  |
| Risk Factors                                                   | Constant | Late  |  |  |  |  |
| Patient Risk Factors                                           |          |       |  |  |  |  |
| ANGINA                                                         |          |       |  |  |  |  |
| Other than stable angina                                       | •        |       |  |  |  |  |
| (Longer) Duration of anginal symptoms                          | •        |       |  |  |  |  |
| DISTRIBUTION OF CORONARY ARTERY DISEASE                        |          |       |  |  |  |  |
| Three-system disease                                           | •        |       |  |  |  |  |
| Absence of left main disease > 50%                             | •        |       |  |  |  |  |
| ARTERIOSCLEROTIC DISEASE                                       |          |       |  |  |  |  |
| Peripheral arterial disease                                    | •        |       |  |  |  |  |
| (Poorer) Quality of aortic anastomotic sites                   | •        |       |  |  |  |  |
| LEFT VENTRICULAR FUNCTION                                      |          |       |  |  |  |  |
| (Lower) Ejection fraction                                      | •        |       |  |  |  |  |
| PROCEDURAL RISK FACTOR                                         |          |       |  |  |  |  |
| Incomplete revascularization                                   | •        |       |  |  |  |  |

Data from Sergeant and colleagues<sup>529</sup>; KU Leuven, 1971 to July 1987; n = 5880.

postoperatively that proportion drops to only about 10% to 30%. H10,N7,R17 Prevalence is unfavorably affected by preoperative and postoperative anxiety and depression and by older age. T11 Only rarely are patients aware of or handicapped by these defects. S38 Of interest, decline in cognitive function occurs in up to 45% of patients who undergo major noncardiac operations and also in patients with CAD who do not undergo CABG. G31,S70

Gross neurologic defects, usually in the form of transient or permanent sequelae of strokes, are more serious but

**Table 7-11** Risk Factors for Time-Related Failure to Work after Coronary Artery Bypass Grafting

| Demographic                       |                                 |
|-----------------------------------|---------------------------------|
| (Older)                           | Age at operation                |
| (Less)                            | Educational time                |
| Preoperative Work Conditions      |                                 |
| (More)                            | Physical effort in job          |
| (Longer)                          | Preoperative absence from work  |
| (Lower)                           | Income from work                |
| Clinical Status                   |                                 |
| (Longer)                          | Duration of preoperative angina |
| (Greater)                         | Severity of preoperative angina |
| Aggressiveness of Atherosclerotic | Process                         |
| (More)                            | Peripheral arterial disease     |
| Coexisting Disease                |                                 |
| (More)                            | Alcohol intake                  |
| Surgical Factor                   |                                 |
| (Earlier)                         | Date of operation               |
| Postoperative Factors             |                                 |
| (Shorter)                         | Duration of absence of angina   |
| (Absence)                         | Cardiac rehabilitation program  |
|                                   |                                 |

Data from Boulay and colleagues<sup>B45</sup> and Varnauskas. V5

**Figure 7-40** Nomogram of specific risk-adjusted solution of multivariable equation for sudden death after coronary artery bypass grafting (CABG), illustrating effect of pre-CABG ejection fraction. Format is as in Fig. 7-31. (From Sergeant and colleagues. 529)

![](_page_47_Figure_13.jpeg)

fortunately less common.R15,T2 Gross defects most likely result from embolization of arteriosclerotic debris from the ascending aorta or from air and intracardiac thrombus rather than from damaging effects of CPB.K4 Prevalence is about 0.5% in relatively young patients but rises to about 5% in patients older than age 70, and about 8% in those older than 75.C38,G7,T2 Randomized trials comparing on- and off-pump procedures showed similar prevalence of adverse neurologic outcomes.B66,P22,S41,V2

# Use of Medication

Almost all studies report a decrease in use of vasodilators and β-blocking agents after CABG. The cooperative randomized study by the European Coronary Surgery Study Group, for example, found about 70% of patients randomized to medical treatment taking β-blockers during the first 3 years of follow-up in contrast to 25% of surgical patients.V7 In the CASS trial, also randomized, surgically treated patients used fewer antianginal medications at 5 years than patients treated medically.R20 By 10 years, however, the difference was likely due to chance.

# Functional Capacity

Maximal exercise capacity of patients is improved by CABG,B1,B8,F18,H26,K21,L6,S30,S43 and ECG abnormalities during exercise are usually importantly reduced.S30 Degree of recovery and ultimate exercise capacity reached depend on preoperative LV function, graft patency, and completeness of revascularization. Increase in functional capacity, as evidenced by an increase in cardiac output with exercise postoperatively, is greater in patients with complete revascularization (26% vs. 6%; *P* = .0001).H25 Maximal exercise capacity generally is improved more by CABG than by medical treatment, at least for 3 to 10 years.M14,V7

The mechanisms of improvement in functional capacity after CABG are complex.H16 Improvements in resting and stress LV function greatly contribute to the improved functional capacity (see next subheading). However, Serruys and colleagues found that an increase in maximal heart rate, presumably secondary to increased myocardial blood flow, is also an important determinant of increased functional capacity.S30

# Left Ventricular Function

## *Resting Perfusion*

Resting regional perfusion defects (at least in patients with unstable angina) are improved after CABG in at least 65% of patients,K25,R25 indicating that preoperative resting perfusion defects were caused at least in part by ischemia; that is, scarred areas (if present) contained considerable amounts of viable muscle.C35,K25,Z2 Most patients who show no improvement commonly have occluded grafts to the area. Wainwright and colleagues demonstrated that resting regional myocardial perfusion defects usually persist in areas supplied by ungrafted vessels (incomplete revascularization).W1

Left ventricular wall segments that are hypokinetic, akinetic, or even dyskinetic at rest preoperatively often have improved systolic function after CABG.C23,C29,L9,W19,Z4 This is associated with increased regional myocardial perfusion.K25 Improvement in segmental wall motion 12 months after CABG has been observed even in areas of scarring from previous MI.M25 Brundage and colleagues showed that 19 of 29 LV wall segments with asynergy at rest preoperatively had improved function, and some even had normal function late postoperatively.B60 This finding supports the concept that viable muscle cells, which may be hibernating, are scattered through hypokinetic and, at times, even akinetic and dyskinetic segments, and that wall motion in such segments can be improved by CABG.D16 When segmental wall contraction does not occur after CABG, incomplete revascularization is the cause in some patients.C29

When preoperative global LV dysfunction is severe (EF < 30%), myocardial scarring is usually greater and usually limits recovery of LV function. In some patients, however, improvement in regional and global LV function occurs with CABG in this setting, and symptoms of pulmonary venous hypertension may regress.A11,E12

Several studies confirm that preoperatively depressed resting global LV systolic function (estimated by EF or dP/dt) is less depressed as early as 2 weeks after CABG.B70,C23,H14 When this improvement fails to occur, incomplete revascularization is usually found.H14,H15 Hellman and colleagues have demonstrated, in a slightly different setting, that 16 of 19 post-CABG patients with preoperative resting EFs of less than 40% showed similar or increased EFs with exercise early postoperatively (±2 weeks) and no deterioration of regional wall motion.H14 Coronary angiography showed that three of four patients with persistence of an abnormal response to exercise had incomplete revascularization. Five years or more after operation, resting global LV function continues to be improved in some patients, whereas in others it is again depressed and may be even worse than preoperatively.T14 Patients with worsened LV function usually have lower graft patency.T14

LV diastolic function, more specifically LV "relaxation," is also improved by successful CABG, and improvement may be immediate.H31 This contributes to overall improvement in resting LV function that often promptly follows CABG.C23,T10

#### *Exercise*

The decrease in EF with exercise that is characteristic of ischemic heart disease is absent 2 weeks after operation in most patients, with EF rising normally with exercise.H15,K9,N6 This favorable response to stress can be brought about only by CABG or PCIS44 and does not result from collateral circulation alone, even when extensive.S31 Furthermore, patients who continue to experience angina postoperatively (presumably from incomplete revascularization) do not have this favorable response.N6 When global and segmental function during exercise is not improved early (3 months) after operation, one or more bypass grafts are usually occluded or stenosed.L15

Most patients with preoperative exercise-induced abnormal increases in LV end-diastolic volume greater than 50% have a normal increase with exercise 2 weeks after operation.H15 Presumably, these favorable early postoperative responses continue until the native CAD progresses or graft closure occurs.

Exercise-induced regional wall motion dysfunction, typically present preoperatively (even in the presence of normal LV function at rest) disappears within 2 weeks of operation in most patients.H15,M10

### Ventricular Arrhythmias

Successful CABG with relief of myocardial ischemia and its symptoms generally does not decrease frequency or severity of exercise-induced or resting ventricular arrhythmias, <sup>D9,G39,L12</sup> including ventricular tachycardia and fibrillation, although reports to the contrary exist. <sup>B62,C31,E5,R12</sup> This lack of favorable effect occurs because areas of ventricular scarring, rather than areas of myocardial ischemia, appear to be essential to arrhythmia development.

Failure of simple CABG to abolish serious ventricular electrical instability in most patients is particularly unfortunate because exercise-induced ventricular tachycardia or ventricular fibrillation carries a poor prognosis in patients with CAD. L12 Sudden death is one mode of death late postoperatively. Therefore, when operation is contemplated in patients with important intractable ventricular tachyarrhythmias, consideration should be given to implantation of a cardioverter-defibrillator (ICD) or procedures directed specifically at the ventricular arrhythmia, even in the absence of LV aneurysm (see Chapter 16).

Exceptions to these general statements are the few patients without ventricular scars or aneurysm in whom life-threatening ventricular arrhythmias occur purely from reversible LV myocardial ischemia. CABG can relieve the arrhythmic tendency in these patients.

A study of 900 patents with depressed LV function (EF < 36%) and abnormalities on resting signal-averaged ECGs suggested increased risk for postoperative ventricular arrhythmias.<sup>B27</sup> In the Coronary Artery Bypass Graft Patch Trial, 454 patients were randomized to CABG and 446 to CABG plus ICD.<sup>B27</sup> During an average follow-up of 32 months, there was no evidence of improved survival among the patients in whom an ICD was implanted.

### Coronary Flow Reserve

CABG is usually successful in improving coronary flow reserve (ability to increase flow in response to increased myocardial oxygen demand or pharmacologic vasodilatation). Surprisingly, coronary flow reserve returns to normal levels in many patients. This subject has been reviewed in detail by Wilson and colleagues. W17,W18 Flow reserve has been obtained from measurements made in the operating room after CABGB28,G30,S59 and has been confirmed in postoperative patients. B12 Ability to increase coronary flow is absent when there is a stenotic coronary lesion beyond the graft.

In general, a patent anastomosis between a graft and a coronary artery perfuses only that segment of myocardium to which the native artery has supplied blood. K26 However, about 25% of grafts distribute blood well beyond the segment of myocardium that would have been expected to be supplied by the native vessel. M18 Often the area unexpectedly perfused by the graft is in the distribution of an occluded native vessel to which there is an obstructed graft. Importantly, segmental contractility is often improved postoperatively in the unexpectedly perfused area. This phenomenon probably explains the finding of a functionally excellent result despite presence of one or two occluded grafts.

Not unexpectedly, in the few studies done late postoperatively, flow is greatest in vein grafts to the LAD system. Using a radiographic densitometric method, Hamby and colleagues found at 2 weeks after operation a mean flow of 79 mL · min<sup>-1</sup> in grafts to the LAD (range, 39-179) and 65 and

![](_page_49_Figure_11.jpeg)

**Figure 7-41** Relationship between change in saphenous vein bypass graft flow and change in diameter between early (2 weeks) and late (average 1.5 years) postoperative study by radiographic methods. In general, decrease in diameter correlates with decrease in flow. Key: *CIRC*, Circumflex coronary artery; *LAD*, left anterior descending coronary artery; *RCA*, right coronary artery. (From Weisz and colleagues. W11)

68 mL · min<sup>-1</sup> in those to the RCA and Cx artery, respectively. H3 Flow through patent grafts during the early postoperative period is not directly related to graft size measured by cineangiographic techniques, and is presumably determined primarily by size of the arterial bed distal to the anastomosis. W11

An average of 2.5 years later, about 35% of vein grafts showed an important (average 45%) reduction in flow compared with early postoperatively. Thirty-five percent showed only a mild decrease during this period, and 30% showed no change. Such reductions of flow probably result largely from morphologic changes in the graft; thus, Weisz and colleagues found that change in graft flow was associated with a similar directional change in graft caliber<sup>W11</sup> (Fig. 7-41).

Although concern has been expressed about flow capabilities of the ITA as a bypass graft, F13,H4,M16 the bulk of evidence supports the ability of this vessel to supply a normal coronary flow reserve to a LAD with distal branches that are free of disease. This evidence has been well summarized by Hodgson and colleagues, who have also shown that adequate coronary flow reserve is provided when the ITA is used for sequential grafting. H21 Separate ITA grafts can provide adequate flow to the entire left coronary system. B5

#### **Graft Patency**

#### Internal Thoracic Arteries

The ITA has proved an excellent conduit for use in CABG. About 90% to 95% of left ITAs whose distal end has been anastomosed end-to-side to the LAD are patent 10 to 20 years after operation<sup>S1</sup> (Fig. 7-42), and closure after that time is uncommon. A6,A27,B6,G29,12,L26,L35,S1,T3,T7,V13 However, up to 10% of patent grafts have stenoses late postoperatively. 12,M4 Accumulated information strongly suggests that most of the stenoses do not progress to occlusion. Use of the

![](_page_50_Figure_2.jpeg)

**Figure 7-42** Patency of internal thoracic artery *(ITA)* and saphenous vein grafts at 1-year intervals after coronary artery bypass grafting. Numbers in parentheses are the number of observations. (From Cleveland Clinic data, 1972 to 1999).

ITA as a free graft from aorta to LAD provides patency almost as high as with an in situ graft.L23

Favorable performance of the ITA when anastomosed to the LAD is partly related to continued function of its endothelial cells. Endothelium-derived relaxing factor and prostacyclin are produced by human ITAs, which may be an important factor in the high patency of ITAs and their excellent function as bypassing conduits.C18,L30 In addition, the ITA, when used for CABG as well as in its native position, has been shown to resist development of arteriosclerosis.B33,S40 Intimal hyperplasia develops in the ITA graft, however, and may be a cause of stenosis.S40 Other factors contributing to occlusion or stenosis (including the "string sign") of ITA conduits include mild target stenosis, competitive flow, and sequential grafting.B25,M4,S1

Another factor favorable to ITA patency is its grafting to the LAD, which has large runoff through the diagonal and septal branches. In support of this, ITA grafts to vessels other than the LAD have lower patency that may not be substantially different from that of vein grafts.B25,H28,M4,T3

Use of bilateral ITA grafts has been favored by some groups,F21,G1,J8,K16,L33,S28 and evidence exists that use of both ITAs enhances survival of some subgroups of patients.C3,E17,L31,L34,R2,T6 Of interest, an analysis of the Society of Thoracic Surgeons database of 540,000 patients undergoing CABG between 2002 and 2005 indicated that bilateral ITA grafts were used in only 4.0%.T1

Wound complications are more prevalent when bilateral ITA grafting is performed, particularly in obese and diabetic patients,K31,L24 and extensive surgical procedures may be required to treat them.F16,F26 Decreased sternal perfusion has been demonstrated after ITA harvesting using the pedicle technique.S33 Skeletonization of the ITA results in greater sternal perfusion than the pedicle techniqueB39 and may be associated with fewer sternal wound complications.S6 A particularly beneficial effect has been observed in diabetic patients.B39

# *Other Arterial Grafts*

The radial artery,A4,B55,C24,R24,W8 right gastroepiploic artery,C11,L32,M23,P23,S63-S65 and inferior epigastric arteryG42,P12,P19

are used by a number of surgeons in combination with one or both ITA grafts or vein grafts and when an ITA graft is not available. Early (<13 months) patency of radial artery grafts exceeds 90% and does not differ from ITA patency.R24,W8 A native coronary stenosis of less than 70% is associated with lower patency of a radial artery graft than if the stenosis is 70% or greater.M30,R24 Tatoulis and colleagues, in a study of long-term patency of 1108 radial artery grafts, reported patency of 89% at a mean follow-up interval of 48 months.T4 Of 318 grafts in place for more than 5 years, 294 (92%) were patent. Of 107 in place for more than 7 years, 99 (92%) were patent. Patency was highest for grafts placed to the LAD (96%) and lowest for grafts to the RCA (83%). Mechanisms of failure did not involve arteriosclerosis. For many surgical groups, the radial artery is currently the conduit of second choice behind the ITA.D8,T4,T12,Z1

In a study by Suma and colleagues of gastroepiploic artery grafts in 685 patients who underwent postoperative angiographic evaluation, patency was 94% within 1 year in all 685 patients, 88% between 1 and 5 years in 102 patients, and 83% between 5 and 10 years in 102 patients.S64 Time-related patency at 1 month, 1 year, 5 years, and 10 years was 96%, 91%, 80%, and 62%, respectively. Principal causes of late occlusion were anastomotic stenoses and anastomoses to less critically stenosed coronary arteries.

Less information is available for the inferior epigastric artery. Gurne and colleagues performed postoperative angiography in 122 patients early (11 ± 5 days) and in 72 patients late (11 ± 6 months) after operation.G42 Early patency was 98%, and late patency was 93%. Of 14 grafts that were occluded or threadlike at the late study, 8 were anastomosed to arteries with a stenosis of 60% or less.

# *Saphenous Vein Grafts*

Saphenous veins used as free aortocoronary grafts develop a unique remodeling and disease complex.S40,U2 The condition begins with diffuse intimal thickening, so-called intimal hyperplasia, which is a universal finding in vein grafts that have been in place for more than 1 month.B2,B56,B65,K10,M24,S50,V12 This process is not progressive.S50 Thickness of the intimal hyperplasia seems to be inversely related to flow in the graft, and the process appears to result in a matching of vein lumen size to that of the coronary arteries supplied by the graft. Intimal hyperplasia is thus best considered as a remodeling process.S50,V12

As a result of these changes, most grafts show an angiographically detectable diffuse reduction in diameter. By 1 year after implantation, the diameter tends to approximate that of the recipient coronary artery; this diffuse smooth narrowing is not related to graft occlusion.S50 Indeed, by increasing velocity of flow, remodeling may be beneficial, particularly when the vein is large initially.B46,S47

Of greater importance is development of lesions in the vein graft that are indistinguishable morphologically from the fibrous plaques of atherosclerosis.B3,B4,B65,C8,G32 These atherosclerotic lesions are rarely found in saphenous vein grafts that have been in place for less than 3.5 years.S50 By 10 years after CABG, however, most saphenous vein grafts have undergone at least some atherosclerotic changes that are sometimes severe.C5,C6,G34,S50 Whether this acceleration is related solely to morphologic damage to the graft caused by its removal and insertion into the arterial system, or whether it is caused by the patient's tendency to develop atherosclerosis, or whether both occur, is uncertain. Both factors probably play a role, because hyperlipidemia is a risk factor for extensive vein graft atherosclerosis.C5,P3,S51,S57,S58 Also, aggressive efforts at controlling cholesterol levels retard progression of vein graft atherosclerosis.B30,C7

About 20% of vein grafts have proximal suture line stenosis within 1 year; about one fourth of these are found to be occluded 5 years later.G43 Almost 50% of patients have some narrowing of the distal anastomosis within 1 year, but most have not progressed by 5 years after CABG.G43 Unfortunately, minimal information is available on the relationship of type of anastomosis (e.g., end-to-side, side-to-side) to frequency and severity of anastomotic strictures. Anastomotic strictures may result from a localized separate process or may be a local manifestation of atherosclerosis.

Thrombosis, another process that can reduce graft patency, may develop early postoperatively. Endothelial cell loss and exposure of the basement membrane and collagen to blood tend to appear early after inserting the vein graft, predisposing it to early accumulation of platelets, fibrin, and thrombus on its luminal surface.B2,B65,F9,J12,R6 More often, thrombosis develops later in heavily atherosclerotic areas.

Related to all these processes, about 10% of vein grafts close within the first few postoperative weeks, at least when antiplatelet therapy is not used. One- to 2-year patency in recently reported trials ranges from 75% to 85%.B17,G16,M2,Z3 Late patency is highly variable, but only 50% to 80% of grafts are patent in heterogeneous groups of patients.B47,G33,H1,K28 However, patency has been about 80% when the greater saphenous vein has been used to bypass the LAD, which has a large runoff.L26 Clopidogrel, when combined with aspirin, has not been shown to increase graft patency or to reduce the frequency of adverse cardiovascular events at 1 year.G5,K38

# *Other Vein Grafts*

Patency of lesser saphenous vein grafts appears to approach that for the greater saphenous vein.C22 Patency is lower when the bypass graft is to a particularly small coronary artery or one that supplies a heavily scarred area, perhaps because in both circumstances there is low graft flow. Upper extremity veins have even lower patency.W15 Cryopreserved allograft veins may be used when no other suitable autologous graft is available; late patency is substantially less than that of ITA and saphenous vein grafts.L7

# Postoperative Progression of Native Coronary Artery Disease

Most important native-vessel coronary artery stenoses proximal to a bypass graft become more severe or totally obstructive within 5 years of CABG.B48,G43,H32,L4 Rates of progression of lesser stenoses proximal to a bypass graft remain uncertain. Important stenoses distal to the anastomosis also have a strong tendency to obstruct within 5 years.G43,N9 Lesser stenoses distal to a functioning bypass graft tend to remain unchanged.G43,I1 However, one study reported considerable progression of lesser distal arterial stenoses when the bypass graft to the artery was nonfunctioning.N9

Lesser stenoses in ungrafted arteries progress in severity with less frequency than important stenoses, but 25% to 50% of such lesions progress within 5 years.G43,L4 In a group of patients undergoing CABG, Laks and colleagues found progression of proximal stenosis in 16 (27%; CL 20%-34%) of 60 nonbypassed RCAs with less than 50% narrowings at a mean follow-up of 20 months.L4 Two (3%; CL 1%-8%) of the 60 had progressed to complete obstruction.

Important stenoses in ungrafted vessels progress after operation, presumably at about the same rate as in the natural history of CAD (see "Stenotic Coronary Artery Disease" earlier in this chapter). Controversy continues as to whether important stenoses progress less rapidly in ungrafted than in grafted vessels.E16,N9 Some information suggests that the rate is the same in both.B48,G43,P2

New stenoses appear in apparently nonstenotic arteries that were not grafted.B48,H3 In following patients randomized to surgical vs. medical treatment, Palac and colleagues found new lesions within 5 years in about 15% of both groups.P2 These figures may be different in patients and populations in whom risk factors for arteriosclerosis are altered.

### Subsequent Reintervention

Prevalence of reintervention (repeat CABG or PCI), as with other outcome events, varies according to the patient's characteristics before the first CABG, details of the first CABG itself, and to a lesser extent, management of the patient after the first operation. In a heterogeneous group of patients, freedom from reintervention is about 97% 5 years after the initial operation, 89% at 10 years, and about 72% at 15 yearsS27 (Fig. 7-43, *A*). Instantaneous rate of reoperation begins to rise appreciably after about 5 years (Fig. 7-43, *B*).

Vein graft atherosclerosis is the most common cause of reintervention, with progression of native-vessel disease the second most common.J4,L27 Thus, more frequent use of the ITA to the LAD has reduced the frequency of reoperation and lengthened the interval between first and second coronary operation.L3,L26,L27,S3 Use of both ITAs may further reduce prevalence of reintervention.E17,L31

Results of a formal risk factor analysis for reintervention in the KU Leuven experience showed that younger age at first CABG increased risk of reoperation (Table 7-12 and Fig. 7-44, *A*). Young age as a risk factor is also evident in other studiesF14,K16,S3,S27 and is a surrogate for "aggressiveness of the atherosclerotic process." In contrast to most other experiences, at KU Leuven, use of the ITA did not reduce reoperations appreciably (Fig. 7-44, *B*).

Operative risk of a second CABG is about twice that of the first.F14,L21,L27,Q1,S3 Higher prevalence of risk factors in patients undergoing repeat CABG, rather than the procedure itself, is the more important reason for this increased early risk. Including hospital deaths, 10-year survival in a heterogeneous group of patients is about 65%.L27,S3 Considering deaths both early and late after repeat CABG, important left main coronary artery disease, three-system involvement, and severity of LV dysfunction are the most important risk factors.L27

Symptomatic improvement is usual in surviving patients, particularly when symptoms are severe before reoperation. Thus, in the Cleveland Clinic experience, 89% of those with severe angina before reoperation experienced either no angina or only mild angina postoperatively.L27

Transmyocardial revascularization using a laser to create transmural channels has been applied to patients with severe angina after CABG (see Special Situations and Controversies later in this chapter).F17 It can be used as sole therapy or in combination with repeat CABG.

![](_page_52_Figure_2.jpeg)

**Figure 7-43** Reintervention after coronary artery bypass grafting. **A,** Freedom from reintervention. **B,** Hazard function. Format is as in Fig. 7-29. (From Sergeant and colleagues.S27)

PCI is being used with increasing frequency in symptomatic patients after CABG. Compared with balloon angioplasty, stenting of vein graft stenoses results in higher procedural effectiveness (92% vs. 69%) and greater increase in luminal diameter early after the procedure.S8 Freedom from death, MI, repeat CABG, or revascularization of the targeted vessel is substantially better in the stent group (73% vs. 58%).

# INDICATIONS FOR OPERATION

The bases of the indications for CABG involve comparative benefits of operation relative to those of no treatment (natural history), medical treatment, or treatment by PCI. A complexity of these apparently simple propositions is that comparative benefit of CABG may be greater in one circumstance (e.g., severe vs. mild LV dysfunction) compared with another, yet the actual time-related survival after CABG is lessC1 (Fig. 7-45). (The manner by which addition of the risk factors appears to amplify the contribution of another is explained under Multivariable Analysis in Chapter 6.)

Operation and other interventional therapies should increase regional coronary flow reserve. Small reductions in flow reserve are minimally life threatening; large reductions are life threatening. Use of techniques to quantify these reductions, such as thallium-201 single-photon emission CT and dobutamine stress echocardiography, permits predictions and comparisons of outcomes that are more accurate and precise.M1

Traditionally, physicians and surgeons have talked with patients about "your chances" of "being alive" or "without pain" 1 year from now, or 5 or 15 years from now. A phrase such as "you have 95 chances out of a 100 of being alive for at least 10 more years" is frequently used, but such estimates have often been made on a qualitative basis. However, in an era when several different treatments are available, these types of predictions and comparisons for an individual patient with ischemic heart disease are often difficult to make. Fortunately, an enormous amount of information has been developed about effects of various risk factors on outcomes after different treatments for ischemic heart disease. Contrary to the belief of some, almost all this information is harmonious rather than internally conflicting. The remaining problem is efficient use of the data for (1) predicting and comparing for individual patients and (2) retrospectively evaluating quality of care and appropriateness of intervention (comparative effectiveness).A5,E2,P9

For most patients with congenital heart disease and for some with other diseases, the condition that requires surgical treatment is similar from patient to patient and is the dominant risk factor. This fact makes predicting and comparing for individual patients straightforward. In contrast, stenotic arteriosclerotic CAD varies enormously from patient to patient, and the variations themselves are powerful risk factors. Therefore, recommendations to patients on the basis of predictions and comparisons of outcomes in heterogeneous groups of patients are of little value. Patient-specific predictions and comparisons are required. General indications for CABG are discussed in the text that follows.

#### Stable Angina

Stable angina is usually well relieved by CABG, even though not permanently so; it can also be favorably influenced by modern medical treatment, and under many circumstances by PCI.B32,D15,E2,G38,H11,K8 Furthermore, it is well established that CABG can accomplish considerably more than simple relief of angina. Thus, presence of chronic stable angina unrelieved by medical treatment is no longer an automatic indication for CABG. Rather, duration of relief of angina and effect on time-related probability of survival must be the major considerations. These factors depend not only on presence of angina but also on all the patient-specific risk factors for unfavorable outcome events in patients with ischemic heart disease (see Box 7-1) and on procedural risk factors for the various interventions.

Patients with *mild* chronic stable angina (Canadian class I or II) can be considered to have mild reversible ischemia, which if confirmed by noninvasive testing, is not per se an indication for CABG or other forms of interventional therapy. However, severity and number of coronary stenoses, ischemic burden assessed by noninvasive testing, and severity of LV dysfunction may combine to give these patients better survival and relief of angina with interventionK24 (see Fig. 7-6). When a clear comparative benefit of CABG over PCI or medical treatment can be predicted for an individual patient with mild reversible ischemia, such as when important stenoses in all three systems and LV dysfunction are present, operation is usually indicated.K24

**Table 7-12** Incremental Risk Factors for Reintervention after Coronary Artery Bypass Grafting*<sup>a</sup>*

|                           |                                                  |       | Hazard Phase |      |
|---------------------------|--------------------------------------------------|-------|--------------|------|
|                           | Risk Factors                                     | Early | Constant     | Late |
| Patient Risk Factors      |                                                  |       |              |      |
| DEMOGRAPHIC               |                                                  |       |              |      |
|                           | Female                                           |       | •            |      |
| (Younger)                 | Age and female                                   | •     |              |      |
| (Lesser)                  | Weight and female                                | •     |              |      |
| (Greater)                 | Height                                           |       |              | •    |
| (Younger)                 | Age                                              |       | •            | •    |
|                           | SYMPTOMS OF REVERSIBLE ISCHEMIA                  |       |              |      |
| (Longer)                  | Anginal history                                  |       | •            |      |
| (Higher)                  | Unstable angina grade (not infarct)              | •     | •            |      |
| CARDIAC COMORBIDITY       |                                                  |       |              |      |
|                           | Preoperative left or right bundle branch block   |       | •            |      |
|                           | Aortic valve stenosis (moderate)                 |       | •            |      |
|                           | Left ventricular hypertrophy                     |       |              | •    |
| NONCARDIAC COMORBIDITY    |                                                  |       |              |      |
|                           | History of peripheral arterial disease           |       |              | •    |
| (Higher)                  | 1-second forced expiratory volume/vital capacity |       | •            |      |
| (Higher)                  | Triglyceride level                               |       |              | •    |
| LEFT VENTRICULAR FUNCTION |                                                  |       |              |      |
|                           | Preoperative anterior and septal infarct         | •     |              |      |
| CORONARY DISEASE          |                                                  |       |              |      |
| (Lesser)                  | Left main stenosis (%)                           |       | •            |      |
|                           | No left main stenosis > 90%                      |       |              | •    |
|                           | One- or two-system disease                       |       | •            |      |
| Procedural Risk Factors   |                                                  |       |              |      |
| CORONARY OPERATION        |                                                  |       |              |      |
|                           | No graft to LAD                                  |       | •            |      |
|                           | Venous graft to LAD                              |       |              | •    |
| (Absence)                 | Two or more internal thoracic artery anastomoses |       |              | •    |
| (More)                    | Distals from venous grafts                       |       |              | •    |
|                           | Incomplete revascularization                     | •     |              |      |
| INSTITUTIONAL EXPERIENCE  |                                                  |       |              |      |
| (Recent)                  | Date of operation                                |       |              | •    |
|                           | One surgeon                                      |       | •            |      |
| (Lower)                   | Preceding year per surgeon volume                | •     |              |      |
|                           |                                                  |       |              |      |

Data from Sergeant and colleaguesS27; KU Leuven, 1971-1992; *n* = 9600. Includes only variables present before first CABG and procedural variables at first CABG. Key: *LAD,* Left anterior descending coronary artery.

When chronic stable angina is *moderate* or *severe* (Canadian class III or IV) despite optimal medical treatment, interventional therapy is usually advisable. When important stenoses are present in only one system, PCI often suffices.P5 Although no benefit on mortality has been demonstrated with PCI compared with medical therapy in this setting, more patients treated with PCI are free from angina at 1 and 5 years.K24 In patients with two-system disease without proximal LAD disease and no or minimal LV dysfunction, randomized trials and meta-analyses indicate that there is no or only a modest survival benefit with CABG compared with PCI, but up to a fivefold reduction in need for reintervention.K24 For patients with high-grade stenosis of the proximal LAD in the setting of two-system disease (particularly with demonstrable ischemia on noninvasive testing and depressed LV function), CABG is preferred over PCI.K24 When important stenoses are present in all three systems, or if left main coronary stenosis is present, CABG is indicated

![](_page_54_Figure_2.jpeg)

**Figure 7-44** Nomograms illustrating strength and shape of risk factors for reintervention after coronary artery bypass grafting (CABG) in KU Leuven experience. **A,** Effect of age at initial CABG, depicted along horizontal axis. Predicted percent freedom is along vertical axis. Isobars represent interval between time of first CABG and time of estimation of prevalence of reintervention. **B,** Effect of using internal thoracic artery *(ITA)* as a conduit to left anterior descending coronary artery *(LAD)* at first CABG. (From Sergeant and colleaguesS27; KU Leuven, 1971-1992; *n* = 9600.)

![](_page_54_Figure_4.jpeg)

**Figure 7-45** Comparison of survival after nonrandomly assigned coronary artery bypass grafting (CABG *[Surgical]*) with initial medical treatment in patients with three-system disease and severe angina, according to severity of left ventricular *(LV)* dysfunction.M35 Symbols represent published nonparametric estimates. Solid line enclosed within dashed CLs are parametric estimates. For survival estimates, CLs are 70%; for survival differences, CLs are 90%. **A,** Survival in patients with mild LV dysfunction. **B,** Comparative benefit, indicating that surgical benefit is unlikely to be caused by chance alone. **C,** Depiction similar to **A**, but in patients with severe LV dysfunction. Survival 1 month and 5 years after CABG is less than when LV dysfunction is mild, whereas survival after initial medical treatment is much less when LV dysfunction is severe. **D,** Depiction similar to **B**, but in patients with severe LV dysfunction. This emphasizes that surgical benefit is greater when LV dysfunction is severe than when it is mild, even though 1-month and 5-year survival after CABG are lower than when dysfunction is mild. Key: *CASS,* Coronary Artery Surgery Study. (From ACC/AHA Guidelines and Indications for Coronary Artery Bypass Graft Surgery.A5)

and preferred because it provides a survival advantage and a marked reduction in need for repeat intervention compared with PCI.K24,P9

# Number of Systems with Important Stenoses

# *Left Main Stenosis*

In general, stenosis of at least 50% in the left main coronary artery, either alone or in combination with stenoses in other coronary arteries, confers a sufficiently poor survival prognosis with medical treatment, and CABG is generally indicated.C20,L25 This is true even when the angina is well controlled by medical treatment or the patient is asymptomatic.T5 The more severe the left main stenosis, the more urgent the need for CABG. There is emerging evidence that PCI in lower-risk subsets of patients with left main stenosis provides equivalent outcomes to CABG at least for the first 3 years after intervention.N2 However, there is a fourfold increase in repeat revascularization with longer follow-up.K24,P7

# *Three-System Disease*

In general, patients with good LV function and mild or moderate reversible ischemia have a sufficiently good outlook with noninterventional therapy that CABG or PCI need not be advised as initial therapy, even with threesystem diseaseB32,M34 (Fig. 7-46, *A*). Periodic reevaluation is clearly indicated, however, because change in any one of a number of variables may make CABG advisable. If patients in this category have impaired LV function, their long-term prognosis with medical treatment is sufficiently poor and the prognosis after CABG sufficiently good that CABG is indicated, even though survival is similar at 5 years (Fig. 7-46, *B*).

When one or more important proximal stenoses are part of the three-system disease, particularly when one is in the LAD, in general the prognosis with noninterventional therapy becomes less favorable, whereas that after CABG is not adversely affected.M34,V6 Thus, even with mild angina and good LV function, CABG is indicated and preferred over PCI when one or more important proximal stenoses coexist with three-system disease.E2,K24,P9

# *Two-System Disease*

In general, PCI appears to be effective interventional therapy for many patients with important (at least 50% stenoses) twosystem CAD.G9,K24 Also, prognosis with medical treatment is considerably better in patients with two-system disease than in those with three-system disease.V9 Thus, CABG is not indicated in the majority of patients with mild angina and two-system disease. However, when such patients have left main equivalent disease, a severe proximal stenosis in the LAD, or impaired LV function, CABG is indicated.E2,K24,P9

Indications for CABG are stronger when angina is more severe (Canadian class III or IV). These indications are in addition to those described for patients with two-system disease without proximal LAD stenosis, but with a large area of viable myocardium and high-risk criteria on noninvasive testing.E2,K24,P7

# *Single-System Disease*

CABG is infrequently indicated for patients with singlesystem disease. Results of CABG in this setting are

![](_page_55_Figure_14.jpeg)

![](_page_55_Figure_15.jpeg)

**Figure 7-46** Survival after medical treatment and after coronary artery bypass grafting *(Surgical)* in a group of patients who are heterogeneous except for all having three-system coronary artery disease (generalizations from Fig. 7-45 pertain). Format is as in Fig. 7-45. **A,** Patients with normal left ventricular (LV) function. **B,** Patients with moderate LV dysfunction. (Modified from Myers and colleagues.M34)

excellent,L36 but results of medical treatment and of PCI are also good, although probably not as long lasting.F19 Bypass of the LAD with the ITA is an appropriate option in asymptomatic and symptomatic patients with proximal LAD stenosis and evidence of extensive ischemia on noninvasive testing or depressed EF (<50%).B49,E2 Results of metaanalyses comparing CABG and PCI in this setting demonstrate no significant difference in mortality or stroke, but a threefold increase in recurrent angina and a fivefold increase in repeat targetvessel revascularization with PCI at 5 years.A28,K2

#### Left Ventricular Function

Patients with good LV function have a good prognosis with medical treatment, even in the presence of important threesystem disease, but in many patients, survival is not improved by immediate CABG (see Fig. 7-46, *A*). Depressed LV function adversely affects outcome after CABG, even though in general the *comparative* benefit of CABG (vis-à-vis medical treatment) is greater the more depressed the LV function, and indications for operation are more compellingF5 (Fig. 7-47). However, risks and benefits of CABG become more uncertain when resting LVEF is less than 30%, and

![](_page_56_Figure_2.jpeg)

**Figure 7-47** Survival after nonrandomly assigned medical treatment and coronary bypass grafting (*Surgical*) treatment in patients with three-system coronary artery disease and severe angina. Format is as in Fig. 7-45. **A**, Patients with normal left ventricular (LV) function. **B**, Patients with moderate LV dysfunction (Coronary Artery Surgery Study [CASS] LV score = 10 to 15). **C**, Patients with severe LV dysfunction (CASS LV score = 16 to 30). (Modified from Myers and colleagues.<sup>M34</sup>)

particularly when it is less than 20% (see "Left Ventricular Dysfunction" under Natural History earlier in this chapter). In some circumstances, risks of CABG may outweigh potential benefits when EF is less than 20%. In some patients, even severe reductions in resting EF can result from myocardial "hibernation," and evidence indicates they benefit from

CABG. A11,E12 Exercise or resting thallium-201 scintigraphy, especially using the technique of enhancement by reinjection of thallium, D18 may be particularly helpful in distinguishing between scar (which would contraindicate interventional therapy) and ischemia. Dobutamine stress echocardiography, positron emission tomographic (PET) scanning, and cardiac magnetic resonance imaging A2 can also distinguish ischemic or hibernating myocardium from scar.

Performing CABG "prophylactically" in asymptomatic patients who have preserved LV function without noninvasive evidence for ischemia is undesirable from several standpoints. Medical treatment, including specific measures against unfavorable lipid profiles, may considerably or even indefinitely delay need for interventional therapy. Duration of the favorable effect of CABG appears to be finite, and for this reason alone, CABG should be delayed as long as is safe for the patient. Ideally, methods for prediction of the imminence of acute MI (the sequelae of which are the usual causes of depressed LV function) should be perfected so that CABG can be performed at the most appropriate time.

#### Unstable Angina

Unstable angina is usually best managed initially by intense medical treatment; surgical intervention in the presence of ongoing ischemic instability is rarely required. B57,Y2 (In this discussion the description of "unstable angina" in the ACC/AHA Joint Task Force Subcommittee report is used. A5)

Once the unstable state is controlled and the patient has been evaluated with noninvasive and invasive studies, the usual indications for CABG pertain. In some situations, however, indications for interventional therapy of some type become stronger than in patients with stable angina. C32 Indications are particularly strong in patients with left main or left main equivalent disease, three-system disease, LV dysfunction, ongoing ischemia, or angina at rest. E2,P6,S37 Indications are less strong in the subset of patients with unstable angina who have "new-onset angina."

# Uncomplicated Non–Q-Wave Myocardial Infarction or Non–ST-Segment Elevation Acute Coronary Syndrome

In general, patients with non–Q-wave MI or non–ST-segment elevation acute coronary syndrome have the same indications for CABG (and for the same reasons) as patients with unstable angina.

# Uncomplicated Q-Wave or ST-Segment Elevation Myocardial Infarction

In an era of increasing success with thrombolytic therapy for acute MI,  $^{G4,M9,R7,R8,R19}$  and more recently with PCI,  $^{F15,M20}$  CABG is infrequently indicated to treat patients with uncomplicated MI. However, contrary opinions to this approach exist.  $^{B20,D12,D13,S19}$ 

When important angina persists early after an episode of acute MI, indications for operation are identical to those for unstable angina, G8,J11,K29 and results are almost as good. Because early risks of undertaking CABG after acute MI are less the longer the interval since onset of the episode, delaying the procedure for a minimum of 48 hours is often advisable. B52,C40,H2,W10

# Myocardial Infarction with Hemodynamic Deterioration

Acute hemodynamic deterioration is a serious and often fatal complication of ongoing MI, and delay in interventional therapy is probably disadvantageous. There is little doubt that more than 50% of patients with this complication can be salvaged by emergency CABG.A15,B19,B34,K14,L5,M19,N5 However, PCI is also effective in this setting.G17,H19,H20,L11

When CABG is used for patients with acute hemodynamic deterioration during ongoing MI, an effective regimen of myocardial management is essentialA14,A15 (see "Cold Cardioplegic, Controlled Aortic Root Reperfusion, and [When Needed] Warm Cardioplegic Induction" in Chapter 3). Even then, recovery of some patients may not be possible, because patients in whom cardiogenic shock develops during an episode of acute MI are often elderly, have a low EF on admission, a history of previous infarctions and coronary artery interventions, and a particularly large area of acute infarction. These are all important risk factors for death in this setting.A24,H7,M19

# Acute Complications during Percutaneous Coronary Intervention

Emergency CABG is indicated after unsuccessful PCI when hemodynamic compromise occurs or when there is evidence of ongoing ischemia or threatened occlusion of a major coronary artery with substantial myocardium at risk. Removal of a fractured guidewire or an undeployed stent may occasionally be required.E2 If the hemodynamic state is severely compromised, CPB can be initiated in the catheterization laboratory (see "Cardiopulmonary Bypass Established by Peripheral Cannulation" in Section III of Chapter 2). When CABG is performed under these conditions, myocardial management should be that described under "Myocardial Infarction with Hemodynamic Deterioration" earlier in this chapter.

Emergency CABG under the circumstances just described is associated with higher mortality and occurrence of perioperative infarction than elective CABG.B43,C39,L2 Factors that affect outcome include presence of cardiogenic shock, older age, LV dysfunction, previous infarction, and previous CABG. With increasing use of intracoronary stents, frequency of emergency CABG after PCI has declined.L16

# Recurring Myocardial Ischemia

Evidence of return of important myocardial ischemia and symptoms may require consideration of repeat CABG. When these symptoms develop and cineangiographic study shows that progression of native-vessel disease is etiologic, PCI is indicated. PCI to the native-vessel disease for which bypass grafting was originally performed is occasionally possible, but in many cases these vessels have occluded by the time reintervention is under consideration.

When the cause of the recurring myocardial ischemia is graft disease, PCI is less effective and risks distal embolization of debris. Stenting of vein grafts is more effective in this setting than balloon angioplasty.S8

If PCI is not feasible, CABG is indicated in patients with moderate or severe angina despite optimal medical treatment if bypassable vessels are present in at least one system with noninvasive evidence for myocardium at risk (but preferably two or more systems). CABG may be the sole therapy or combined with transmyocardial laser revascularization.F17

# SPECIAL SITUATIONS AND CONTROVERSIES

### Coronary Artery Bypass Surgery versus Percutaneous Coronary Intervention

PCI is now an established method of management for many patients with arteriosclerotic CAD. Although initially used for treating single-system disease,G38 PCI is currently being applied to patients with multisystem disease, including left main coronary artery stenosis. In addition to being less invasive, the advantages of PCI over CABG include shorter period of initial hospitalization and shorter recovery time. Disadvantages of PCI as the initial intervention include restenosis of the treated arteries and a higher prevalence of target-vessel revascularization. In general, a lesser degree of revascularization is achieved with PCI than with CABG in comparable patients.

During the 1990s, results of nine randomized clinical trials comparing PCI and CABG were published. Outcomes with respect to the major end points examined were summarized in a document jointly published by the American College of Cardiology and American Heart AssociationE2 (Table 7-13). Several inferences can be drawn from these studies. Early mortality was comparable for the two interventions. Prevalence of early Q-wave MI was generally higher among the CABG patients, but this was unlikely due to chance in only two of the trials. Using a weighted average, prevalence was 4.1% among the CABG patients and 2.3% among the PCI patients. Initial costs and length of stay were lower for PCI than for CABG. Patients with PCI were able to exercise more at 1 month and return to work sooner.P15 In the Balloon Angioplasty Revascularization Investigation (BARI) and the Emory Angioplasty versus Surgery Trial (EAST), extent of revascularization achieved with CABG was higher than with PCI.B70,K13

When late results were examined, there was no statistically significant difference in survival in any of the nine trials at follow-up periods ranging from 1 to 5 years (see Table 7-13).E2 In the subset of patients with diabetes, however, all-cause mortality and cardiac mortality were higher in those treated with PCI in BARI (35% vs. 19% and 11% vs. 5.8%, respectively).E2 A similar finding in diabetic patients was observed in the Coronary Angioplasty versus Bypass Revascularisation Investigation (CABRI),F11 but not in EAST.K13

No difference in prevalence of Q-wave MI or the combined end point of death and MI was demonstrated in any of the trials (see Table 7-13) or in subsequent metaanalyses.P16,S45 Most of the trials found that CABG resulted in greater freedom from angina.

The most striking difference between CABG and PCI was need for subsequent procedures. Prevalence was 4 to 10 times higher for PCI in every trial (see Table 7-13).E2

In several studies that examined quality of life and cost, physical activity and employment were similar for both procedures after 3 years, and functional status was equivalent at 5 years in BARI.H18,P15 Employment and emotional health were also similar.E2,W9 The early cost benefit of PCI decreased during follow-up because of more frequent need for repeat procedures and hospitalization.E2,H18,P16,S17,W9

**Table 7-13** Comparison between Coronary artery Bypass Grafting and Percutaneous Coronary Intervention in Nine Randomized Controlled Trials

|             |                   |       |      |                      |                      |              |       | Acute Outcome (5) |              |                         |                  | Late Outcome (%) |                       |                          |
|-------------|-------------------|-------|------|----------------------|----------------------|--------------|-------|-------------------|--------------|-------------------------|------------------|------------------|-----------------------|--------------------------|
| Triala      | (% Female)<br>Age | CAD   | n    | End Point<br>Primary | Follow-up<br>(Years) | Intervention | Death | Wave<br>Ml<br>Q-  | Hosp<br>CABG | Early and<br>Late Death | Wave<br>Ml<br>Q- | Angina           | Reintervention<br>(%) | End Point (%)<br>Primary |
| BARIB70     | 61 (26)           | MV    | 1792 | D                    | 5c                   | CABG         | 1.3   | 4.6               |              | 10.7                    | 19.6             |                  | 8                     | 10.7                     |
|             |                   |       |      |                      |                      | PCI          | 1.1   | 2.1               | 6.3          | 13.7                    | 21.3             |                  | 54                    | 13.7                     |
| EASTK13     | 61 (26)           | MV    | 392  | D+MI+T               | 3                    | CABG         | 1.0   | 10.3              |              | 6.2                     | 19.6             | 12               | 13                    | 27.3                     |
|             |                   |       |      |                      |                      | PCI          | 1.0   | 3.0b              | 10.1         | 7.1                     | 16.6             | 20               | 54                    | 28.8                     |
| GABIH5      | (20)              | MV    | 359  | A                    | 1                    | CABG         | 2.5   | 8.0               |              | 6.5                     | 9.4              | 26               | 6                     | 26.0                     |
|             |                   |       |      |                      |                      | PCI          | 1.1   | 2.3b              | 8.5          | 2.6                     | 4.5              | 29               | 44                    | 29.0                     |
| ToulouseC10 | 67 (23)           | MV    | 152  | A                    | 5                    | CABG         | 1.3   | 6.6               |              | 10.5                    | 1.3              | 5.3              | 9                     | 5.2                      |
|             |                   |       |      |                      |                      | PCI          | 1.3   | 3.9               | 3.9          | 13.2                    | 5.3              | 21.1b            | 29                    | 21.1b                    |
| RITAC37     | 57 (19)           | SV+   | 1011 | D+MI                 | 212d                 | CABG         | 1.2   | 2.4               |              | 3.6                     | 5.2              | 21.5             | 4                     | 8.6                      |
|             |                   | MVc   |      |                      |                      | PCI          | 0.8   | 3.5               | 4.5          | 3.1                     | 6.7              | 31.3             | 31                    | 9.8                      |
| ERACIR18    | 58 (13)           | MV    | 127  | D+MI+A+RR            | 1                    | CABG         | 4.6   | 6.2               |              | 4.7                     | 7.8              | 3.2              | 6                     | 23                       |
|             |                   |       |      |                      |                      | PCI          | 1.5   | 6.3               | 1.5          | 9.5                     | 7.8              | 4.8              | 37                    | 53b                      |
| MASSH29     | 56 (42)           | SV    | 142  | D+MI+RR              | 3                    | CABG         | 1.4   | 1.4               |              |                         |                  | 2                | 0                     | 3.0                      |
|             |                   | (LAD) |      |                      |                      | PCI          | 1.4   | 0                 | 11           |                         |                  | 18               | 22                    | 24b                      |
| LausanneG23 | 56 (20)           | SV    | 134  | D+MI+RR              | 2d                   | CABG         | 0     | 0                 |              | 1.5                     | 1.5              | 5                | 3                     | 7.6                      |
|             |                   | (LAD) |      |                      |                      | PCI          | 0     | 0                 | 2.9          | 0                       | 2.9              | 6                | 25                    | 36.8b                    |
| CABRIF11    | 60 (22)           | MV    | 1054 | D                    | 1                    | CABG         | 1.3   |                   |              | 2.7                     | 3.5              | 10.1             | 9                     | 2.7                      |
|             |                   |       |      |                      |                      | PCI          | 1.3   |                   |              | 3.9                     | 4.9              | 13.9b            | 36                    | 3.9                      |
| Weighted    | 60 (23)           |       |      |                      |                      | CABG         | 1.3   | 4.1               |              | 6.5                     | 11.3             | 10.4             | 7.3                   |                          |
| average     |                   |       |      |                      |                      | PCI          | 1.0   | 2.3               | 5.9          | 7.7                     | 11.0             | 15.5             | 42.3                  |                          |
|             |                   |       |      |                      |                      |              |       |                   |              |                         |                  |                  |                       |                          |

Data from Eagle and colleagues.E2

Key: *A,* Angina; *BARI,* Balloon Angioplasty Revascularization Investigation; *CABG,* coronary artery bypass grafting; *CABRI,* Coronary Angioplasty versus Bypass Revascularisation Investigation; *CAD,* coronary artery disease; *D,* death; *EAST,* Emory Angioplasty versus Surgery Trial; *ERAC1,* Estudio Randomizado Argentino de Angioplastia versus Cirugia; *GABI,* German Angioplasty Bypass Surgery Investigation; *Hosp CABG,* required CABG after PCI and before hospital discharge; *LAD,* left anterior descending coronary artery; *MASS,* Medicine, Angioplasty, or Surgery Study; *MI,* myocardial infarction; *MV,* multivessel; *PCI,* percutaneous coronary intervention; *RITA,* Randomised Intervention Treatment of Angina; *RR,* repeated revascularization; *SV,* single vessel; *T,* thallium defect.

*aP* < .05 comparing CABG and PCI cohorts.

*bP* < .05 comparing CABG and PCI cohorts.

*c*Included total occlusion.

*d*Planned 5-year follow-up (interim results).

It must be emphasized that, for the most part, these trials excluded patients in whom survival had previously been shown to be better with CABG compared with medical therapy (i.e., patients with left main CAD, patients with multisystem disease and impaired LV function). To achieve a high degree of validity, randomized trials of this type must have high compliance with the original treatment, and only a small percentage of patients should cross over to the other form of therapy. Patients who are randomized must also be similar to those patients who are not enrolled to permit generalization of the findings. Many of the randomized trials conducted to date have been deficient in one or more of these categories.E2 In addition, major advances in technology have occurred with both forms of treatment since these trials were completed, most notably use of intracoronary stents followed by drug-eluting stents in PCI patients, and multiple arterial grafts in patients undergoing CABG. Use of stents has substantially reduced need for urgent CABG and subsequent interventions, including repeat CABG.M31 Nevertheless, results of these randomized trials, meta-analyses based on them, and results of large observational studies provide useful information that permits selection of the most appropriate form of interventional therapy for the individual patient with coronary arteriosclerotic heart disease.

#### Endarterectomy

Although some surgeons freequently use endarterectomy, particularly in the distal RCA, most prefer to use the more distal branches of this artery for anastomosis to a bypass graft rather than endarterectomize the parent trunk and graft to it. Some surgeons continue to employ long endarterectomies, even in the LAD, and report good results.B53,P8,Q2

Lower patency of grafts to endarterectomized arteries has been reported. Yeh and colleagues reported graft patency of 64% when endarterectomy was done to the artery grafted, compared with 92% when endarterectomy was not done.Y3 However, many studies suggest that patency and flow in grafts to endarterectomized arteries compare favorably with those to nonendarterectomized arteries. Whether perioperative MI is more likely to occur when endarterectomy is employed is controversial,M22 as is the relative completeness of revascularization that can be achieved with the two techniques.

#### Surgical Angioplasty

Surgical angioplasty of major coronary artery branches has limited value. However, some surgeons have successfully used angioplasty for the left main coronary artery and to a lesser extent for ostial lesions of the RCA.D11,D19,M15,S2

For the left main coronary artery, the anterior approach is preferable. With CPB and appropriate myocardial management, the pulmonary trunk is dissected away from the ascending aorta, and the left main coronary artery is exposed. The pulmonary artery can be divided to facilitate exposure.M15 An incision in the aorta just anterior to the left main coronary artery is extended a variable distance onto the left main artery. After excising arteriosclerotic debris, patch-graft enlargement is performed using saphenous vein, autologous pericardium, or a segment of the ITA.D19,M15,R1,S62 Contraindications to this approach include extensive calcification of the left main coronary artery, bifurcation involvement, and older age.

# Small Distal Vessels

Small distal vessel size does not represent a contraindication to operation. Levin and colleagues found that bypass grafts could be successfully placed in 73% of vessels considered inadequate because of severe distal narrowing or absence of filling on the angiogram.L13

### Transmyocardial Laser Revascularization

In the 1950s, Goldman and colleaguesG18 and Massimo and BoffiM12 proposed that conduits could be created in the subendocardium through the LV cavity to direct blood through the coronary sinusoids and into ischemic areas of the myocardium. Subsequently, Sen and colleagues used direct needle acupuncture to create communicating channels in ischemic myocardium.S22 Mihroseini and CaytonM26 and Okada and colleaguesO4 used a laser to create transmyocardial channels. Initial observational studies in patients with severe angina who underwent transmyocardial laser revascularization (TMLR) suggested that the procedure improved symptoms.H22,H23

Currently, TMLR is performed with a carbon dioxide or holmium laser. In a typical procedure, 10 to 50 channels are created in areas of ischemic myocardium. If TMLR is the sole therapy, a left anterior thoracotomy is made, and the procedure is performed without use of CPB. TMLR can also be performed in conjunction with primary or repeat CABG using CPB or with OPCAB. Laser channels are created in ischemic areas that are not amenable to bypass grafting.

Four randomized clinical trials compared TMLR with medical therapy in patients with severe angina refractory to medical treatment, reversible ischemia of the LV wall, and CAD not amenable to CABG or PCI. Findings indicated that TMLR results in substantial improvement in symptoms.A1,A19,F17,S12 In three of the trials, sustained relief of angina at 5 years was greater in the TMLR patients.A2,A17,H22 Exercise tolerance was not improved in the two studies that evaluated it.A1,S12 In two of the three trials in which myocardial perfusion was assessed at rest and during stress, TMLR did not improve it.A19,S12 In the third study, magnitude of improvement in symptoms was disproportionate to improvement in perfusion.F17 TMLR was not associated with improved LV systolic function or survival 1 year after enrollment.

Mechanisms of action for TMLR remain unclear. These include placebo effect, creating channels that provide increased blood flow to the ischemic myocardium, proliferation of new blood vessels (angiogenesis), denervation of ischemic myocardium, and infarction of ischemic myocardium.

TMLR can be performed with hospital mortality not exceeding 5% to 10% in properly selected patients.A18,A19,B68,F17,H23,S12 It can be performed as adjunctive therapy in patients undergoing CABG who would be incompletely revascularized by CABG alone. Superior relief of angina at 5 years has been demonstrated in a randomized trial.A20 Guidelines for TMRL as sole therapy or in combination with CABG have been published by the Society of Thoracic Surgeons.B31

#### Gene Therapy

Enhanced understanding of the molecular biology of vascular cell activation and proliferation has resulted in development of interventions at the level of gene expression to enhance the microcirculation of ischemic muscle and alter the course of vein graft atherosclerosis. *Vascular endothelial growth factor* (VEGF) has been administered to patients with ischemic myocardium as sole therapy by direct injection using a mini-thoracotomy or as an adjunct to CABG.L28,R23,V1 *Human fibroblast growth factor* (FGF) has been used for a similar purpose.P10,S14 These studies have demonstrated evidence for improved myocardial perfusion in treated areas of the LV and improvement in symptoms early after treatment.

Ehsan and colleagues have demonstrated experimentally that a single intraoperative transfection of vein grafts with a decoy oligonucleotide that blocks cell-cycle gene transactivation, provides long-term resistance to neointimal hyperplasia and atherosclerosis.E11 This has resulted in a reduction in primary graft failure unlikely to be due to chance when used in high-risk patients having CABG or peripheral arterial occlusions.M6 However, a large randomized trial of more than 3000 patients whose vein grafts were treated with oligonucleotide or placebo failed to demonstrate higher patency of the treated grafts at 12 to 18 months.A12

# Combined Carotid and Coronary Artery Disease

Carotid artery disease is an important risk factor for stroke after CABG.D1,F1,R15 Hemodynamically significant carotid artery stenoses are associated with as many as 30% of strokes occurring after CABG.D1 Prevalence of hemodynamically significant carotid artery disease among patients undergoing CABG increases with increasing age. In a nonconsecutive series of 1087 patients 65 years of age and older undergoing cardiac surgical procedures (91% with CAD) who had preoperative carotid duplex ultrasonography, prevalence of a 50% or greater stenosis of one or both carotid arteries was 17%; for an 80% or greater stenosis, it was 5.9%.B18 Prevalence of a 50% or greater stenosis was 8% in patients between ages 65 and 69, increasing to 17% for patients age 80 and older. Incremental risk factors for presence of an 80% or greater stenosis were a previous history of transient ischemic attack or stroke, female gender, left main coronary artery disease, peripheral arterial disease, and history of smoking.

Presence or absence of a cervical bruit is poorly predictive of high-grade stenosis even in the setting of known symptomatic carotid artery disease (sensitivity 63%, specificity 61%).S7 Carotid duplex ultrasonography is currently the most widely used preoperative screening technique to detect important carotid artery disease in patients undergoing CABG. It is used selectively in some centers and routinely in others to detect disease in older patients. If the preoperative carotid duplex study demonstrates high-grade (>75% to 80%) stenosis, and the patient's hemodynamic state is stable with no critically stenotic coronary arteries, carotid angiography is usually performed. Carotid and CABG procedures are staged, performing the carotid endarterectomy first. If the patient is hemodynamically unstable, or if there is high-grade left main coronary artery or proximal LAD disease, the carotid angiogram is often omitted, and a combined carotid and CABG procedure is performed.M11 This approach is justified because prophylactic carotid endarterectomy has been shown to be superior to conservative therapy for preventing stroke in symptomatic or asymptomatic patients with high-grade stenosis, and carotid artery disease is an important risk factor for stroke in patients with CAD.E14,E15,N10

When a combined procedure is performed, carotid endarterectomy may be done before CPB is established. Alternatively, endarterectomy can be performed during hypothermic CPB, which may provide additional brain protection during occlusion of the carotid artery. In patients with severe stenosis of one carotid artery and severe stenosis or occlusion of the contralateral carotid artery, deep hypothermia with or without a brief interval of circulatory arrest may be advantageous.K27

Superiority of the combined vs. staged approach has not been established by prospective trials. An individualized, patient-specific approach, with the decision based on symptoms and relative severity of the carotid and coronary artery disease, appears prudent and is used in many institutions.E2,S70 In experienced centers, staged or concomitant carotid endarterectomy and CABG can be accomplished with an early mortality that does not exceed 4%, stroke occurrence of less than 4%, and 10-year freedom from stroke of 88% to 96%.A10,C17,F1,R14,V8,W12

### Coronary Artery Aneurysm and Dissection

*Coronary artery aneurysm* is a localized dilatation that is saccular or fusiform in shape and exceeds the diameter of normal adjacent segments or the diameter of the patient's largest coronary artery by 1.5 times. In patients undergoing coronary angiography, prevalence ranges from 0.4% to 4.9%.S69 The majority of coronary aneurysms are arteriosclerotic in origin. These aneurysms may also be congenital, result from Kawasaki disease, or develop after PCI. Aneurysms occur most often in the RCA; the left main coronary artery is involved infrequently.

No clinical features distinguish coronary aneurysms, and the natural history is largely unknown. Diagnosis is usually made by coronary angiography. Rupture was reported in 12% of a series of 53 autopsied cases reported by Daoud and colleagues in 1963.D2 In CASS, however, which included more than 20,000 patients who underwent coronary angiography, no case of rupture was observed among 978 patients in whom coronary artery aneurysms were detected.S68 Thrombus develops in these aneurysms and may be a source for distal embolization.B22 Bypass grafting of an artery containing an aneurysm, with or without ligation of the artery distal to the aneurysm, may be indicated in patients who have important occlusive disease in the artery or evidence of distal embolization in the absence of occlusive disease.A9,A13,A22,E3

*Coronary artery dissection* is a rare cause of ischemic heart disease and sudden death. Coronary dissection can occur spontaneously or result from aortic dissection, blunt chest trauma, cardiac catheterization, coronary angioplasty, or CABG.B11,D6,L29 Dissection has been observed after intense physical exercise and cocaine abuse.E13,J2 Predisposing factors include arteriosclerotic CAD, pregnancy, and Marfan and Ehlers-Danlos syndromes. Sudden death is the most frequent clinical presentation. In patients who survive the initial event, medical therapy is appropriate for those without ongoing ischemia. Stenting or CABG is advisable for symptomatic patients.B35,D6,H27,K19,O5 Patients with dissection of the left main coronary artery should undergo CABG.T9